id	sid	tid	token	lemma	pos
chd-120	1	1	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	AUX
chd-120	1	2	e1	e1	NOUN
chd-120	1	3	cancer	cancer	NOUN
chd-120	1	4	health	health	NOUN
chd-120	1	5	disparities	disparity	NOUN
chd-120	1	6	research	research	VERB
chd-120	1	7	epidemiology	epidemiology	NOUN
chd-120	1	8	of	of	ADP
chd-120	1	9	prostate	prostate	NOUN
chd-120	1	10	cancer	cancer	NOUN
chd-120	1	11	in	in	ADP
chd-120	1	12	nigeria	nigeria	PROPN
chd-120	1	13	:	:	PUNCT
chd-120	1	14	observations	observation	NOUN
chd-120	1	15	at	at	ADP
chd-120	1	16	lagos	lagos	PROPN
chd-120	1	17	state	state	NOUN
chd-120	1	18	university	university	PROPN
chd-120	1	19	teaching	teaching	NOUN
chd-120	1	20	hospital	hospital	NOUN
chd-120	1	21	⃰emiogun	⃰emiogun	PROPN
chd-120	1	22	festus	festus	PROPN
chd-120	1	23	edobor	edobor	PROPN
chd-120	1	24	,	,	PUNCT
chd-120	1	25	williams	williams	PROPN
chd-120	1	26	oluwaseun	oluwaseun	PROPN
chd-120	1	27	olatunde	olatunde	PROPN
chd-120	1	28	,	,	PUNCT
chd-120	1	29	obafunwa	obafunwa	PROPN
chd-120	1	30	john	john	PROPN
chd-120	1	31	oladapo	oladapo	PROPN
chd-120	1	32	department	department	PROPN
chd-120	1	33	of	of	ADP
chd-120	1	34	pathology	pathology	PROPN
chd-120	1	35	and	and	CCONJ
chd-120	1	36	forensic	forensic	ADJ
chd-120	1	37	medicine	medicine	NOUN
chd-120	1	38	,	,	PUNCT
chd-120	1	39	lagos	lagos	NOUN
chd-120	1	40	state	state	NOUN
chd-120	1	41	university	university	PROPN
chd-120	1	42	teaching	teaching	NOUN
chd-120	1	43	hospital	hospital	NOUN
chd-120	1	44	,	,	PUNCT
chd-120	1	45	1	1	NUM
chd-120	1	46	–	–	SYM
chd-120	1	47	5	5	NUM
chd-120	1	48	oba	oba	PROPN
chd-120	1	49	akinjobi	akinjobi	PROPN
chd-120	1	50	way	way	NOUN
chd-120	1	51	,	,	PUNCT
chd-120	1	52	ikeja	ikeja	NOUN
chd-120	1	53	,	,	PUNCT
chd-120	1	54	lagos	lago	NOUN
chd-120	1	55	,	,	PUNCT
chd-120	1	56	nigeria	nigeria	PROPN
chd-120	1	57	.	.	PUNCT
chd-120	2	1	*	*	PUNCT
chd-120	2	2	corresponding	correspond	VERB
chd-120	2	3	author	author	NOUN
chd-120	2	4	:	:	PUNCT
chd-120	2	5	e	e	NOUN
chd-120	2	6	-	-	NOUN
chd-120	2	7	mail	mail	NOUN
chd-120	2	8	:	:	PUNCT
chd-120	2	9	edos2infinity@yahoo.com	edos2infinity@yahoo.com	X
chd-120	2	10	abstract	abstract	ADJ
chd-120	2	11	prostate	prostate	NOUN
chd-120	2	12	cancer	cancer	NOUN
chd-120	2	13	is	be	AUX
chd-120	2	14	a	a	DET
chd-120	2	15	leading	lead	VERB
chd-120	2	16	cause	cause	NOUN
chd-120	2	17	of	of	ADP
chd-120	2	18	morbidity	morbidity	NOUN
chd-120	2	19	and	and	CCONJ
chd-120	2	20	mortality	mortality	NOUN
chd-120	2	21	among	among	ADP
chd-120	2	22	men	man	NOUN
chd-120	2	23	,	,	PUNCT
chd-120	2	24	especially	especially	ADV
chd-120	2	25	of	of	ADP
chd-120	2	26	african	african	ADJ
chd-120	2	27	descent	descent	NOUN
chd-120	2	28	.	.	PUNCT
chd-120	3	1	over	over	ADP
chd-120	3	2	the	the	DET
chd-120	3	3	years	year	NOUN
chd-120	3	4	,	,	PUNCT
chd-120	3	5	there	there	PRON
chd-120	3	6	has	have	AUX
chd-120	3	7	been	be	AUX
chd-120	3	8	relative	relative	ADJ
chd-120	3	9	paucity	paucity	NOUN
chd-120	3	10	of	of	ADP
chd-120	3	11	research	research	NOUN
chd-120	3	12	work	work	NOUN
chd-120	3	13	on	on	ADP
chd-120	3	14	the	the	DET
chd-120	3	15	subject	subject	NOUN
chd-120	3	16	of	of	ADP
chd-120	3	17	prostate	prostate	NOUN
chd-120	3	18	cancer	cancer	NOUN
chd-120	3	19	in	in	ADP
chd-120	3	20	sub	sub	ADJ
chd-120	3	21	-	-	ADJ
chd-120	3	22	saharan	saharan	ADJ
chd-120	3	23	africa	africa	PROPN
chd-120	3	24	.	.	PUNCT
chd-120	4	1	the	the	DET
chd-120	4	2	objective	objective	NOUN
chd-120	4	3	of	of	ADP
chd-120	4	4	the	the	DET
chd-120	4	5	study	study	NOUN
chd-120	4	6	is	be	AUX
chd-120	4	7	to	to	PART
chd-120	4	8	examine	examine	VERB
chd-120	4	9	records	record	NOUN
chd-120	4	10	of	of	ADP
chd-120	4	11	prostate	prostate	NOUN
chd-120	4	12	cancers	cancer	NOUN
chd-120	4	13	diagnosed	diagnose	VERB
chd-120	4	14	at	at	ADP
chd-120	4	15	mayo	mayo	NOUN
chd-120	4	16	height	height	PROPN
chd-120	4	17	laboratory	laboratory	NOUN
chd-120	4	18	,	,	PUNCT
chd-120	4	19	lagos	lagos	NOUN
chd-120	4	20	state	state	NOUN
chd-120	4	21	university	university	PROPN
chd-120	4	22	teaching	teaching	NOUN
chd-120	4	23	hospital	hospital	NOUN
chd-120	4	24	,	,	PUNCT
chd-120	4	25	lagos	lagos	PROPN
chd-120	4	26	,	,	PUNCT
chd-120	4	27	nigeria	nigeria	PROPN
chd-120	4	28	between	between	ADP
chd-120	4	29	january	january	PROPN
chd-120	4	30	2015	2015	NUM
chd-120	4	31	and	and	CCONJ
chd-120	4	32	june	june	PROPN
chd-120	4	33	2018	2018	NUM
chd-120	4	34	,	,	PUNCT
chd-120	4	35	with	with	ADP
chd-120	4	36	a	a	DET
chd-120	4	37	view	view	NOUN
chd-120	4	38	to	to	ADP
chd-120	4	39	studying	study	VERB
chd-120	4	40	the	the	DET
chd-120	4	41	epidemiological	epidemiological	ADJ
chd-120	4	42	variables	variable	NOUN
chd-120	4	43	and	and	CCONJ
chd-120	4	44	pattern	pattern	NOUN
chd-120	4	45	seen	see	VERB
chd-120	4	46	.	.	PUNCT
chd-120	5	1	histopathological	histopathological	ADJ
chd-120	5	2	slides	slide	NOUN
chd-120	5	3	were	be	AUX
chd-120	5	4	retrieved	retrieve	VERB
chd-120	5	5	and	and	CCONJ
chd-120	5	6	reviewed	review	VERB
chd-120	5	7	;	;	PUNCT
chd-120	5	8	relevant	relevant	ADJ
chd-120	5	9	data	datum	NOUN
chd-120	5	10	were	be	AUX
chd-120	5	11	extracted	extract	VERB
chd-120	5	12	from	from	ADP
chd-120	5	13	the	the	DET
chd-120	5	14	laboratory	laboratory	NOUN
chd-120	5	15	information	information	NOUN
chd-120	5	16	systems	system	NOUN
chd-120	5	17	,	,	PUNCT
chd-120	5	18	laboratory	laboratory	NOUN
chd-120	5	19	requisition	requisition	NOUN
chd-120	5	20	forms	form	NOUN
chd-120	5	21	and	and	CCONJ
chd-120	5	22	the	the	DET
chd-120	5	23	hospital	hospital	NOUN
chd-120	5	24	records	record	NOUN
chd-120	5	25	where	where	SCONJ
chd-120	5	26	necessary	necessary	ADJ
chd-120	5	27	.	.	PUNCT
chd-120	6	1	the	the	DET
chd-120	6	2	data	datum	NOUN
chd-120	6	3	were	be	AUX
chd-120	6	4	statistically	statistically	ADV
chd-120	6	5	analyzed	analyze	VERB
chd-120	6	6	.	.	PUNCT
chd-120	7	1	a	a	DET
chd-120	7	2	total	total	NOUN
chd-120	7	3	of	of	ADP
chd-120	7	4	333	333	NUM
chd-120	7	5	cases	case	NOUN
chd-120	7	6	of	of	ADP
chd-120	7	7	prostate	prostate	NOUN
chd-120	7	8	cancer	cancer	NOUN
chd-120	7	9	were	be	AUX
chd-120	7	10	diagnosed	diagnose	VERB
chd-120	7	11	during	during	ADP
chd-120	7	12	the	the	DET
chd-120	7	13	study	study	NOUN
chd-120	7	14	period	period	NOUN
chd-120	7	15	,	,	PUNCT
chd-120	7	16	representing	represent	VERB
chd-120	7	17	46.4	46.4	NUM
chd-120	7	18	%	%	NOUN
chd-120	7	19	of	of	ADP
chd-120	7	20	all	all	DET
chd-120	7	21	prostate	prostate	NOUN
chd-120	7	22	specimens	specimen	NOUN
chd-120	7	23	received	receive	VERB
chd-120	7	24	.	.	PUNCT
chd-120	8	1	the	the	DET
chd-120	8	2	median	median	ADJ
chd-120	8	3	age	age	NOUN
chd-120	8	4	of	of	ADP
chd-120	8	5	the	the	DET
chd-120	8	6	patients	patient	NOUN
chd-120	8	7	at	at	ADP
chd-120	8	8	diagnosis	diagnosis	NOUN
chd-120	8	9	was	be	AUX
chd-120	8	10	70	70	NUM
chd-120	8	11	years	year	NOUN
chd-120	8	12	,	,	PUNCT
chd-120	8	13	with	with	ADP
chd-120	8	14	the	the	DET
chd-120	8	15	lowest	low	ADJ
chd-120	8	16	recorded	record	VERB
chd-120	8	17	age	age	NOUN
chd-120	8	18	being	be	AUX
chd-120	8	19	50	50	NUM
chd-120	8	20	years	year	NOUN
chd-120	8	21	,	,	PUNCT
chd-120	8	22	while	while	SCONJ
chd-120	8	23	the	the	DET
chd-120	8	24	highest	high	ADJ
chd-120	8	25	age	age	NOUN
chd-120	8	26	was	be	AUX
chd-120	8	27	90	90	NUM
chd-120	8	28	years	year	NOUN
chd-120	8	29	.	.	PUNCT
chd-120	9	1	individuals	individual	NOUN
chd-120	9	2	in	in	ADP
chd-120	9	3	the	the	DET
chd-120	9	4	7th	7th	ADJ
chd-120	9	5	decade	decade	NOUN
chd-120	9	6	of	of	ADP
chd-120	9	7	life	life	NOUN
chd-120	9	8	(	(	PUNCT
chd-120	9	9	61	61	NUM
chd-120	9	10	-	-	SYM
chd-120	9	11	70	70	NUM
chd-120	9	12	years	year	NOUN
chd-120	9	13	)	)	PUNCT
chd-120	9	14	were	be	AUX
chd-120	9	15	the	the	DET
chd-120	9	16	most	most	ADV
chd-120	9	17	commonly	commonly	ADV
chd-120	9	18	affected	affect	VERB
chd-120	9	19	.	.	PUNCT
chd-120	10	1	overwhelming	overwhelming	ADJ
chd-120	10	2	number	number	NOUN
chd-120	10	3	of	of	ADP
chd-120	10	4	cases	case	NOUN
chd-120	10	5	(	(	PUNCT
chd-120	10	6	97.3	97.3	NUM
chd-120	10	7	%	%	NOUN
chd-120	10	8	)	)	PUNCT
chd-120	10	9	were	be	AUX
chd-120	10	10	diagnosed	diagnose	VERB
chd-120	10	11	based	base	VERB
chd-120	10	12	on	on	ADP
chd-120	10	13	trucut	trucut	ADJ
chd-120	10	14	biopsy	biopsy	NOUN
chd-120	10	15	specimens	specimen	NOUN
chd-120	10	16	,	,	PUNCT
chd-120	10	17	compared	compare	VERB
chd-120	10	18	to	to	PART
chd-120	10	19	open	open	VERB
chd-120	10	20	prostatectomy	prostatectomy	ADP
chd-120	10	21	specimen	speciman	NOUN
chd-120	10	22	.	.	PUNCT
chd-120	11	1	majority	majority	NOUN
chd-120	11	2	of	of	ADP
chd-120	11	3	the	the	DET
chd-120	11	4	cancers	cancer	NOUN
chd-120	11	5	were	be	AUX
chd-120	11	6	histologically	histologically	ADV
chd-120	11	7	adenocarcinomas	adenocarcinoma	NOUN
chd-120	11	8	(	(	PUNCT
chd-120	11	9	97.3	97.3	NUM
chd-120	11	10	%	%	NOUN
chd-120	11	11	)	)	PUNCT
chd-120	11	12	and	and	CCONJ
chd-120	11	13	majority	majority	NOUN
chd-120	11	14	of	of	ADP
chd-120	11	15	the	the	DET
chd-120	11	16	tumours	tumour	NOUN
chd-120	11	17	were	be	AUX
chd-120	11	18	of	of	ADP
chd-120	11	19	high	high	ADJ
chd-120	11	20	grade	grade	NOUN
chd-120	11	21	(	(	PUNCT
chd-120	11	22	gleason	gleason	PROPN
chd-120	11	23	grade	grade	PROPN
chd-120	11	24	5	5	NUM
chd-120	11	25	)	)	PUNCT
chd-120	11	26	representing	represent	VERB
chd-120	11	27	37.5	37.5	NUM
chd-120	11	28	%	%	NOUN
chd-120	11	29	.	.	PUNCT
chd-120	12	1	prostate	prostate	NOUN
chd-120	12	2	cancer	cancer	NOUN
chd-120	12	3	is	be	AUX
chd-120	12	4	an	an	DET
chd-120	12	5	obvious	obvious	ADJ
chd-120	12	6	scourge	scourge	NOUN
chd-120	12	7	in	in	ADP
chd-120	12	8	nigeria	nigeria	PROPN
chd-120	12	9	.	.	PUNCT
chd-120	13	1	it	it	PRON
chd-120	13	2	is	be	AUX
chd-120	13	3	commonly	commonly	ADV
chd-120	13	4	seen	see	VERB
chd-120	13	5	in	in	ADP
chd-120	13	6	the	the	DET
chd-120	13	7	7th	7th	ADJ
chd-120	13	8	decade	decade	NOUN
chd-120	13	9	of	of	ADP
chd-120	13	10	life	life	NOUN
chd-120	13	11	.	.	PUNCT
chd-120	14	1	majority	majority	NOUN
chd-120	14	2	of	of	ADP
chd-120	14	3	the	the	DET
chd-120	14	4	patients	patient	NOUN
chd-120	14	5	had	have	VERB
chd-120	14	6	high	high	ADJ
chd-120	14	7	grade	grade	NOUN
chd-120	14	8	adenocarcinoma	adenocarcinoma	NOUN
chd-120	14	9	.	.	PUNCT
chd-120	15	1	keywords	keyword	NOUN
chd-120	15	2	:	:	PUNCT
chd-120	15	3	prostatic	prostatic	ADJ
chd-120	15	4	carcinoma	carcinoma	NOUN
chd-120	15	5	,	,	PUNCT
chd-120	15	6	histopathology	histopathology	NOUN
chd-120	15	7	,	,	PUNCT
chd-120	15	8	epidemiology	epidemiology	NOUN
chd-120	15	9	,	,	PUNCT
chd-120	15	10	lagos	lagos	PROPN
chd-120	15	11	,	,	PUNCT
chd-120	15	12	nigeria	nigeria	PROPN
chd-120	15	13	.	.	PUNCT
chd-120	16	1	citation	citation	NOUN
chd-120	16	2	:	:	PUNCT
chd-120	16	3	emiogun	emiogun	PROPN
chd-120	16	4	fe	fe	PROPN
chd-120	16	5	,	,	PUNCT
chd-120	16	6	williams	williams	PROPN
chd-120	16	7	oo	oo	PROPN
chd-120	16	8	,	,	PUNCT
chd-120	16	9	obafunwa	obafunwa	PROPN
chd-120	16	10	jo	jo	X
chd-120	16	11	(	(	PUNCT
chd-120	16	12	2019	2019	NUM
chd-120	16	13	)	)	PUNCT
chd-120	16	14	epidemiology	epidemiology	NOUN
chd-120	16	15	of	of	ADP
chd-120	16	16	prostate	prostate	NOUN
chd-120	16	17	cancer	cancer	NOUN
chd-120	16	18	in	in	ADP
chd-120	16	19	nigeria	nigeria	PROPN
chd-120	16	20	:	:	PUNCT
chd-120	16	21	observations	observation	NOUN
chd-120	16	22	at	at	ADP
chd-120	16	23	lagos	lagos	PROPN
chd-120	16	24	state	state	NOUN
chd-120	16	25	university	university	PROPN
chd-120	16	26	teaching	teaching	NOUN
chd-120	16	27	hospital	hospital	NOUN
chd-120	16	28	.	.	PUNCT
chd-120	17	1	cancer	cancer	NOUN
chd-120	17	2	health	health	NOUN
chd-120	17	3	disparities	disparity	NOUN
chd-120	17	4	4	4	NUM
chd-120	17	5	:	:	PUNCT
chd-120	17	6	e1	e1	NOUN
chd-120	17	7	-	-	PUNCT
chd-120	17	8	e-9	e-9	NOUN
chd-120	17	9	.	.	PUNCT
chd-120	18	1	doi:10.9777	doi:10.9777	PROPN
chd-120	18	2	/	/	SYM
chd-120	18	3	chd.2019.1003	chd.2019.1003	PROPN
chd-120	18	4	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	PROPN
chd-120	18	5	e2	e2	PROPN
chd-120	18	6	cancer	cancer	NOUN
chd-120	18	7	health	health	NOUN
chd-120	18	8	disparities	disparity	NOUN
chd-120	18	9	research	research	NOUN
chd-120	18	10	introduction	introduction	NOUN
chd-120	18	11	prostate	prostate	NOUN
chd-120	18	12	cancer	cancer	NOUN
chd-120	18	13	is	be	AUX
chd-120	18	14	rated	rate	VERB
chd-120	18	15	the	the	DET
chd-120	18	16	second	second	ADJ
chd-120	18	17	most	most	ADV
chd-120	18	18	common	common	ADJ
chd-120	18	19	cancer	cancer	NOUN
chd-120	18	20	and	and	CCONJ
chd-120	18	21	sixth	sixth	ADJ
chd-120	18	22	leading	leading	ADJ
chd-120	18	23	cause	cause	NOUN
chd-120	18	24	of	of	ADP
chd-120	18	25	cancer	cancer	NOUN
chd-120	18	26	deaths	death	NOUN
chd-120	18	27	among	among	ADP
chd-120	18	28	men	man	NOUN
chd-120	18	29	globally	globally	ADV
chd-120	18	30	,	,	PUNCT
chd-120	18	31	making	make	VERB
chd-120	18	32	it	it	PRON
chd-120	18	33	an	an	DET
chd-120	18	34	important	important	ADJ
chd-120	18	35	cause	cause	NOUN
chd-120	18	36	of	of	ADP
chd-120	18	37	morbidity	morbidity	NOUN
chd-120	18	38	and	and	CCONJ
chd-120	18	39	mortality	mortality	NOUN
chd-120	18	40	(	(	PUNCT
chd-120	18	41	ferlay	ferlay	NOUN
chd-120	18	42	et	et	PROPN
chd-120	18	43	al	al	PROPN
chd-120	18	44	.	.	PROPN
chd-120	18	45	,	,	PUNCT
chd-120	18	46	2012	2012	NUM
chd-120	18	47	)	)	PUNCT
chd-120	18	48	.	.	PUNCT
chd-120	19	1	prostate	prostate	NOUN
chd-120	19	2	cancer	cancer	NOUN
chd-120	19	3	is	be	AUX
chd-120	19	4	the	the	DET
chd-120	19	5	most	most	ADV
chd-120	19	6	frequent	frequent	ADJ
chd-120	19	7	cancer	cancer	NOUN
chd-120	19	8	in	in	ADP
chd-120	19	9	men	man	NOUN
chd-120	19	10	in	in	ADP
chd-120	19	11	the	the	DET
chd-120	19	12	united	united	PROPN
chd-120	19	13	states	states	PROPN
chd-120	19	14	.	.	PUNCT
chd-120	20	1	african	african	ADJ
chd-120	20	2	american	american	PROPN
chd-120	20	3	ancestry	ancestry	PROPN
chd-120	20	4	,	,	PUNCT
chd-120	20	5	family	family	NOUN
chd-120	20	6	history	history	NOUN
chd-120	20	7	,	,	PUNCT
chd-120	20	8	and	and	CCONJ
chd-120	20	9	increased	increase	VERB
chd-120	20	10	age	age	NOUN
chd-120	20	11	are	be	AUX
chd-120	20	12	the	the	DET
chd-120	20	13	primary	primary	ADJ
chd-120	20	14	risk	risk	NOUN
chd-120	20	15	factors	factor	NOUN
chd-120	20	16	for	for	ADP
chd-120	20	17	prostate	prostate	NOUN
chd-120	20	18	cancer	cancer	NOUN
chd-120	20	19	(	(	PUNCT
chd-120	20	20	haas	haas	PROPN
chd-120	20	21	et	et	PROPN
chd-120	20	22	al	al	PROPN
chd-120	20	23	.	.	PROPN
chd-120	20	24	,	,	PUNCT
chd-120	20	25	2008	2008	NUM
chd-120	20	26	)	)	PUNCT
chd-120	20	27	.	.	PUNCT
chd-120	21	1	prostate	prostate	NOUN
chd-120	21	2	cancer	cancer	NOUN
chd-120	21	3	is	be	AUX
chd-120	21	4	the	the	DET
chd-120	21	5	most	most	ADV
chd-120	21	6	common	common	ADJ
chd-120	21	7	urological	urological	ADJ
chd-120	21	8	malignancy	malignancy	NOUN
chd-120	21	9	affecting	affect	VERB
chd-120	21	10	black	black	ADJ
chd-120	21	11	africans	africans	PROPN
chd-120	21	12	(	(	PUNCT
chd-120	21	13	magoha	magoha	PROPN
chd-120	21	14	,	,	PUNCT
chd-120	21	15	2007	2007	NUM
chd-120	21	16	and	and	CCONJ
chd-120	21	17	baade	baade	VERB
chd-120	21	18	et	et	PROPN
chd-120	21	19	al	al	PROPN
chd-120	21	20	.	.	PROPN
chd-120	21	21	,	,	PUNCT
chd-120	21	22	2009	2009	NUM
chd-120	21	23	)	)	PUNCT
chd-120	21	24	the	the	DET
chd-120	21	25	incidence	incidence	NOUN
chd-120	21	26	of	of	ADP
chd-120	21	27	prostate	prostate	NOUN
chd-120	21	28	cancer	cancer	NOUN
chd-120	21	29	has	have	AUX
chd-120	21	30	tripled	triple	VERB
chd-120	21	31	during	during	ADP
chd-120	21	32	the	the	DET
chd-120	21	33	past	past	ADJ
chd-120	21	34	decade	decade	NOUN
chd-120	21	35	,	,	PUNCT
chd-120	21	36	chiefly	chiefly	ADV
chd-120	21	37	because	because	SCONJ
chd-120	21	38	of	of	ADP
chd-120	21	39	increased	increase	VERB
chd-120	21	40	diagnosis	diagnosis	NOUN
chd-120	21	41	with	with	ADP
chd-120	21	42	the	the	DET
chd-120	21	43	widespread	widespread	ADJ
chd-120	21	44	use	use	NOUN
chd-120	21	45	of	of	ADP
chd-120	21	46	serum	serum	NOUN
chd-120	21	47	prostate	prostate	NOUN
chd-120	21	48	-	-	PUNCT
chd-120	21	49	specific	specific	ADJ
chd-120	21	50	antigen	antigen	NOUN
chd-120	21	51	(	(	PUNCT
chd-120	21	52	psa	psa	NOUN
chd-120	21	53	)	)	PUNCT
chd-120	21	54	testing	testing	NOUN
chd-120	21	55	,	,	PUNCT
chd-120	21	56	digital	digital	ADJ
chd-120	21	57	rectal	rectal	ADJ
chd-120	21	58	examination	examination	NOUN
chd-120	21	59	(	(	PUNCT
chd-120	21	60	dre	dre	PROPN
chd-120	21	61	)	)	PUNCT
chd-120	21	62	,	,	PUNCT
chd-120	21	63	transrectal	transrectal	ADJ
chd-120	21	64	ultrasound	ultrasound	NOUN
chd-120	21	65	and	and	CCONJ
chd-120	21	66	needle	needle	NOUN
chd-120	21	67	biopsy	biopsy	NOUN
chd-120	21	68	of	of	ADP
chd-120	21	69	the	the	DET
chd-120	21	70	prostate	prostate	NOUN
chd-120	21	71	(	(	PUNCT
chd-120	21	72	oluwole	oluwole	NOUN
chd-120	21	73	,	,	PUNCT
chd-120	21	74	et	et	PROPN
chd-120	21	75	al	al	PROPN
chd-120	21	76	.	.	PROPN
chd-120	21	77	,	,	PUNCT
chd-120	21	78	2015	2015	NUM
chd-120	21	79	and	and	CCONJ
chd-120	21	80	amin	amin	PROPN
chd-120	21	81	et	et	PROPN
chd-120	21	82	al	al	PROPN
chd-120	21	83	.	.	PROPN
chd-120	21	84	,	,	PUNCT
chd-120	21	85	2005	2005	NUM
chd-120	21	86	)	)	PUNCT
chd-120	21	87	.	.	PUNCT
chd-120	22	1	cancer	cancer	NOUN
chd-120	22	2	of	of	ADP
chd-120	22	3	the	the	DET
chd-120	22	4	prostate	prostate	NOUN
chd-120	22	5	is	be	AUX
chd-120	22	6	currently	currently	ADV
chd-120	22	7	the	the	DET
chd-120	22	8	most	most	ADV
chd-120	22	9	frequent	frequent	ADJ
chd-120	22	10	malignancy	malignancy	NOUN
chd-120	22	11	of	of	ADP
chd-120	22	12	the	the	DET
chd-120	22	13	adult	adult	NOUN
chd-120	22	14	nigerian	nigerian	ADJ
chd-120	22	15	male	male	NOUN
chd-120	22	16	with	with	ADP
chd-120	22	17	increasing	increase	VERB
chd-120	22	18	incidence	incidence	NOUN
chd-120	22	19	annually	annually	ADV
chd-120	22	20	.	.	PUNCT
chd-120	23	1	studies	study	NOUN
chd-120	23	2	on	on	ADP
chd-120	23	3	prostate	prostate	NOUN
chd-120	23	4	cancer	cancer	NOUN
chd-120	23	5	from	from	ADP
chd-120	23	6	the	the	DET
chd-120	23	7	ibadan	ibadan	PROPN
chd-120	23	8	cancer	cancer	NOUN
chd-120	23	9	registry	registry	NOUN
chd-120	23	10	showed	show	VERB
chd-120	23	11	that	that	SCONJ
chd-120	23	12	the	the	DET
chd-120	23	13	relative	relative	ADJ
chd-120	23	14	ratio	ratio	NOUN
chd-120	23	15	frequency	frequency	NOUN
chd-120	23	16	for	for	ADP
chd-120	23	17	prostate	prostate	NOUN
chd-120	23	18	cancer	cancer	NOUN
chd-120	23	19	when	when	SCONJ
chd-120	23	20	compared	compare	VERB
chd-120	23	21	to	to	ADP
chd-120	23	22	other	other	ADJ
chd-120	23	23	male	male	ADJ
chd-120	23	24	cancers	cancer	NOUN
chd-120	23	25	increased	increase	VERB
chd-120	23	26	from	from	ADP
chd-120	23	27	4.45	4.45	NUM
chd-120	23	28	%	%	NOUN
chd-120	23	29	to	to	ADP
chd-120	23	30	10.5	10.5	NUM
chd-120	23	31	%	%	NOUN
chd-120	23	32	over	over	ADP
chd-120	23	33	the	the	DET
chd-120	23	34	last	last	ADJ
chd-120	23	35	three	three	NUM
chd-120	23	36	decades	decade	NOUN
chd-120	23	37	(	(	PUNCT
chd-120	23	38	okolo	okolo	PROPN
chd-120	23	39	et	et	PROPN
chd-120	23	40	al	al	PROPN
chd-120	23	41	.	.	PROPN
chd-120	23	42	,	,	PUNCT
chd-120	23	43	2008	2008	NUM
chd-120	23	44	and	and	CCONJ
chd-120	23	45	ogunbiyi	ogunbiyi	PROPN
chd-120	23	46	et	et	PROPN
chd-120	23	47	al	al	PROPN
chd-120	23	48	.	.	PROPN
chd-120	23	49	,	,	PUNCT
chd-120	23	50	1999	1999	NUM
chd-120	23	51	)	)	PUNCT
chd-120	23	52	.	.	PUNCT
chd-120	24	1	most	most	ADJ
chd-120	24	2	cases	case	NOUN
chd-120	24	3	of	of	ADP
chd-120	24	4	prostate	prostate	NOUN
chd-120	24	5	cancer	cancer	NOUN
chd-120	24	6	occur	occur	VERB
chd-120	24	7	after	after	ADP
chd-120	24	8	the	the	DET
chd-120	24	9	age	age	NOUN
chd-120	24	10	of	of	ADP
chd-120	24	11	50	50	NUM
chd-120	24	12	years	year	NOUN
chd-120	24	13	and	and	CCONJ
chd-120	24	14	there	there	PRON
chd-120	24	15	is	be	VERB
chd-120	24	16	an	an	DET
chd-120	24	17	exponential	exponential	ADJ
chd-120	24	18	increase	increase	NOUN
chd-120	24	19	in	in	ADP
chd-120	24	20	incidence	incidence	NOUN
chd-120	24	21	which	which	PRON
chd-120	24	22	peaks	peak	VERB
chd-120	24	23	in	in	ADP
chd-120	24	24	the	the	DET
chd-120	24	25	70s	70	NOUN
chd-120	24	26	.	.	PUNCT
chd-120	25	1	worldwide	worldwide	ADV
chd-120	25	2	,	,	PUNCT
chd-120	25	3	about	about	ADV
chd-120	25	4	three	three	NUM
chd-120	25	5	-	-	PUNCT
chd-120	25	6	quarters	quarter	NOUN
chd-120	25	7	of	of	ADP
chd-120	25	8	all	all	DET
chd-120	25	9	cases	case	NOUN
chd-120	25	10	occur	occur	VERB
chd-120	25	11	in	in	ADP
chd-120	25	12	men	man	NOUN
chd-120	25	13	aged	age	VERB
chd-120	25	14	65	65	NUM
chd-120	25	15	or	or	CCONJ
chd-120	25	16	more	more	ADJ
chd-120	25	17	(	(	PUNCT
chd-120	25	18	who	who	PRON
chd-120	25	19	,	,	PUNCT
chd-120	25	20	2004	2004	NUM
chd-120	25	21	)	)	PUNCT
chd-120	25	22	.	.	PUNCT
chd-120	26	1	various	various	ADJ
chd-120	26	2	histologic	histologic	ADJ
chd-120	26	3	studies	study	NOUN
chd-120	26	4	on	on	ADP
chd-120	26	5	prostate	prostate	NOUN
chd-120	26	6	specimens	specimen	NOUN
chd-120	26	7	taken	take	VERB
chd-120	26	8	in	in	ADP
chd-120	26	9	different	different	ADJ
chd-120	26	10	centres	centre	NOUN
chd-120	26	11	across	across	ADP
chd-120	26	12	nigeria	nigeria	PROPN
chd-120	26	13	have	have	AUX
chd-120	26	14	shown	show	VERB
chd-120	26	15	prostate	prostate	NOUN
chd-120	26	16	cancer	cancer	NOUN
chd-120	26	17	incidences	incidence	NOUN
chd-120	26	18	ranging	range	VERB
chd-120	26	19	from	from	ADP
chd-120	26	20	22.4	22.4	NUM
chd-120	26	21	%	%	NOUN
chd-120	26	22	to	to	ADP
chd-120	26	23	37.4	37.4	NUM
chd-120	26	24	%	%	NOUN
chd-120	26	25	(	(	PUNCT
chd-120	26	26	mohammed	mohammed	PROPN
chd-120	26	27	et	et	PROPN
chd-120	26	28	al	al	PROPN
chd-120	26	29	.	.	PROPN
chd-120	26	30	,	,	PUNCT
chd-120	26	31	2003	2003	NUM
chd-120	26	32	,	,	PUNCT
chd-120	26	33	okeke	okeke	VERB
chd-120	26	34	et	et	PROPN
chd-120	26	35	al	al	PROPN
chd-120	26	36	.	.	PROPN
chd-120	26	37	,	,	PUNCT
chd-120	26	38	2017	2017	NUM
chd-120	26	39	and	and	CCONJ
chd-120	26	40	obiorah	obiorah	NOUN
chd-120	26	41	et	et	PROPN
chd-120	26	42	al	al	PROPN
chd-120	26	43	.	.	PROPN
chd-120	26	44	,	,	PUNCT
chd-120	26	45	2011	2011	NUM
chd-120	26	46	)	)	PUNCT
chd-120	26	47	.	.	PUNCT
chd-120	27	1	the	the	DET
chd-120	27	2	incidence	incidence	NOUN
chd-120	27	3	of	of	ADP
chd-120	27	4	prostate	prostate	NOUN
chd-120	27	5	cancer	cancer	NOUN
chd-120	27	6	has	have	AUX
chd-120	27	7	also	also	ADV
chd-120	27	8	been	be	AUX
chd-120	27	9	shown	show	VERB
chd-120	27	10	to	to	PART
chd-120	27	11	vary	vary	VERB
chd-120	27	12	across	across	ADP
chd-120	27	13	various	various	ADJ
chd-120	27	14	african	african	ADJ
chd-120	27	15	countries	country	NOUN
chd-120	27	16	to	to	PART
chd-120	27	17	include	include	VERB
chd-120	27	18	gambia	gambia	PROPN
chd-120	27	19	2.5	2.5	NUM
chd-120	27	20	per	per	ADP
chd-120	27	21	100,000	100,000	NUM
chd-120	27	22	,	,	PUNCT
chd-120	27	23	south	south	PROPN
chd-120	27	24	africa	africa	PROPN
chd-120	27	25	30.8	30.8	NUM
chd-120	27	26	per	per	ADP
chd-120	27	27	100,000	100,000	NUM
chd-120	27	28	and	and	CCONJ
chd-120	27	29	uganda	uganda	PROPN
chd-120	27	30	35.5	35.5	NUM
chd-120	27	31	per	per	ADP
chd-120	27	32	100,000	100,000	NUM
chd-120	27	33	(	(	PUNCT
chd-120	27	34	bah	bah	INTJ
chd-120	27	35	et	et	PROPN
chd-120	27	36	al	al	PROPN
chd-120	27	37	.	.	PROPN
chd-120	27	38	,	,	PUNCT
chd-120	27	39	2001	2001	NUM
chd-120	27	40	,	,	PUNCT
chd-120	27	41	baab	baab	PROPN
chd-120	27	42	et	et	PROPN
chd-120	27	43	al	al	PROPN
chd-120	27	44	.	.	PROPN
chd-120	27	45	,	,	PUNCT
chd-120	27	46	2014	2014	NUM
chd-120	27	47	and	and	CCONJ
chd-120	27	48	parkin	parkin	NOUN
chd-120	27	49	et	et	PROPN
chd-120	27	50	al	al	PROPN
chd-120	27	51	.	.	PROPN
chd-120	27	52	,	,	PUNCT
chd-120	27	53	2010	2010	NUM
chd-120	27	54	)	)	PUNCT
chd-120	27	55	.	.	PUNCT
chd-120	28	1	the	the	DET
chd-120	28	2	low	low	ADJ
chd-120	28	3	incidence	incidence	NOUN
chd-120	28	4	areas	area	NOUN
chd-120	28	5	globally	globally	ADV
chd-120	28	6	include	include	VERB
chd-120	28	7	the	the	DET
chd-120	28	8	asiapacific	asiapacific	ADJ
chd-120	28	9	region	region	NOUN
chd-120	28	10	and	and	CCONJ
chd-120	28	11	north	north	NOUN
chd-120	28	12	africa	africa	PROPN
chd-120	28	13	with	with	ADP
chd-120	28	14	3	3	NUM
chd-120	28	15	per	per	ADP
chd-120	28	16	100,000	100,000	NUM
chd-120	28	17	and	and	CCONJ
chd-120	28	18	10.6	10.6	NUM
chd-120	28	19	per	per	ADP
chd-120	28	20	100,000	100,000	NUM
chd-120	28	21	respectively	respectively	ADV
chd-120	28	22	(	(	PUNCT
chd-120	28	23	baade	baade	PROPN
chd-120	28	24	et	et	PROPN
chd-120	28	25	al	al	PROPN
chd-120	28	26	.	.	PROPN
chd-120	28	27	,	,	PUNCT
chd-120	28	28	2013	2013	NUM
chd-120	28	29	)	)	PUNCT
chd-120	28	30	.	.	PUNCT
chd-120	29	1	the	the	DET
chd-120	29	2	most	most	ADV
chd-120	29	3	common	common	ADJ
chd-120	29	4	histologic	histologic	ADJ
chd-120	29	5	type	type	NOUN
chd-120	29	6	of	of	ADP
chd-120	29	7	prostate	prostate	NOUN
chd-120	29	8	cancer	cancer	NOUN
chd-120	29	9	type	type	NOUN
chd-120	29	10	is	be	AUX
chd-120	29	11	adenocarcinoma	adenocarcinoma	ADJ
chd-120	29	12	with	with	ADP
chd-120	29	13	other	other	ADJ
chd-120	29	14	histologic	histologic	ADJ
chd-120	29	15	types	type	NOUN
chd-120	29	16	being	be	AUX
chd-120	29	17	quite	quite	ADV
chd-120	29	18	rare	rare	ADJ
chd-120	29	19	(	(	PUNCT
chd-120	29	20	haaa	haaa	NOUN
chd-120	29	21	et	et	NOUN
chd-120	29	22	al	al	PROPN
chd-120	29	23	.	.	PROPN
chd-120	29	24	,	,	PUNCT
chd-120	29	25	2008	2008	NUM
chd-120	29	26	)	)	PUNCT
chd-120	29	27	.	.	PUNCT
chd-120	30	1	the	the	DET
chd-120	30	2	gleason	gleason	PROPN
chd-120	30	3	score	score	NOUN
chd-120	30	4	system	system	NOUN
chd-120	30	5	is	be	AUX
chd-120	30	6	the	the	DET
chd-120	30	7	most	most	ADV
chd-120	30	8	widespread	widespread	ADJ
chd-120	30	9	grading	grading	NOUN
chd-120	30	10	tool	tool	NOUN
chd-120	30	11	for	for	ADP
chd-120	30	12	prostate	prostate	NOUN
chd-120	30	13	cancer	cancer	NOUN
chd-120	30	14	.	.	PUNCT
chd-120	31	1	it	it	PRON
chd-120	31	2	is	be	AUX
chd-120	31	3	the	the	DET
chd-120	31	4	system	system	NOUN
chd-120	31	5	recommended	recommend	VERB
chd-120	31	6	by	by	ADP
chd-120	31	7	the	the	DET
chd-120	31	8	1993	1993	NUM
chd-120	31	9	who	who	PRON
chd-120	31	10	consensus	consensus	VERB
chd-120	31	11	conference	conference	NOUN
chd-120	31	12	on	on	ADP
chd-120	31	13	prostate	prostate	NOUN
chd-120	31	14	cancer	cancer	NOUN
chd-120	31	15	diagnosis	diagnosis	NOUN
chd-120	31	16	due	due	ADP
chd-120	31	17	to	to	ADP
chd-120	31	18	its	its	PRON
chd-120	31	19	high	high	ADJ
chd-120	31	20	reproducibility	reproducibility	NOUN
chd-120	31	21	across	across	ADP
chd-120	31	22	different	different	ADJ
chd-120	31	23	institutions	institution	NOUN
chd-120	31	24	(	(	PUNCT
chd-120	31	25	murphy	murphy	PROPN
chd-120	31	26	et	et	PROPN
chd-120	31	27	al	al	PROPN
chd-120	31	28	.	.	PROPN
chd-120	31	29	,	,	PUNCT
chd-120	31	30	1994	1994	NUM
chd-120	31	31	)	)	PUNCT
chd-120	31	32	.	.	PUNCT
chd-120	32	1	it	it	PRON
chd-120	32	2	is	be	AUX
chd-120	32	3	one	one	NUM
chd-120	32	4	of	of	ADP
chd-120	32	5	the	the	DET
chd-120	32	6	most	most	ADV
chd-120	32	7	reliable	reliable	ADJ
chd-120	32	8	predictors	predictor	NOUN
chd-120	32	9	of	of	ADP
chd-120	32	10	prostate	prostate	NOUN
chd-120	32	11	cancer	cancer	NOUN
chd-120	32	12	progression	progression	NOUN
chd-120	32	13	and	and	CCONJ
chd-120	32	14	survival	survival	NOUN
chd-120	32	15	(	(	PUNCT
chd-120	32	16	seyed	seyed	PROPN
chd-120	32	17	et	et	PROPN
chd-120	32	18	al	al	PROPN
chd-120	32	19	.	.	PROPN
chd-120	32	20	,	,	PUNCT
chd-120	32	21	2004	2004	NUM
chd-120	32	22	)	)	PUNCT
chd-120	32	23	.	.	PUNCT
chd-120	33	1	the	the	DET
chd-120	33	2	system	system	NOUN
chd-120	33	3	is	be	AUX
chd-120	33	4	based	base	VERB
chd-120	33	5	on	on	ADP
chd-120	33	6	glandular	glandular	ADJ
chd-120	33	7	architecture	architecture	NOUN
chd-120	33	8	which	which	PRON
chd-120	33	9	is	be	AUX
chd-120	33	10	used	use	VERB
chd-120	33	11	to	to	PART
chd-120	33	12	define	define	VERB
chd-120	33	13	five	five	NUM
chd-120	33	14	histological	histological	ADJ
chd-120	33	15	patterns	pattern	NOUN
chd-120	33	16	or	or	CCONJ
chd-120	33	17	grades	grade	NOUN
chd-120	33	18	with	with	ADP
chd-120	33	19	decreasing	decrease	VERB
chd-120	33	20	differentiation	differentiation	NOUN
chd-120	33	21	(	(	PUNCT
chd-120	33	22	gleason	gleason	PROPN
chd-120	33	23	,	,	PUNCT
chd-120	33	24	1966	1966	NUM
chd-120	33	25	)	)	PUNCT
chd-120	33	26	.	.	PUNCT
chd-120	34	1	this	this	DET
chd-120	34	2	study	study	NOUN
chd-120	34	3	aims	aim	VERB
chd-120	34	4	to	to	PART
chd-120	34	5	examine	examine	VERB
chd-120	34	6	the	the	DET
chd-120	34	7	pattern	pattern	NOUN
chd-120	34	8	of	of	ADP
chd-120	34	9	prostate	prostate	NOUN
chd-120	34	10	cancer	cancer	NOUN
chd-120	34	11	seen	see	VERB
chd-120	34	12	among	among	ADP
chd-120	34	13	men	man	NOUN
chd-120	34	14	of	of	ADP
chd-120	34	15	nigerian	nigerian	ADJ
chd-120	34	16	descent	descent	NOUN
chd-120	34	17	.	.	PUNCT
chd-120	35	1	the	the	DET
chd-120	35	2	finding	finding	NOUN
chd-120	35	3	in	in	ADP
chd-120	35	4	this	this	DET
chd-120	35	5	study	study	NOUN
chd-120	35	6	will	will	AUX
chd-120	35	7	enrich	enrich	VERB
chd-120	35	8	the	the	DET
chd-120	35	9	understanding	understanding	NOUN
chd-120	35	10	of	of	ADP
chd-120	35	11	the	the	DET
chd-120	35	12	characteristics	characteristic	NOUN
chd-120	35	13	of	of	ADP
chd-120	35	14	prostate	prostate	NOUN
chd-120	35	15	cancer	cancer	NOUN
chd-120	35	16	among	among	ADP
chd-120	35	17	african	african	ADJ
chd-120	35	18	men	man	NOUN
chd-120	35	19	which	which	PRON
chd-120	35	20	in	in	ADP
chd-120	35	21	turn	turn	NOUN
chd-120	35	22	will	will	AUX
chd-120	35	23	guide	guide	VERB
chd-120	35	24	further	further	ADJ
chd-120	35	25	effort	effort	NOUN
chd-120	35	26	at	at	ADP
chd-120	35	27	curbing	curb	VERB
chd-120	35	28	the	the	DET
chd-120	35	29	scourge	scourge	NOUN
chd-120	35	30	.	.	PUNCT
chd-120	36	1	materials	material	NOUN
chd-120	36	2	and	and	CCONJ
chd-120	36	3	methods	method	NOUN
chd-120	36	4	laboratory	laboratory	NOUN
chd-120	36	5	reports	report	NOUN
chd-120	36	6	on	on	ADP
chd-120	36	7	all	all	DET
chd-120	36	8	cases	case	NOUN
chd-120	36	9	of	of	ADP
chd-120	36	10	prostate	prostate	NOUN
chd-120	36	11	samples	sample	NOUN
chd-120	36	12	(	(	PUNCT
chd-120	36	13	core	core	NOUN
chd-120	36	14	biopsies	biopsy	NOUN
chd-120	36	15	and	and	CCONJ
chd-120	36	16	prostatectomy	prostatectomy	ADP
chd-120	36	17	submissions	submission	NOUN
chd-120	36	18	)	)	PUNCT
chd-120	36	19	were	be	AUX
chd-120	36	20	retrieved	retrieve	VERB
chd-120	36	21	from	from	ADP
chd-120	36	22	the	the	DET
chd-120	36	23	laboratory	laboratory	NOUN
chd-120	36	24	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	AUX
chd-120	36	25	e3	e3	NOUN
chd-120	36	26	cancer	cancer	NOUN
chd-120	36	27	health	health	NOUN
chd-120	36	28	disparities	disparity	NOUN
chd-120	36	29	research	research	NOUN
chd-120	36	30	information	information	NOUN
chd-120	36	31	system	system	NOUN
chd-120	36	32	at	at	ADP
chd-120	36	33	mayo	mayo	NOUN
chd-120	36	34	heights	height	NOUN
chd-120	36	35	laboratory	laboratory	NOUN
chd-120	36	36	of	of	ADP
chd-120	36	37	the	the	DET
chd-120	36	38	lagos	lagos	PROPN
chd-120	36	39	state	state	PROPN
chd-120	36	40	university	university	PROPN
chd-120	36	41	teaching	teaching	NOUN
chd-120	36	42	hospital	hospital	NOUN
chd-120	36	43	.	.	PUNCT
chd-120	37	1	the	the	DET
chd-120	37	2	laboratory	laboratory	NOUN
chd-120	37	3	receives	receive	VERB
chd-120	37	4	and	and	CCONJ
chd-120	37	5	process	process	VERB
chd-120	37	6	samples	sample	NOUN
chd-120	37	7	from	from	ADP
chd-120	37	8	the	the	DET
chd-120	37	9	teaching	teaching	NOUN
chd-120	37	10	hospital	hospital	NOUN
chd-120	37	11	where	where	SCONJ
chd-120	37	12	the	the	DET
chd-120	37	13	department	department	NOUN
chd-120	37	14	is	be	AUX
chd-120	37	15	located	locate	VERB
chd-120	37	16	.	.	PUNCT
chd-120	38	1	samples	sample	NOUN
chd-120	38	2	are	be	AUX
chd-120	38	3	also	also	ADV
chd-120	38	4	received	receive	VERB
chd-120	38	5	from	from	ADP
chd-120	38	6	across	across	ADP
chd-120	38	7	the	the	DET
chd-120	38	8	general	general	ADJ
chd-120	38	9	hospitals	hospital	NOUN
chd-120	38	10	within	within	ADP
chd-120	38	11	lagos	lagos	NOUN
chd-120	38	12	state	state	NOUN
chd-120	38	13	,	,	PUNCT
chd-120	38	14	and	and	CCONJ
chd-120	38	15	many	many	ADJ
chd-120	38	16	of	of	ADP
chd-120	38	17	the	the	DET
chd-120	38	18	private	private	ADJ
chd-120	38	19	hospitals	hospital	NOUN
chd-120	38	20	.	.	PUNCT
chd-120	39	1	the	the	DET
chd-120	39	2	formalin	formalin	NOUN
chd-120	39	3	-	-	PUNCT
chd-120	39	4	fixed	fix	VERB
chd-120	39	5	paraffin	paraffin	NOUN
chd-120	39	6	embedded	embed	VERB
chd-120	39	7	samples	sample	NOUN
chd-120	39	8	of	of	ADP
chd-120	39	9	tissues	tissue	NOUN
chd-120	39	10	of	of	ADP
chd-120	39	11	prostatic	prostatic	ADJ
chd-120	39	12	origin	origin	NOUN
chd-120	39	13	,	,	PUNCT
chd-120	39	14	and	and	CCONJ
chd-120	39	15	associated	associate	VERB
chd-120	39	16	histological	histological	ADJ
chd-120	39	17	slides	slide	NOUN
chd-120	39	18	were	be	AUX
chd-120	39	19	retrieved	retrieve	VERB
chd-120	39	20	from	from	ADP
chd-120	39	21	storage	storage	NOUN
chd-120	39	22	and	and	CCONJ
chd-120	39	23	reviewed	review	VERB
chd-120	39	24	independently	independently	ADV
chd-120	39	25	by	by	ADP
chd-120	39	26	the	the	DET
chd-120	39	27	authors	author	NOUN
chd-120	39	28	to	to	PART
chd-120	39	29	reach	reach	VERB
chd-120	39	30	a	a	DET
chd-120	39	31	consensus	consensus	NOUN
chd-120	39	32	as	as	ADP
chd-120	39	33	to	to	ADP
chd-120	39	34	the	the	DET
chd-120	39	35	diagnosis	diagnosis	NOUN
chd-120	39	36	.	.	PUNCT
chd-120	40	1	relevant	relevant	ADJ
chd-120	40	2	clinical	clinical	ADJ
chd-120	40	3	data	datum	NOUN
chd-120	40	4	were	be	AUX
chd-120	40	5	also	also	ADV
chd-120	40	6	retrieved	retrieve	VERB
chd-120	40	7	from	from	ADP
chd-120	40	8	the	the	DET
chd-120	40	9	requisition	requisition	NOUN
chd-120	40	10	forms	form	NOUN
chd-120	40	11	.	.	PUNCT
chd-120	41	1	data	datum	NOUN
chd-120	41	2	were	be	AUX
chd-120	41	3	then	then	ADV
chd-120	41	4	specifically	specifically	ADV
chd-120	41	5	extracted	extract	VERB
chd-120	41	6	for	for	ADP
chd-120	41	7	the	the	DET
chd-120	41	8	malignant	malignant	ADJ
chd-120	41	9	cases	case	NOUN
chd-120	41	10	.	.	PUNCT
chd-120	42	1	prostate	prostate	NOUN
chd-120	42	2	cancer	cancer	NOUN
chd-120	42	3	grading	grading	NOUN
chd-120	42	4	was	be	AUX
chd-120	42	5	done	do	VERB
chd-120	42	6	using	use	VERB
chd-120	42	7	the	the	DET
chd-120	42	8	gleason	gleason	PROPN
chd-120	42	9	score	score	NOUN
chd-120	42	10	system	system	NOUN
chd-120	42	11	.	.	PUNCT
chd-120	43	1	the	the	DET
chd-120	43	2	data	datum	NOUN
chd-120	43	3	compiled	compile	VERB
chd-120	43	4	were	be	AUX
chd-120	43	5	analysed	analyse	VERB
chd-120	43	6	and	and	CCONJ
chd-120	43	7	also	also	ADV
chd-120	43	8	where	where	SCONJ
chd-120	43	9	indicated	indicate	VERB
chd-120	43	10	,	,	PUNCT
chd-120	43	11	subjected	subject	VERB
chd-120	43	12	to	to	ADP
chd-120	43	13	statistical	statistical	ADJ
chd-120	43	14	analysis	analysis	NOUN
chd-120	43	15	,	,	PUNCT
chd-120	43	16	utilizing	utilize	VERB
chd-120	43	17	spss	spss	ADJ
chd-120	43	18	statistical	statistical	ADJ
chd-120	43	19	package	package	NOUN
chd-120	43	20	software	software	NOUN
chd-120	43	21	version	version	NOUN
chd-120	43	22	19	19	NUM
chd-120	43	23	.	.	PUNCT
chd-120	43	24	results	result	VERB
chd-120	43	25	a	a	DET
chd-120	43	26	total	total	NOUN
chd-120	43	27	of	of	ADP
chd-120	43	28	717	717	NUM
chd-120	43	29	prostate	prostate	NOUN
chd-120	43	30	specimens	specimen	NOUN
chd-120	43	31	were	be	AUX
chd-120	43	32	received	receive	VERB
chd-120	43	33	in	in	ADP
chd-120	43	34	mayo	mayo	NOUN
chd-120	43	35	heights	height	NOUN
chd-120	43	36	laboratory	laboratory	NOUN
chd-120	43	37	,	,	PUNCT
chd-120	43	38	lagos	lagos	NOUN
chd-120	43	39	state	state	NOUN
chd-120	43	40	university	university	PROPN
chd-120	43	41	teaching	teaching	NOUN
chd-120	43	42	hospital	hospital	NOUN
chd-120	43	43	,	,	PUNCT
chd-120	43	44	over	over	ADP
chd-120	43	45	a	a	DET
chd-120	43	46	42	42	NUM
chd-120	43	47	-	-	PUNCT
chd-120	43	48	month	month	NOUN
chd-120	43	49	period	period	NOUN
chd-120	43	50	between	between	ADP
chd-120	43	51	january	january	PROPN
chd-120	43	52	2015	2015	NUM
chd-120	43	53	and	and	CCONJ
chd-120	43	54	june	june	PROPN
chd-120	43	55	2018	2018	NUM
chd-120	43	56	.	.	PUNCT
chd-120	44	1	of	of	ADP
chd-120	44	2	this	this	DET
chd-120	44	3	number	number	NOUN
chd-120	44	4	,	,	PUNCT
chd-120	44	5	333	333	NUM
chd-120	44	6	were	be	AUX
chd-120	44	7	prostate	prostate	NOUN
chd-120	44	8	cancers	cancer	NOUN
chd-120	44	9	,	,	PUNCT
chd-120	44	10	representing	represent	VERB
chd-120	44	11	46.4	46.4	NUM
chd-120	44	12	%	%	NOUN
chd-120	44	13	(	(	PUNCT
chd-120	44	14	table	table	NOUN
chd-120	44	15	1	1	NUM
chd-120	44	16	)	)	PUNCT
chd-120	44	17	.	.	PUNCT
chd-120	45	1	the	the	DET
chd-120	45	2	lowest	low	ADJ
chd-120	45	3	age	age	NOUN
chd-120	45	4	at	at	ADP
chd-120	45	5	diagnosis	diagnosis	NOUN
chd-120	45	6	was	be	AUX
chd-120	45	7	50	50	NUM
chd-120	45	8	years	year	NOUN
chd-120	45	9	,	,	PUNCT
chd-120	45	10	while	while	SCONJ
chd-120	45	11	90	90	NUM
chd-120	45	12	years	year	NOUN
chd-120	45	13	was	be	AUX
chd-120	45	14	the	the	DET
chd-120	45	15	highest	high	ADJ
chd-120	45	16	age	age	NOUN
chd-120	45	17	recorded	record	VERB
chd-120	45	18	at	at	ADP
chd-120	45	19	diagnosis	diagnosis	NOUN
chd-120	45	20	(	(	PUNCT
chd-120	45	21	figure	figure	NOUN
chd-120	45	22	1	1	NUM
chd-120	45	23	)	)	PUNCT
chd-120	45	24	.	.	PUNCT
chd-120	46	1	the	the	DET
chd-120	46	2	mean	mean	ADJ
chd-120	46	3	age	age	NOUN
chd-120	46	4	was	be	AUX
chd-120	46	5	69	69	NUM
chd-120	46	6	±	±	NUM
chd-120	46	7	8.0	8.0	NUM
chd-120	46	8	years	year	NOUN
chd-120	46	9	while	while	SCONJ
chd-120	46	10	the	the	DET
chd-120	46	11	median	median	ADJ
chd-120	46	12	age	age	NOUN
chd-120	46	13	was	be	AUX
chd-120	46	14	70	70	NUM
chd-120	46	15	(	(	PUNCT
chd-120	46	16	24	24	NUM
chd-120	46	17	cases	case	NOUN
chd-120	46	18	)	)	PUNCT
chd-120	46	19	.	.	PUNCT
chd-120	47	1	the	the	DET
chd-120	47	2	most	most	ADV
chd-120	47	3	frequent	frequent	ADJ
chd-120	47	4	age	age	NOUN
chd-120	47	5	group	group	NOUN
chd-120	47	6	was	be	AUX
chd-120	47	7	61	61	NUM
chd-120	47	8	–	–	SYM
chd-120	47	9	70	70	NUM
chd-120	47	10	years	year	NOUN
chd-120	47	11	(	(	PUNCT
chd-120	47	12	141	141	NUM
chd-120	47	13	,	,	PUNCT
chd-120	47	14	42.3	42.3	NUM
chd-120	47	15	%	%	NOUN
chd-120	47	16	)	)	PUNCT
chd-120	47	17	,	,	PUNCT
chd-120	47	18	followed	follow	VERB
chd-120	47	19	by	by	ADP
chd-120	47	20	71	71	NUM
chd-120	47	21	–	–	SYM
chd-120	47	22	80	80	NUM
chd-120	47	23	years	year	NOUN
chd-120	47	24	(	(	PUNCT
chd-120	47	25	112	112	NUM
chd-120	47	26	,	,	PUNCT
chd-120	47	27	33.6	33.6	NUM
chd-120	47	28	%	%	NOUN
chd-120	47	29	)	)	PUNCT
chd-120	47	30	while	while	SCONJ
chd-120	47	31	26	26	NUM
chd-120	47	32	(	(	PUNCT
chd-120	47	33	7.8	7.8	NUM
chd-120	47	34	%	%	NOUN
chd-120	47	35	)	)	PUNCT
chd-120	47	36	was	be	AUX
chd-120	47	37	recorded	record	VERB
chd-120	47	38	for	for	ADP
chd-120	47	39	patients	patient	NOUN
chd-120	47	40	above	above	ADP
chd-120	47	41	80	80	NUM
chd-120	47	42	years	year	NOUN
chd-120	47	43	.	.	PUNCT
chd-120	48	1	table	table	NOUN
chd-120	48	2	1	1	NUM
chd-120	48	3	.	.	PUNCT
chd-120	48	4	annual	annual	ADJ
chd-120	48	5	distribution	distribution	NOUN
chd-120	48	6	.	.	PUNCT
chd-120	49	1	year	year	NOUN
chd-120	49	2	number	number	NOUN
chd-120	49	3	percentage	percentage	NOUN
chd-120	49	4	2015	2015	NUM
chd-120	49	5	63	63	NUM
chd-120	49	6	19.0	19.0	NUM
chd-120	49	7	2016	2016	NUM
chd-120	49	8	114	114	NUM
chd-120	49	9	34.2	34.2	NUM
chd-120	49	10	2017	2017	NUM
chd-120	49	11	122	122	NUM
chd-120	49	12	36.6	36.6	NUM
chd-120	49	13	2018	2018	NUM
chd-120	49	14	(	(	PUNCT
chd-120	49	15	6	6	NUM
chd-120	49	16	months	month	NOUN
chd-120	49	17	)	)	PUNCT
chd-120	49	18	34	34	NUM
chd-120	49	19	10.2	10.2	NUM
chd-120	49	20	total	total	NOUN
chd-120	49	21	333	333	NUM
chd-120	49	22	100	100	NUM
chd-120	49	23	figure	figure	NOUN
chd-120	49	24	1	1	NUM
chd-120	49	25	.	.	PUNCT
chd-120	49	26	age	age	NOUN
chd-120	49	27	at	at	ADP
chd-120	49	28	diagnosis	diagnosis	NOUN
chd-120	49	29	.	.	PUNCT
chd-120	50	1	0.0	0.0	NUM
chd-120	50	2	%	%	NOUN
chd-120	50	3	5.0	5.0	NUM
chd-120	50	4	%	%	NOUN
chd-120	50	5	10.0	10.0	NUM
chd-120	50	6	%	%	NOUN
chd-120	50	7	15.0	15.0	NUM
chd-120	50	8	%	%	NOUN
chd-120	50	9	20.0	20.0	NUM
chd-120	50	10	%	%	NOUN
chd-120	50	11	25.0	25.0	NUM
chd-120	50	12	%	%	NOUN
chd-120	50	13	30.0	30.0	NUM
chd-120	50	14	%	%	NOUN
chd-120	50	15	35.0	35.0	NUM
chd-120	50	16	%	%	NOUN
chd-120	50	17	40.0	40.0	NUM
chd-120	50	18	%	%	NOUN
chd-120	50	19	45.0	45.0	NUM
chd-120	50	20	%	%	NOUN
chd-120	50	21	50	50	NUM
chd-120	50	22	–	–	PUNCT
chd-120	50	23	60	60	NUM
chd-120	50	24	61	61	NUM
chd-120	50	25	–	–	PUNCT
chd-120	50	26	70	70	NUM
chd-120	50	27	71	71	NUM
chd-120	50	28	–	–	PUNCT
chd-120	50	29	80	80	NUM
chd-120	50	30	above	above	ADP
chd-120	50	31	80	80	NUM
chd-120	50	32	not	not	PART
chd-120	50	33	stated	state	VERB
chd-120	50	34	43	43	NUM
chd-120	50	35	(	(	PUNCT
chd-120	50	36	12.9	12.9	NUM
chd-120	50	37	%	%	NOUN
chd-120	50	38	)	)	PUNCT
chd-120	50	39	141	141	NUM
chd-120	50	40	(	(	PUNCT
chd-120	50	41	42.3	42.3	NUM
chd-120	50	42	%	%	NOUN
chd-120	50	43	)	)	PUNCT
chd-120	50	44	112	112	NUM
chd-120	50	45	(	(	PUNCT
chd-120	50	46	33.6	33.6	NUM
chd-120	50	47	%	%	NOUN
chd-120	50	48	)	)	PUNCT
chd-120	50	49	26	26	NUM
chd-120	50	50	(	(	PUNCT
chd-120	50	51	7.8	7.8	NUM
chd-120	50	52	%	%	NOUN
chd-120	50	53	)	)	PUNCT
chd-120	50	54	11	11	NUM
chd-120	50	55	(	(	PUNCT
chd-120	50	56	3.4	3.4	NUM
chd-120	50	57	%	%	NOUN
chd-120	50	58	)	)	PUNCT
chd-120	50	59	pe	pe	PROPN
chd-120	51	1	rc	rc	PROPN
chd-120	51	2	en	en	PROPN
chd-120	51	3	t	t	PROPN
chd-120	51	4	age	age	NOUN
chd-120	51	5	at	at	ADP
chd-120	51	6	diagnosis	diagnosis	NOUN
chd-120	51	7	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	PART
chd-120	51	8	e4	e4	PROPN
chd-120	51	9	cancer	cancer	NOUN
chd-120	51	10	health	health	NOUN
chd-120	51	11	disparities	disparity	NOUN
chd-120	51	12	research	research	NOUN
chd-120	51	13	majority	majority	NOUN
chd-120	51	14	of	of	ADP
chd-120	51	15	the	the	DET
chd-120	51	16	patients	patient	NOUN
chd-120	51	17	were	be	AUX
chd-120	51	18	yorubas	yorubas	PROPN
chd-120	51	19	(	(	PUNCT
chd-120	51	20	247	247	NUM
chd-120	51	21	,	,	PUNCT
chd-120	51	22	74.2	74.2	NUM
chd-120	51	23	%	%	NOUN
chd-120	51	24	)	)	PUNCT
chd-120	51	25	followed	follow	VERB
chd-120	51	26	by	by	ADP
chd-120	51	27	ibos	ibo	NOUN
chd-120	51	28	(	(	PUNCT
chd-120	51	29	77	77	NUM
chd-120	51	30	,	,	PUNCT
chd-120	51	31	23.1	23.1	NUM
chd-120	51	32	%	%	NOUN
chd-120	51	33	)	)	PUNCT
chd-120	51	34	while	while	SCONJ
chd-120	51	35	only	only	ADV
chd-120	51	36	9	9	NUM
chd-120	51	37	(	(	PUNCT
chd-120	51	38	2.7	2.7	NUM
chd-120	51	39	%	%	NOUN
chd-120	51	40	)	)	PUNCT
chd-120	51	41	were	be	AUX
chd-120	51	42	from	from	ADP
chd-120	51	43	other	other	ADJ
chd-120	51	44	ethnic	ethnic	ADJ
chd-120	51	45	groups	group	NOUN
chd-120	51	46	(	(	PUNCT
chd-120	51	47	table	table	NOUN
chd-120	51	48	2	2	NUM
chd-120	51	49	)	)	PUNCT
chd-120	51	50	.	.	PUNCT
chd-120	52	1	table	table	NOUN
chd-120	52	2	2	2	NUM
chd-120	52	3	.	.	X
chd-120	52	4	ethnic	ethnic	ADJ
chd-120	52	5	distribution	distribution	NOUN
chd-120	52	6	.	.	PUNCT
chd-120	53	1	ethnic	ethnic	ADJ
chd-120	53	2	group	group	NOUN
chd-120	53	3	number	number	NOUN
chd-120	53	4	of	of	ADP
chd-120	53	5	cases	case	NOUN
chd-120	53	6	percentage	percentage	NOUN
chd-120	53	7	yoruba	yoruba	NOUN
chd-120	53	8	247	247	NUM
chd-120	53	9	74.2	74.2	NUM
chd-120	53	10	ibo	ibo	PROPN
chd-120	53	11	77	77	NUM
chd-120	53	12	23.1	23.1	NUM
chd-120	53	13	others	other	NOUN
chd-120	53	14	9	9	NUM
chd-120	53	15	2.7	2.7	NUM
chd-120	53	16	total	total	NOUN
chd-120	53	17	333	333	NUM
chd-120	53	18	100	100	NUM
chd-120	53	19	prostate	prostate	NOUN
chd-120	53	20	cancer	cancer	NOUN
chd-120	53	21	diagnosis	diagnosis	NOUN
chd-120	53	22	was	be	AUX
chd-120	53	23	made	make	VERB
chd-120	53	24	on	on	ADP
chd-120	53	25	316	316	NUM
chd-120	53	26	(	(	PUNCT
chd-120	53	27	94.9	94.9	NUM
chd-120	53	28	%	%	NOUN
chd-120	53	29	)	)	PUNCT
chd-120	53	30	trucut	trucut	VERB
chd-120	53	31	biopsy	biopsy	NOUN
chd-120	53	32	specimens	specimen	NOUN
chd-120	53	33	,	,	PUNCT
chd-120	53	34	while	while	SCONJ
chd-120	53	35	17	17	NUM
chd-120	53	36	(	(	PUNCT
chd-120	53	37	5.1	5.1	NUM
chd-120	53	38	%	%	NOUN
chd-120	53	39	)	)	PUNCT
chd-120	53	40	were	be	AUX
chd-120	53	41	prostatectomy	prostatectomy	ADP
chd-120	53	42	specimens	specimen	NOUN
chd-120	53	43	(	(	PUNCT
chd-120	53	44	figure	figure	NOUN
chd-120	53	45	2	2	NUM
chd-120	53	46	)	)	PUNCT
chd-120	53	47	.	.	PUNCT
chd-120	54	1	figure	figure	NOUN
chd-120	54	2	2	2	NUM
chd-120	54	3	.	.	PUNCT
chd-120	54	4	showing	show	VERB
chd-120	54	5	type	type	NOUN
chd-120	54	6	of	of	ADP
chd-120	54	7	tissue	tissue	NOUN
chd-120	54	8	for	for	ADP
chd-120	54	9	diagnosis	diagnosis	NOUN
chd-120	54	10	.	.	PUNCT
chd-120	55	1	majority	majority	NOUN
chd-120	55	2	(	(	PUNCT
chd-120	55	3	324	324	NUM
chd-120	55	4	,	,	PUNCT
chd-120	55	5	97.3	97.3	NUM
chd-120	55	6	%	%	NOUN
chd-120	55	7	)	)	PUNCT
chd-120	55	8	were	be	AUX
chd-120	55	9	diagnosed	diagnose	VERB
chd-120	55	10	as	as	ADP
chd-120	55	11	adenocarcinoma	adenocarcinoma	NOUN
chd-120	55	12	;	;	PUNCT
chd-120	55	13	papillary	papillary	ADJ
chd-120	55	14	carcinoma	carcinoma	NOUN
chd-120	55	15	accounted	account	VERB
chd-120	55	16	for	for	ADP
chd-120	55	17	7	7	NUM
chd-120	55	18	(	(	PUNCT
chd-120	55	19	2.1	2.1	NUM
chd-120	55	20	%	%	NOUN
chd-120	55	21	)	)	PUNCT
chd-120	55	22	of	of	ADP
chd-120	55	23	the	the	DET
chd-120	55	24	cases	case	NOUN
chd-120	55	25	,	,	PUNCT
chd-120	55	26	while	while	SCONJ
chd-120	55	27	clear	clear	ADJ
chd-120	55	28	cell	cell	NOUN
chd-120	55	29	carcinoma	carcinoma	NOUN
chd-120	55	30	and	and	CCONJ
chd-120	55	31	mucinous	mucinous	ADJ
chd-120	55	32	carcinoma	carcinoma	NOUN
chd-120	55	33	represented	represent	VERB
chd-120	55	34	0.3	0.3	NUM
chd-120	55	35	%	%	NOUN
chd-120	55	36	each	each	DET
chd-120	55	37	(	(	PUNCT
chd-120	55	38	table	table	NOUN
chd-120	55	39	3	3	NUM
chd-120	55	40	)	)	PUNCT
chd-120	55	41	.	.	PUNCT
chd-120	56	1	table	table	NOUN
chd-120	57	1	3	3	NUM
chd-120	57	2	.	.	PUNCT
chd-120	58	1	histological	histological	ADJ
chd-120	58	2	types	type	NOUN
chd-120	58	3	.	.	PUNCT
chd-120	59	1	type	type	NOUN
chd-120	59	2	number	number	NOUN
chd-120	59	3	percentage	percentage	NOUN
chd-120	59	4	adenocarcinoma	adenocarcinoma	NOUN
chd-120	59	5	324	324	NUM
chd-120	59	6	97.3	97.3	NUM
chd-120	59	7	papillary	papillary	ADJ
chd-120	59	8	carcinoma	carcinoma	NOUN
chd-120	59	9	7	7	NUM
chd-120	59	10	2.1	2.1	NUM
chd-120	59	11	clear	clear	ADJ
chd-120	59	12	cell	cell	NOUN
chd-120	59	13	carcinoma	carcinoma	NOUN
chd-120	59	14	1	1	NUM
chd-120	59	15	0.3	0.3	NUM
chd-120	59	16	mucinous	mucinous	ADJ
chd-120	59	17	carcinoma	carcinoma	NOUN
chd-120	59	18	1	1	NUM
chd-120	59	19	0.3	0.3	NUM
chd-120	59	20	adenocarcinomas	adenocarcinoma	NOUN
chd-120	59	21	were	be	AUX
chd-120	59	22	categorized	categorize	VERB
chd-120	59	23	according	accord	VERB
chd-120	59	24	to	to	ADP
chd-120	59	25	the	the	DET
chd-120	59	26	gleason	gleason	PROPN
chd-120	59	27	patterns	pattern	NOUN
chd-120	59	28	observed	observe	VERB
chd-120	59	29	.	.	PUNCT
chd-120	60	1	figures	figure	NOUN
chd-120	60	2	3	3	NUM
chd-120	60	3	-	-	SYM
chd-120	60	4	7	7	NUM
chd-120	60	5	typifies	typify	VERB
chd-120	60	6	gleason	gleason	PROPN
chd-120	60	7	patterns	pattern	NOUN
chd-120	60	8	1	1	NUM
chd-120	60	9	to	to	PART
chd-120	60	10	5	5	NUM
chd-120	60	11	as	as	SCONJ
chd-120	60	12	seen	see	VERB
chd-120	60	13	in	in	ADP
chd-120	60	14	this	this	DET
chd-120	60	15	series	series	NOUN
chd-120	60	16	.	.	PUNCT
chd-120	61	1	most	most	ADJ
chd-120	61	2	of	of	ADP
chd-120	61	3	the	the	DET
chd-120	61	4	prostate	prostate	NOUN
chd-120	61	5	cancers	cancer	NOUN
chd-120	61	6	diagnosed	diagnose	VERB
chd-120	61	7	at	at	ADP
chd-120	61	8	our	our	PRON
chd-120	61	9	centre	centre	NOUN
chd-120	61	10	were	be	AUX
chd-120	61	11	gleason	gleason	PROPN
chd-120	61	12	grade	grade	PROPN
chd-120	61	13	5	5	NUM
chd-120	61	14	(	(	PUNCT
chd-120	61	15	high	high	ADJ
chd-120	61	16	grade	grade	NOUN
chd-120	61	17	,	,	PUNCT
chd-120	61	18	figs	fig	NOUN
chd-120	61	19	.	.	X
chd-120	62	1	6	6	NUM
chd-120	62	2	and	and	CCONJ
chd-120	62	3	7	7	NUM
chd-120	62	4	)	)	PUNCT
chd-120	62	5	which	which	PRON
chd-120	62	6	accounted	account	VERB
chd-120	62	7	for	for	ADP
chd-120	62	8	125	125	NUM
chd-120	62	9	(	(	PUNCT
chd-120	62	10	37.5	37.5	NUM
chd-120	62	11	%	%	NOUN
chd-120	62	12	)	)	PUNCT
chd-120	62	13	of	of	ADP
chd-120	62	14	all	all	DET
chd-120	62	15	the	the	DET
chd-120	62	16	tumours	tumour	NOUN
chd-120	62	17	,	,	PUNCT
chd-120	62	18	while	while	SCONJ
chd-120	62	19	grade	grade	NOUN
chd-120	62	20	3	3	NUM
chd-120	62	21	(	(	PUNCT
chd-120	62	22	fig	fig	NOUN
chd-120	62	23	.	.	NOUN
chd-120	62	24	4	4	NUM
chd-120	62	25	and	and	CCONJ
chd-120	62	26	5	5	NUM
chd-120	62	27	)	)	PUNCT
chd-120	62	28	was	be	AUX
chd-120	62	29	the	the	DET
chd-120	62	30	least	least	ADJ
chd-120	62	31	with	with	ADP
chd-120	62	32	34	34	NUM
chd-120	62	33	(	(	PUNCT
chd-120	62	34	10.2	10.2	NUM
chd-120	62	35	%	%	NOUN
chd-120	62	36	)	)	PUNCT
chd-120	62	37	.	.	PUNCT
chd-120	63	1	low	low	ADJ
chd-120	63	2	grade	grade	NOUN
chd-120	63	3	tumour	tumour	NOUN
chd-120	63	4	(	(	PUNCT
chd-120	63	5	grade	grade	NOUN
chd-120	63	6	1	1	NUM
chd-120	63	7	)	)	PUNCT
chd-120	63	8	was	be	AUX
chd-120	63	9	observed	observe	VERB
chd-120	63	10	in	in	ADP
chd-120	63	11	37	37	NUM
chd-120	63	12	(	(	PUNCT
chd-120	63	13	11.1	11.1	NUM
chd-120	63	14	%	%	NOUN
chd-120	63	15	)	)	PUNCT
chd-120	63	16	of	of	ADP
chd-120	63	17	the	the	DET
chd-120	63	18	cases	case	NOUN
chd-120	63	19	(	(	PUNCT
chd-120	63	20	figures	figure	NOUN
chd-120	63	21	3	3	NUM
chd-120	63	22	and	and	CCONJ
chd-120	63	23	4	4	NUM
chd-120	63	24	)	)	PUNCT
chd-120	63	25	.	.	PUNCT
chd-120	64	1	figure	figure	VERB
chd-120	64	2	3	3	NUM
chd-120	64	3	.	.	PUNCT
chd-120	65	1	photomicrograph	photomicrograph	NOUN
chd-120	65	2	(	(	PUNCT
chd-120	65	3	x	x	PROPN
chd-120	65	4	100	100	NUM
chd-120	65	5	,	,	PUNCT
chd-120	65	6	h&e	h&e	PROPN
chd-120	65	7	)	)	PUNCT
chd-120	65	8	showing	show	VERB
chd-120	65	9	closely	closely	ADV
chd-120	65	10	packed	pack	VERB
chd-120	65	11	glands	gland	NOUN
chd-120	65	12	with	with	ADP
chd-120	65	13	little	little	ADJ
chd-120	65	14	intervening	intervene	VERB
chd-120	65	15	stroma	stroma	ADJ
chd-120	65	16	prostatic	prostatic	ADJ
chd-120	65	17	adenocarcinoma	adenocarcinoma	PROPN
chd-120	65	18	gleason	gleason	PROPN
chd-120	65	19	pattern	pattern	NOUN
chd-120	65	20	1	1	NUM
chd-120	65	21	.	.	PUNCT
chd-120	65	22	figure	figure	VERB
chd-120	65	23	4	4	NUM
chd-120	65	24	.	.	PUNCT
chd-120	66	1	photomicrograph	photomicrograph	PROPN
chd-120	66	2	(	(	PUNCT
chd-120	66	3	x40	x40	PROPN
chd-120	66	4	h&e	h&e	PROPN
chd-120	66	5	)	)	PUNCT
chd-120	67	1	showing	show	VERB
chd-120	67	2	infiltrating	infiltrate	VERB
chd-120	67	3	small	small	ADJ
chd-120	67	4	-	-	PUNCT
chd-120	67	5	sized	sized	ADJ
chd-120	67	6	distinct	distinct	ADJ
chd-120	67	7	neoplastic	neoplastic	ADJ
chd-120	67	8	glands	gland	NOUN
chd-120	67	9	with	with	ADP
chd-120	67	10	appreciable	appreciable	ADJ
chd-120	67	11	amount	amount	NOUN
chd-120	67	12	of	of	ADP
chd-120	67	13	intervening	intervene	VERB
chd-120	67	14	stroma	stroma	NOUN
chd-120	67	15	.	.	PUNCT
chd-120	68	1	prostatic	prostatic	ADJ
chd-120	68	2	adenocarcinoma	adenocarcinoma	PROPN
chd-120	68	3	gleason	gleason	PROPN
chd-120	68	4	pattern	pattern	NOUN
chd-120	68	5	2	2	NUM
chd-120	68	6	.	.	PUNCT
chd-120	68	7	94.9	94.9	NUM
chd-120	68	8	%	%	NOUN
chd-120	68	9	5.1	5.1	NUM
chd-120	68	10	%	%	NOUN
chd-120	68	11	biopsy	biopsy	NOUN
chd-120	68	12	prostatectomy	prostatectomy	ADP
chd-120	68	13	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	NUM
chd-120	68	14	e5	e5	PROPN
chd-120	68	15	cancer	cancer	NOUN
chd-120	68	16	health	health	NOUN
chd-120	68	17	disparities	disparity	NOUN
chd-120	68	18	research	research	NOUN
chd-120	68	19	figure	figure	NOUN
chd-120	68	20	5	5	NUM
chd-120	68	21	.	.	PUNCT
chd-120	69	1	photomicrograph	photomicrograph	PROPN
chd-120	69	2	(	(	PUNCT
chd-120	69	3	x40	x40	PROPN
chd-120	69	4	h&e	h&e	PROPN
chd-120	69	5	)	)	PUNCT
chd-120	69	6	showing	show	VERB
chd-120	69	7	infiltrating	infiltrate	VERB
chd-120	69	8	,	,	PUNCT
chd-120	69	9	irregular	irregular	ADJ
chd-120	69	10	small	small	ADJ
chd-120	69	11	-	-	PUNCT
chd-120	69	12	sized	sized	ADJ
chd-120	69	13	neoplastic	neoplastic	ADJ
chd-120	69	14	glands	gland	NOUN
chd-120	69	15	.	.	PUNCT
chd-120	70	1	prostatic	prostatic	ADJ
chd-120	70	2	adenocarcinoma	adenocarcinoma	NOUN
chd-120	70	3	,	,	PUNCT
chd-120	70	4	gleason	gleason	PROPN
chd-120	70	5	pattern	pattern	NOUN
chd-120	70	6	3	3	NUM
chd-120	70	7	.	.	PUNCT
chd-120	70	8	figure	figure	NOUN
chd-120	70	9	6	6	NUM
chd-120	70	10	.	.	PUNCT
chd-120	71	1	photomicrograph	photomicrograph	PROPN
chd-120	71	2	(	(	PUNCT
chd-120	71	3	x40	x40	PROPN
chd-120	71	4	h&e	h&e	PROPN
chd-120	71	5	)	)	PUNCT
chd-120	71	6	showing	show	VERB
chd-120	71	7	fused	fuse	VERB
chd-120	71	8	neoplastic	neoplastic	ADJ
chd-120	71	9	glands	gland	NOUN
chd-120	71	10	forming	form	VERB
chd-120	71	11	a	a	DET
chd-120	71	12	cribriform	cribriform	NOUN
chd-120	71	13	pattern	pattern	NOUN
chd-120	71	14	.	.	PUNCT
chd-120	72	1	prostatic	prostatic	ADJ
chd-120	72	2	adenocarcinoma	adenocarcinoma	PROPN
chd-120	72	3	gleason	gleason	PROPN
chd-120	72	4	pattern	pattern	NOUN
chd-120	72	5	4	4	NUM
chd-120	72	6	.	.	PUNCT
chd-120	72	7	figure	figure	VERB
chd-120	72	8	7	7	NUM
chd-120	72	9	.	.	PUNCT
chd-120	73	1	photomicrograph	photomicrograph	PROPN
chd-120	73	2	(	(	PUNCT
chd-120	73	3	x100	x100	PROPN
chd-120	73	4	h&e	h&e	PROPN
chd-120	73	5	)	)	PUNCT
chd-120	73	6	showing	show	VERB
chd-120	73	7	sheet	sheet	NOUN
chd-120	73	8	of	of	ADP
chd-120	73	9	neoplastic	neoplastic	ADJ
chd-120	73	10	cells	cell	NOUN
chd-120	73	11	.	.	PUNCT
chd-120	74	1	prostatic	prostatic	ADJ
chd-120	74	2	adenocarcinoma	adenocarcinoma	PROPN
chd-120	74	3	gleason	gleason	PROPN
chd-120	74	4	pattern	pattern	NOUN
chd-120	74	5	5	5	NUM
chd-120	74	6	.	.	PUNCT
chd-120	74	7	grade	grade	NOUN
chd-120	74	8	1	1	NUM
chd-120	74	9	tumour	tumour	NOUN
chd-120	74	10	was	be	AUX
chd-120	74	11	most	most	ADV
chd-120	74	12	commonly	commonly	ADV
chd-120	74	13	observed	observe	VERB
chd-120	74	14	in	in	ADP
chd-120	74	15	the	the	DET
chd-120	74	16	50	50	NUM
chd-120	74	17	-	-	SYM
chd-120	74	18	60	60	NUM
chd-120	74	19	years	year	NOUN
chd-120	74	20	age	age	NOUN
chd-120	74	21	group	group	NOUN
chd-120	74	22	(	(	PUNCT
chd-120	74	23	11	11	NUM
chd-120	74	24	,	,	PUNCT
chd-120	74	25	28.2	28.2	NUM
chd-120	74	26	%	%	NOUN
chd-120	74	27	)	)	PUNCT
chd-120	74	28	,	,	PUNCT
chd-120	74	29	while	while	SCONJ
chd-120	74	30	grade	grade	NOUN
chd-120	74	31	5	5	NUM
chd-120	74	32	was	be	AUX
chd-120	74	33	most	most	ADV
chd-120	74	34	frequently	frequently	ADV
chd-120	74	35	seen	see	VERB
chd-120	74	36	in	in	ADP
chd-120	74	37	the	the	DET
chd-120	74	38	71	71	NUM
chd-120	74	39	-	-	SYM
chd-120	74	40	80	80	NUM
chd-120	74	41	years	year	NOUN
chd-120	74	42	group	group	NOUN
chd-120	74	43	this	this	DET
chd-120	74	44	study	study	NOUN
chd-120	74	45	showed	show	VERB
chd-120	74	46	that	that	SCONJ
chd-120	74	47	the	the	DET
chd-120	74	48	commonest	commonest	NOUN
chd-120	74	49	number	number	NOUN
chd-120	74	50	of	of	ADP
chd-120	74	51	prostate	prostate	NOUN
chd-120	74	52	biopsy	biopsy	NOUN
chd-120	74	53	cores	core	NOUN
chd-120	74	54	sent	send	VERB
chd-120	74	55	to	to	ADP
chd-120	74	56	our	our	PRON
chd-120	74	57	laboratory	laboratory	NOUN
chd-120	74	58	by	by	ADP
chd-120	74	59	surgeons	surgeon	NOUN
chd-120	74	60	is	be	AUX
chd-120	74	61	10	10	NUM
chd-120	74	62	(	(	PUNCT
chd-120	74	63	11.2	11.2	NUM
chd-120	74	64	%	%	NOUN
chd-120	74	65	)	)	PUNCT
chd-120	74	66	.	.	PUNCT
chd-120	75	1	in	in	ADP
chd-120	75	2	some	some	DET
chd-120	75	3	cases	case	NOUN
chd-120	75	4	,	,	PUNCT
chd-120	75	5	as	as	ADV
chd-120	75	6	few	few	ADJ
chd-120	75	7	as	as	ADP
chd-120	75	8	2	2	NUM
chd-120	75	9	cores	core	NOUN
chd-120	75	10	(	(	PUNCT
chd-120	75	11	2	2	NUM
chd-120	75	12	,	,	PUNCT
chd-120	75	13	3.0	3.0	NUM
chd-120	75	14	%	%	NOUN
chd-120	75	15	)	)	PUNCT
chd-120	75	16	and	and	CCONJ
chd-120	75	17	as	as	ADV
chd-120	75	18	many	many	ADJ
chd-120	75	19	as	as	ADP
chd-120	75	20	32	32	NUM
chd-120	75	21	cores	core	NOUN
chd-120	75	22	(	(	PUNCT
chd-120	75	23	1	1	NUM
chd-120	75	24	,	,	PUNCT
chd-120	75	25	0.3	0.3	NUM
chd-120	75	26	%	%	NOUN
chd-120	75	27	)	)	PUNCT
chd-120	75	28	were	be	AUX
chd-120	75	29	received	receive	VERB
chd-120	75	30	(	(	PUNCT
chd-120	75	31	table	table	NOUN
chd-120	75	32	5	5	NUM
chd-120	75	33	)	)	PUNCT
chd-120	75	34	.	.	PUNCT
chd-120	76	1	table	table	NOUN
chd-120	76	2	4	4	NUM
chd-120	76	3	.	.	X
chd-120	76	4	association	association	NOUN
chd-120	76	5	between	between	ADP
chd-120	76	6	grades	grade	NOUN
chd-120	76	7	and	and	CCONJ
chd-120	76	8	age	age	NOUN
chd-120	76	9	(	(	PUNCT
chd-120	76	10	p	p	NOUN
chd-120	76	11	=	=	NOUN
chd-120	76	12	0.380	0.380	NUM
chd-120	76	13	)	)	PUNCT
chd-120	76	14	.	.	PUNCT
chd-120	77	1	age	age	NOUN
chd-120	77	2	group	group	NOUN
chd-120	77	3	in	in	ADP
chd-120	77	4	years	year	NOUN
chd-120	77	5	(	(	PUNCT
chd-120	77	6	%	%	INTJ
chd-120	77	7	)	)	PUNCT
chd-120	77	8	gleason	gleason	PROPN
chd-120	77	9	grade	grade	PROPN
chd-120	77	10	50	50	NUM
chd-120	77	11	–	–	PUNCT
chd-120	77	12	60	60	NUM
chd-120	77	13	61	61	NUM
chd-120	77	14	–	–	PUNCT
chd-120	77	15	70	70	NUM
chd-120	77	16	71	71	NUM
chd-120	77	17	–	–	PUNCT
chd-120	77	18	80	80	NUM
chd-120	77	19	above	above	ADP
chd-120	77	20	80	80	NUM
chd-120	77	21	grade	grade	NOUN
chd-120	77	22	1	1	NUM
chd-120	77	23	11	11	NUM
chd-120	77	24	(	(	PUNCT
chd-120	77	25	28.2	28.2	NUM
chd-120	77	26	%	%	NOUN
chd-120	77	27	)	)	PUNCT
chd-120	77	28	14	14	NUM
chd-120	77	29	(	(	PUNCT
chd-120	77	30	10.6	10.6	NUM
chd-120	77	31	%	%	NOUN
chd-120	77	32	)	)	PUNCT
chd-120	77	33	11	11	NUM
chd-120	77	34	(	(	PUNCT
chd-120	77	35	11.7	11.7	NUM
chd-120	77	36	%	%	NOUN
chd-120	77	37	)	)	PUNCT
chd-120	77	38	1	1	NUM
chd-120	77	39	(	(	PUNCT
chd-120	77	40	4.5	4.5	NUM
chd-120	77	41	%	%	NOUN
chd-120	77	42	)	)	PUNCT
chd-120	77	43	grade	grade	NOUN
chd-120	77	44	2	2	NUM
chd-120	77	45	4	4	NUM
chd-120	77	46	(	(	PUNCT
chd-120	77	47	10.3	10.3	NUM
chd-120	77	48	%	%	NOUN
chd-120	77	49	)	)	PUNCT
chd-120	77	50	20	20	NUM
chd-120	77	51	(	(	PUNCT
chd-120	77	52	15.2	15.2	NUM
chd-120	77	53	%	%	NOUN
chd-120	77	54	)	)	PUNCT
chd-120	77	55	10	10	NUM
chd-120	77	56	(	(	PUNCT
chd-120	77	57	10.6	10.6	NUM
chd-120	77	58	%	%	NOUN
chd-120	77	59	)	)	PUNCT
chd-120	77	60	2	2	NUM
chd-120	77	61	(	(	PUNCT
chd-120	77	62	9.1	9.1	NUM
chd-120	77	63	%	%	NOUN
chd-120	77	64	)	)	PUNCT
chd-120	77	65	grade	grade	NOUN
chd-120	77	66	3	3	NUM
chd-120	77	67	4	4	NUM
chd-120	77	68	(	(	PUNCT
chd-120	77	69	10.3	10.3	NUM
chd-120	77	70	%	%	NOUN
chd-120	77	71	)	)	PUNCT
chd-120	77	72	16	16	NUM
chd-120	77	73	(	(	PUNCT
chd-120	77	74	12.1	12.1	NUM
chd-120	77	75	%	%	NOUN
chd-120	77	76	)	)	PUNCT
chd-120	77	77	10	10	NUM
chd-120	77	78	(	(	PUNCT
chd-120	77	79	10.6	10.6	NUM
chd-120	77	80	%	%	NOUN
chd-120	77	81	)	)	PUNCT
chd-120	77	82	3	3	NUM
chd-120	77	83	(	(	PUNCT
chd-120	77	84	13.6	13.6	NUM
chd-120	77	85	%	%	NOUN
chd-120	77	86	)	)	PUNCT
chd-120	77	87	grade	grade	NOUN
chd-120	77	88	4	4	NUM
chd-120	77	89	5	5	NUM
chd-120	77	90	(	(	PUNCT
chd-120	77	91	12.8	12.8	NUM
chd-120	77	92	%	%	NOUN
chd-120	77	93	)	)	PUNCT
chd-120	77	94	28	28	NUM
chd-120	77	95	(	(	PUNCT
chd-120	77	96	21.2	21.2	NUM
chd-120	77	97	%	%	NOUN
chd-120	77	98	)	)	PUNCT
chd-120	77	99	19	19	NUM
chd-120	77	100	(	(	PUNCT
chd-120	77	101	20.2	20.2	NUM
chd-120	77	102	%	%	NOUN
chd-120	77	103	)	)	PUNCT
chd-120	77	104	6	6	NUM
chd-120	77	105	(	(	PUNCT
chd-120	77	106	27.3	27.3	NUM
chd-120	77	107	%	%	NOUN
chd-120	77	108	)	)	PUNCT
chd-120	77	109	grade	grade	NOUN
chd-120	77	110	5	5	NUM
chd-120	77	111	15	15	NUM
chd-120	77	112	(	(	PUNCT
chd-120	77	113	38.5	38.5	NUM
chd-120	77	114	%	%	NOUN
chd-120	77	115	)	)	PUNCT
chd-120	77	116	54	54	NUM
chd-120	77	117	(	(	PUNCT
chd-120	77	118	40.9	40.9	NUM
chd-120	77	119	%	%	NOUN
chd-120	77	120	)	)	PUNCT
chd-120	77	121	44	44	NUM
chd-120	77	122	(	(	PUNCT
chd-120	77	123	46.8	46.8	NUM
chd-120	77	124	%	%	NOUN
chd-120	77	125	)	)	PUNCT
chd-120	77	126	10	10	NUM
chd-120	77	127	(	(	PUNCT
chd-120	77	128	45.5	45.5	NUM
chd-120	77	129	%	%	NOUN
chd-120	77	130	)	)	PUNCT
chd-120	77	131	total	total	NOUN
chd-120	77	132	39	39	NUM
chd-120	77	133	(	(	PUNCT
chd-120	77	134	100.0	100.0	NUM
chd-120	77	135	%	%	NOUN
chd-120	77	136	)	)	PUNCT
chd-120	77	137	132	132	NUM
chd-120	77	138	(	(	PUNCT
chd-120	77	139	100.0	100.0	NUM
chd-120	77	140	%	%	NOUN
chd-120	77	141	)	)	PUNCT
chd-120	77	142	94	94	NUM
chd-120	77	143	(	(	PUNCT
chd-120	77	144	100.0	100.0	NUM
chd-120	77	145	%	%	NOUN
chd-120	77	146	)	)	PUNCT
chd-120	77	147	22	22	NUM
chd-120	77	148	(	(	PUNCT
chd-120	77	149	100.0	100.0	NUM
chd-120	77	150	%	%	NOUN
chd-120	77	151	)	)	PUNCT
chd-120	77	152	table	table	NOUN
chd-120	77	153	5	5	NUM
chd-120	77	154	.	.	PUNCT
chd-120	77	155	frequency	frequency	NOUN
chd-120	77	156	of	of	ADP
chd-120	77	157	the	the	DET
chd-120	77	158	number	number	NOUN
chd-120	77	159	of	of	ADP
chd-120	77	160	cores	core	NOUN
chd-120	77	161	.	.	PUNCT
chd-120	78	1	number	number	NOUN
chd-120	78	2	of	of	ADP
chd-120	78	3	cores	core	NOUN
chd-120	78	4	frequency	frequency	NOUN
chd-120	78	5	percent	percent	NOUN
chd-120	78	6	1	1	NUM
chd-120	78	7	-	-	SYM
chd-120	78	8	5	5	NUM
chd-120	78	9	30	30	NUM
chd-120	78	10	17.2	17.2	NUM
chd-120	78	11	6	6	NUM
chd-120	78	12	-	-	SYM
chd-120	78	13	10	10	NUM
chd-120	78	14	129	129	NUM
chd-120	78	15	74.1	74.1	NUM
chd-120	78	16	11	11	NUM
chd-120	78	17	-	-	SYM
chd-120	78	18	15	15	NUM
chd-120	78	19	106	106	NUM
chd-120	78	20	60.9	60.9	NUM
chd-120	78	21	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	NUM
chd-120	78	22	e6	e6	NOUN
chd-120	78	23	cancer	cancer	NOUN
chd-120	78	24	health	health	NOUN
chd-120	78	25	disparities	disparity	NOUN
chd-120	78	26	research	research	VERB
chd-120	78	27	16	16	NUM
chd-120	78	28	-	-	SYM
chd-120	78	29	20	20	NUM
chd-120	78	30	16	16	NUM
chd-120	78	31	9.2	9.2	NUM
chd-120	78	32	above	above	ADP
chd-120	78	33	20	20	NUM
chd-120	78	34	5	5	NUM
chd-120	78	35	2.9	2.9	NUM
chd-120	78	36	not	not	PART
chd-120	78	37	stated	state	VERB
chd-120	78	38	47	47	NUM
chd-120	78	39	27.0	27.0	NUM
chd-120	78	40	total	total	NOUN
chd-120	78	41	174	174	NUM
chd-120	78	42	100.0	100.0	NUM
chd-120	78	43	discussion	discussion	NOUN
chd-120	78	44	this	this	DET
chd-120	78	45	study	study	NOUN
chd-120	78	46	revealed	reveal	VERB
chd-120	78	47	that	that	SCONJ
chd-120	78	48	prostate	prostate	NOUN
chd-120	78	49	cancer	cancer	NOUN
chd-120	78	50	accounted	account	VERB
chd-120	78	51	for	for	ADP
chd-120	78	52	46.4	46.4	NUM
chd-120	78	53	%	%	NOUN
chd-120	78	54	of	of	ADP
chd-120	78	55	all	all	DET
chd-120	78	56	newly	newly	ADV
chd-120	78	57	diagnosed	diagnose	VERB
chd-120	78	58	prostate	prostate	NOUN
chd-120	78	59	pathologies	pathology	NOUN
chd-120	78	60	at	at	ADP
chd-120	78	61	our	our	PRON
chd-120	78	62	centre	centre	NOUN
chd-120	78	63	.	.	PUNCT
chd-120	79	1	this	this	PRON
chd-120	79	2	is	be	AUX
chd-120	79	3	higher	high	ADJ
chd-120	79	4	than	than	ADP
chd-120	79	5	a	a	DET
chd-120	79	6	range	range	NOUN
chd-120	79	7	of	of	ADP
chd-120	79	8	22.4	22.4	NUM
chd-120	79	9	%	%	NOUN
chd-120	79	10	to	to	ADP
chd-120	79	11	37.4	37.4	NUM
chd-120	79	12	%	%	NOUN
chd-120	79	13	reported	report	VERB
chd-120	79	14	from	from	ADP
chd-120	79	15	studies	study	NOUN
chd-120	79	16	from	from	ADP
chd-120	79	17	other	other	ADJ
chd-120	79	18	parts	part	NOUN
chd-120	79	19	of	of	ADP
chd-120	79	20	nigeria	nigeria	PROPN
chd-120	79	21	(	(	PUNCT
chd-120	79	22	mohammed	mohammed	PROPN
chd-120	79	23	et	et	PROPN
chd-120	79	24	al	al	PROPN
chd-120	79	25	.	.	PROPN
chd-120	79	26	,	,	PUNCT
chd-120	79	27	2003	2003	NUM
chd-120	79	28	,	,	PUNCT
chd-120	79	29	okeke	okeke	VERB
chd-120	79	30	et	et	PROPN
chd-120	79	31	al	al	PROPN
chd-120	79	32	.	.	PROPN
chd-120	79	33	,	,	PUNCT
chd-120	79	34	2017	2017	NUM
chd-120	79	35	and	and	CCONJ
chd-120	79	36	obiorah	obiorah	NOUN
chd-120	79	37	et	et	PROPN
chd-120	79	38	al	al	PROPN
chd-120	79	39	.	.	PROPN
chd-120	79	40	,	,	PUNCT
chd-120	79	41	2011	2011	NUM
chd-120	79	42	)	)	PUNCT
chd-120	79	43	.	.	PUNCT
chd-120	80	1	the	the	DET
chd-120	80	2	higher	high	ADJ
chd-120	80	3	incidence	incidence	NOUN
chd-120	80	4	reported	report	VERB
chd-120	80	5	in	in	ADP
chd-120	80	6	our	our	PRON
chd-120	80	7	study	study	NOUN
chd-120	80	8	may	may	AUX
chd-120	80	9	be	be	AUX
chd-120	80	10	due	due	ADJ
chd-120	80	11	to	to	ADP
chd-120	80	12	the	the	DET
chd-120	80	13	considerably	considerably	ADV
chd-120	80	14	higher	high	ADJ
chd-120	80	15	sample	sample	NOUN
chd-120	80	16	size	size	NOUN
chd-120	80	17	in	in	ADP
chd-120	80	18	our	our	PRON
chd-120	80	19	study	study	NOUN
chd-120	80	20	as	as	ADP
chd-120	80	21	compared	compare	VERB
chd-120	80	22	to	to	ADP
chd-120	80	23	the	the	DET
chd-120	80	24	works	work	NOUN
chd-120	80	25	done	do	VERB
chd-120	80	26	in	in	ADP
chd-120	80	27	kano	kano	PROPN
chd-120	80	28	,	,	PUNCT
chd-120	80	29	port	port	NOUN
chd-120	80	30	harcourt	harcourt	PROPN
chd-120	80	31	and	and	CCONJ
chd-120	80	32	a	a	DET
chd-120	80	33	previous	previous	ADJ
chd-120	80	34	study	study	NOUN
chd-120	80	35	in	in	ADP
chd-120	80	36	lagos	lago	NOUN
chd-120	80	37	(	(	PUNCT
chd-120	80	38	okeke	okeke	VERB
chd-120	80	39	et	et	PROPN
chd-120	80	40	al	al	PROPN
chd-120	80	41	.	.	PROPN
chd-120	80	42	,	,	PUNCT
chd-120	80	43	2017	2017	NUM
chd-120	80	44	,	,	PUNCT
chd-120	80	45	obiorah	obiorah	NOUN
chd-120	80	46	et	et	PROPN
chd-120	80	47	al	al	PROPN
chd-120	80	48	.	.	PROPN
chd-120	80	49	,	,	PUNCT
chd-120	80	50	2011	2011	NUM
chd-120	80	51	and	and	CCONJ
chd-120	80	52	bah	bah	INTJ
chd-120	80	53	et	et	PROPN
chd-120	80	54	al	al	PROPN
chd-120	80	55	.	.	PROPN
chd-120	80	56	,	,	PUNCT
chd-120	80	57	2001	2001	NUM
chd-120	80	58	)	)	PUNCT
chd-120	80	59	.	.	PUNCT
chd-120	81	1	the	the	DET
chd-120	81	2	higher	high	ADJ
chd-120	81	3	sample	sample	NOUN
chd-120	81	4	size	size	NOUN
chd-120	81	5	at	at	ADP
chd-120	81	6	our	our	PRON
chd-120	81	7	centre	centre	NOUN
chd-120	81	8	may	may	AUX
chd-120	81	9	also	also	ADV
chd-120	81	10	be	be	AUX
chd-120	81	11	partly	partly	ADV
chd-120	81	12	due	due	ADJ
chd-120	81	13	to	to	ADP
chd-120	81	14	the	the	DET
chd-120	81	15	fact	fact	NOUN
chd-120	81	16	that	that	SCONJ
chd-120	81	17	the	the	DET
chd-120	81	18	lagos	lagos	NOUN
chd-120	81	19	state	state	NOUN
chd-120	81	20	government	government	NOUN
chd-120	81	21	has	have	AUX
chd-120	81	22	in	in	ADP
chd-120	81	23	the	the	DET
chd-120	81	24	recent	recent	ADJ
chd-120	81	25	years	year	NOUN
chd-120	81	26	embarked	embark	VERB
chd-120	81	27	on	on	ADP
chd-120	81	28	free	free	ADJ
chd-120	81	29	prostate	prostate	NOUN
chd-120	81	30	cancer	cancer	NOUN
chd-120	81	31	screening	screen	VERB
chd-120	81	32	exercise	exercise	NOUN
chd-120	81	33	for	for	ADP
chd-120	81	34	some	some	DET
chd-120	81	35	elderly	elderly	ADJ
chd-120	81	36	citizens	citizen	NOUN
chd-120	81	37	which	which	PRON
chd-120	81	38	resulted	result	VERB
chd-120	81	39	in	in	ADP
chd-120	81	40	a	a	DET
chd-120	81	41	high	high	ADJ
chd-120	81	42	turn	turn	NOUN
chd-120	81	43	-	-	PUNCT
chd-120	81	44	out	out	NOUN
chd-120	81	45	of	of	ADP
chd-120	81	46	subjects	subject	NOUN
chd-120	81	47	,	,	PUNCT
chd-120	81	48	some	some	PRON
chd-120	81	49	of	of	ADP
chd-120	81	50	whom	whom	PRON
chd-120	81	51	were	be	AUX
chd-120	81	52	diagnosed	diagnose	VERB
chd-120	81	53	with	with	ADP
chd-120	81	54	prostate	prostate	NOUN
chd-120	81	55	cancer	cancer	NOUN
chd-120	81	56	.	.	PUNCT
chd-120	82	1	besides	besides	SCONJ
chd-120	82	2	,	,	PUNCT
chd-120	82	3	lagos	lago	NOUN
chd-120	82	4	is	be	AUX
chd-120	82	5	nigeria	nigeria	PROPN
chd-120	82	6	’s	’s	PART
chd-120	82	7	commercial	commercial	ADJ
chd-120	82	8	capital	capital	NOUN
chd-120	82	9	and	and	CCONJ
chd-120	82	10	the	the	DET
chd-120	82	11	most	most	ADV
chd-120	82	12	populous	populous	ADJ
chd-120	82	13	city	city	NOUN
chd-120	82	14	in	in	ADP
chd-120	82	15	the	the	DET
chd-120	82	16	country	country	NOUN
chd-120	82	17	.	.	PUNCT
chd-120	83	1	the	the	DET
chd-120	83	2	median	median	ADJ
chd-120	83	3	age	age	NOUN
chd-120	83	4	of	of	ADP
chd-120	83	5	men	man	NOUN
chd-120	83	6	diagnosed	diagnose	VERB
chd-120	83	7	with	with	ADP
chd-120	83	8	prostate	prostate	NOUN
chd-120	83	9	cancer	cancer	NOUN
chd-120	83	10	in	in	ADP
chd-120	83	11	our	our	PRON
chd-120	83	12	series	series	NOUN
chd-120	83	13	is	be	AUX
chd-120	83	14	70	70	NUM
chd-120	83	15	years	year	NOUN
chd-120	83	16	,	,	PUNCT
chd-120	83	17	with	with	ADP
chd-120	83	18	the	the	DET
chd-120	83	19	lowest	low	ADJ
chd-120	83	20	age	age	NOUN
chd-120	83	21	being	be	AUX
chd-120	83	22	50	50	NUM
chd-120	83	23	years	year	NOUN
chd-120	83	24	,	,	PUNCT
chd-120	83	25	while	while	SCONJ
chd-120	83	26	the	the	DET
chd-120	83	27	highest	high	ADJ
chd-120	83	28	was	be	AUX
chd-120	83	29	90	90	NUM
chd-120	83	30	years	year	NOUN
chd-120	83	31	.	.	PUNCT
chd-120	84	1	this	this	DET
chd-120	84	2	finding	finding	NOUN
chd-120	84	3	is	be	AUX
chd-120	84	4	consistent	consistent	ADJ
chd-120	84	5	with	with	ADP
chd-120	84	6	a	a	PRON
chd-120	84	7	who	who	PRON
chd-120	84	8	report	report	NOUN
chd-120	84	9	which	which	PRON
chd-120	84	10	states	state	VERB
chd-120	84	11	that	that	SCONJ
chd-120	84	12	majority	majority	NOUN
chd-120	84	13	of	of	ADP
chd-120	84	14	cases	case	NOUN
chd-120	84	15	of	of	ADP
chd-120	84	16	cancer	cancer	NOUN
chd-120	84	17	of	of	ADP
chd-120	84	18	the	the	DET
chd-120	84	19	prostate	prostate	NOUN
chd-120	84	20	occur	occur	VERB
chd-120	84	21	after	after	ADP
chd-120	84	22	the	the	DET
chd-120	84	23	age	age	NOUN
chd-120	84	24	of	of	ADP
chd-120	84	25	50	50	NUM
chd-120	84	26	years	year	NOUN
chd-120	84	27	and	and	CCONJ
chd-120	84	28	its	its	PRON
chd-120	84	29	incidence	incidence	NOUN
chd-120	84	30	peaks	peak	NOUN
chd-120	84	31	in	in	ADP
chd-120	84	32	the	the	DET
chd-120	84	33	70s	70	NOUN
chd-120	84	34	(	(	PUNCT
chd-120	84	35	who	who	PRON
chd-120	84	36	,	,	PUNCT
chd-120	84	37	2004	2004	NUM
chd-120	84	38	)	)	PUNCT
chd-120	84	39	.	.	PUNCT
chd-120	85	1	the	the	PRON
chd-120	85	2	who	who	PRON
chd-120	85	3	report	report	NOUN
chd-120	85	4	further	far	ADV
chd-120	85	5	stated	state	VERB
chd-120	85	6	that	that	SCONJ
chd-120	85	7	worldwide	worldwide	ADV
chd-120	85	8	,	,	PUNCT
chd-120	85	9	about	about	ADV
chd-120	85	10	three	three	NUM
chd-120	85	11	-	-	PUNCT
chd-120	85	12	quarters	quarter	NOUN
chd-120	85	13	of	of	ADP
chd-120	85	14	all	all	DET
chd-120	85	15	cases	case	NOUN
chd-120	85	16	occur	occur	VERB
chd-120	85	17	in	in	ADP
chd-120	85	18	men	man	NOUN
chd-120	85	19	aged	age	VERB
chd-120	85	20	65	65	NUM
chd-120	85	21	or	or	CCONJ
chd-120	85	22	more	more	ADJ
chd-120	85	23	.	.	PUNCT
chd-120	86	1	studies	study	NOUN
chd-120	86	2	from	from	ADP
chd-120	86	3	other	other	ADJ
chd-120	86	4	parts	part	NOUN
chd-120	86	5	of	of	ADP
chd-120	86	6	africa	africa	PROPN
chd-120	86	7	show	show	VERB
chd-120	86	8	that	that	SCONJ
chd-120	86	9	the	the	DET
chd-120	86	10	incidence	incidence	NOUN
chd-120	86	11	of	of	ADP
chd-120	86	12	prostate	prostate	NOUN
chd-120	86	13	cancer	cancer	NOUN
chd-120	86	14	rises	rise	VERB
chd-120	86	15	from	from	ADP
chd-120	86	16	the	the	DET
chd-120	86	17	age	age	NOUN
chd-120	86	18	of	of	ADP
chd-120	86	19	50	50	NUM
chd-120	86	20	years	year	NOUN
chd-120	86	21	(	(	PUNCT
chd-120	86	22	bah	bah	INTJ
chd-120	86	23	et	et	PROPN
chd-120	86	24	al	al	PROPN
chd-120	86	25	.	.	PROPN
chd-120	86	26	,	,	PUNCT
chd-120	86	27	2001	2001	NUM
chd-120	86	28	and	and	CCONJ
chd-120	86	29	babb	babb	VERB
chd-120	86	30	et	et	PROPN
chd-120	86	31	al	al	PROPN
chd-120	86	32	.	.	PROPN
chd-120	86	33	,	,	PUNCT
chd-120	86	34	2014	2014	NUM
chd-120	86	35	)	)	PUNCT
chd-120	86	36	.	.	PUNCT
chd-120	87	1	oluwole	oluwole	PROPN
chd-120	87	2	et	et	PROPN
chd-120	87	3	al	al	PROPN
chd-120	87	4	in	in	ADP
chd-120	87	5	zaria	zaria	PROPN
chd-120	87	6	,	,	PUNCT
chd-120	87	7	nigeria	nigeria	PROPN
chd-120	87	8	,	,	PUNCT
chd-120	87	9	reported	report	VERB
chd-120	87	10	that	that	SCONJ
chd-120	87	11	prostate	prostate	NOUN
chd-120	87	12	cancer	cancer	NOUN
chd-120	87	13	was	be	AUX
chd-120	87	14	seen	see	VERB
chd-120	87	15	in	in	ADP
chd-120	87	16	two	two	NUM
chd-120	87	17	subjects	subject	NOUN
chd-120	87	18	aged	age	VERB
chd-120	87	19	30	30	NUM
chd-120	87	20	and	and	CCONJ
chd-120	87	21	32	32	NUM
chd-120	87	22	years	year	NOUN
chd-120	87	23	,	,	PUNCT
chd-120	87	24	with	with	ADP
chd-120	87	25	a	a	DET
chd-120	87	26	peak	peak	NOUN
chd-120	87	27	age	age	NOUN
chd-120	87	28	of	of	ADP
chd-120	87	29	diagnosis	diagnosis	NOUN
chd-120	87	30	being	be	AUX
chd-120	87	31	the	the	DET
chd-120	87	32	sixth	sixth	ADJ
chd-120	87	33	decade	decade	NOUN
chd-120	87	34	and	and	CCONJ
chd-120	87	35	a	a	DET
chd-120	87	36	mean	mean	NOUN
chd-120	87	37	of	of	ADP
chd-120	87	38	64.5	64.5	NUM
chd-120	87	39	years	year	NOUN
chd-120	87	40	.	.	PUNCT
chd-120	88	1	majority	majority	NOUN
chd-120	88	2	of	of	ADP
chd-120	88	3	the	the	DET
chd-120	88	4	subjects	subject	NOUN
chd-120	88	5	in	in	ADP
chd-120	88	6	this	this	DET
chd-120	88	7	study	study	NOUN
chd-120	88	8	are	be	AUX
chd-120	88	9	of	of	ADP
chd-120	88	10	the	the	DET
chd-120	88	11	yoruba	yoruba	PROPN
chd-120	88	12	ethnic	ethnic	ADJ
chd-120	88	13	extraction	extraction	NOUN
chd-120	88	14	,	,	PUNCT
chd-120	88	15	representing	represent	VERB
chd-120	88	16	74.2	74.2	NUM
chd-120	88	17	%	%	NOUN
chd-120	88	18	.	.	PUNCT
chd-120	89	1	the	the	DET
chd-120	89	2	reason	reason	NOUN
chd-120	89	3	for	for	ADP
chd-120	89	4	this	this	DET
chd-120	89	5	observation	observation	NOUN
chd-120	89	6	is	be	AUX
chd-120	89	7	that	that	SCONJ
chd-120	89	8	the	the	DET
chd-120	89	9	study	study	NOUN
chd-120	89	10	was	be	AUX
chd-120	89	11	done	do	VERB
chd-120	89	12	in	in	ADP
chd-120	89	13	lagos	lago	NOUN
chd-120	89	14	,	,	PUNCT
chd-120	89	15	which	which	PRON
chd-120	89	16	is	be	AUX
chd-120	89	17	located	locate	VERB
chd-120	89	18	in	in	ADP
chd-120	89	19	the	the	DET
chd-120	89	20	south	south	NOUN
chd-120	89	21	-	-	PUNCT
chd-120	89	22	west	west	NOUN
chd-120	89	23	of	of	ADP
chd-120	89	24	nigeria	nigeria	PROPN
chd-120	89	25	,	,	PUNCT
chd-120	89	26	home	home	ADV
chd-120	89	27	to	to	ADP
chd-120	89	28	the	the	DET
chd-120	89	29	yoruba	yoruba	PROPN
chd-120	89	30	ethnic	ethnic	ADJ
chd-120	89	31	group	group	NOUN
chd-120	89	32	.	.	PUNCT
chd-120	90	1	the	the	DET
chd-120	90	2	remarkable	remarkable	ADJ
chd-120	90	3	proportion	proportion	NOUN
chd-120	90	4	of	of	ADP
chd-120	90	5	non	non	ADJ
chd-120	90	6	-	-	ADJ
chd-120	90	7	yoruba	yoruba	ADJ
chd-120	90	8	men	man	NOUN
chd-120	90	9	in	in	ADP
chd-120	90	10	this	this	DET
chd-120	90	11	study	study	NOUN
chd-120	90	12	,	,	PUNCT
chd-120	90	13	representing	represent	VERB
chd-120	90	14	25.8	25.8	NUM
chd-120	90	15	%	%	NOUN
chd-120	90	16	,	,	PUNCT
chd-120	90	17	gives	give	VERB
chd-120	90	18	credence	credence	NOUN
chd-120	90	19	to	to	ADP
chd-120	90	20	the	the	DET
chd-120	90	21	fact	fact	NOUN
chd-120	90	22	that	that	SCONJ
chd-120	90	23	lagos	lagos	NOUN
chd-120	90	24	is	be	AUX
chd-120	90	25	a	a	DET
chd-120	90	26	cosmopolitan	cosmopolitan	ADJ
chd-120	90	27	city	city	NOUN
chd-120	90	28	,	,	PUNCT
chd-120	90	29	where	where	SCONJ
chd-120	90	30	people	people	NOUN
chd-120	90	31	of	of	ADP
chd-120	90	32	all	all	DET
chd-120	90	33	ethnic	ethnic	ADJ
chd-120	90	34	nationalities	nationality	NOUN
chd-120	90	35	,	,	PUNCT
chd-120	90	36	including	include	VERB
chd-120	90	37	foreign	foreign	ADJ
chd-120	90	38	nationals	national	NOUN
chd-120	90	39	in	in	ADP
chd-120	90	40	nigeria	nigeria	PROPN
chd-120	90	41	live	live	VERB
chd-120	90	42	and	and	CCONJ
chd-120	90	43	work	work	VERB
chd-120	90	44	.	.	PUNCT
chd-120	91	1	most	most	ADJ
chd-120	91	2	of	of	ADP
chd-120	91	3	the	the	DET
chd-120	91	4	cancer	cancer	NOUN
chd-120	91	5	diagnoses	diagnosis	NOUN
chd-120	91	6	in	in	ADP
chd-120	91	7	this	this	DET
chd-120	91	8	study	study	NOUN
chd-120	91	9	were	be	AUX
chd-120	91	10	made	make	VERB
chd-120	91	11	on	on	ADP
chd-120	91	12	trucut	trucut	VERB
chd-120	91	13	prostate	prostate	NOUN
chd-120	91	14	biopsy	biopsy	NOUN
chd-120	91	15	specimens	specimen	NOUN
chd-120	91	16	(	(	PUNCT
chd-120	91	17	94.9	94.9	NUM
chd-120	91	18	%	%	NOUN
chd-120	91	19	)	)	PUNCT
chd-120	91	20	as	as	ADP
chd-120	91	21	against	against	ADP
chd-120	91	22	prostatectomy	prostatectomy	ADP
chd-120	91	23	specimens	specimen	NOUN
chd-120	91	24	which	which	PRON
chd-120	91	25	represent	represent	VERB
chd-120	91	26	only	only	ADV
chd-120	91	27	5.1	5.1	NUM
chd-120	91	28	%	%	NOUN
chd-120	91	29	.	.	PUNCT
chd-120	92	1	this	this	PRON
chd-120	92	2	is	be	AUX
chd-120	92	3	similar	similar	ADJ
chd-120	92	4	to	to	ADP
chd-120	92	5	the	the	DET
chd-120	92	6	report	report	NOUN
chd-120	92	7	in	in	ADP
chd-120	92	8	a	a	DET
chd-120	92	9	study	study	NOUN
chd-120	92	10	done	do	VERB
chd-120	92	11	in	in	ADP
chd-120	92	12	port	port	NOUN
chd-120	92	13	harcourt	harcourt	PROPN
chd-120	92	14	,	,	PUNCT
chd-120	92	15	nigeria	nigeria	PROPN
chd-120	92	16	by	by	ADP
chd-120	92	17	(	(	PUNCT
chd-120	92	18	obiorah	obiorah	NOUN
chd-120	92	19	et	et	PROPN
chd-120	92	20	al	al	PROPN
chd-120	92	21	.	.	PROPN
chd-120	92	22	,	,	PUNCT
chd-120	92	23	2011	2011	NUM
chd-120	92	24	)	)	PUNCT
chd-120	92	25	which	which	PRON
chd-120	92	26	also	also	ADV
chd-120	92	27	shows	show	VERB
chd-120	92	28	a	a	DET
chd-120	92	29	much	much	ADV
chd-120	92	30	higher	high	ADJ
chd-120	92	31	proportion	proportion	NOUN
chd-120	92	32	of	of	ADP
chd-120	92	33	cancer	cancer	NOUN
chd-120	92	34	diagnosis	diagnosis	NOUN
chd-120	92	35	on	on	ADP
chd-120	92	36	trucut	trucut	ADJ
chd-120	92	37	biopsy	biopsy	NOUN
chd-120	92	38	specimens	specimen	NOUN
chd-120	92	39	(	(	PUNCT
chd-120	92	40	82.8	82.8	NUM
chd-120	92	41	%	%	NOUN
chd-120	92	42	)	)	PUNCT
chd-120	92	43	compared	compare	VERB
chd-120	92	44	to	to	ADP
chd-120	92	45	prostatectomy	prostatectomy	ADP
chd-120	92	46	specimen	speciman	NOUN
chd-120	92	47	(	(	PUNCT
chd-120	92	48	17.2	17.2	NUM
chd-120	92	49	%	%	NOUN
chd-120	92	50	)	)	PUNCT
chd-120	92	51	.	.	PUNCT
chd-120	93	1	on	on	ADP
chd-120	93	2	the	the	DET
chd-120	93	3	other	other	ADJ
chd-120	93	4	hand	hand	NOUN
chd-120	93	5	,	,	PUNCT
chd-120	93	6	a	a	DET
chd-120	93	7	study	study	NOUN
chd-120	93	8	in	in	ADP
chd-120	93	9	zaria	zaria	PROPN
chd-120	93	10	(	(	PUNCT
chd-120	93	11	oluwole	oluwole	NOUN
chd-120	93	12	et	et	PROPN
chd-120	93	13	al	al	PROPN
chd-120	93	14	.	.	PROPN
chd-120	93	15	,	,	PUNCT
chd-120	93	16	2015	2015	NUM
chd-120	93	17	)	)	PUNCT
chd-120	93	18	revealed	reveal	VERB
chd-120	93	19	a	a	DET
chd-120	93	20	much	much	ADV
chd-120	93	21	lower	low	ADJ
chd-120	93	22	proportion	proportion	NOUN
chd-120	93	23	of	of	ADP
chd-120	93	24	cancer	cancer	NOUN
chd-120	93	25	diagnosis	diagnosis	NOUN
chd-120	93	26	in	in	ADP
chd-120	93	27	trucut	trucut	ADJ
chd-120	93	28	biopsies	biopsy	NOUN
chd-120	93	29	(	(	PUNCT
chd-120	93	30	57	57	NUM
chd-120	93	31	%	%	NOUN
chd-120	93	32	)	)	PUNCT
chd-120	93	33	as	as	SCONJ
chd-120	93	34	compared	compare	VERB
chd-120	93	35	to	to	PART
chd-120	93	36	open	open	VERB
chd-120	93	37	prostatectomy	prostatectomy	ADV
chd-120	93	38	(	(	PUNCT
chd-120	93	39	43	43	NUM
chd-120	93	40	%	%	NOUN
chd-120	93	41	)	)	PUNCT
chd-120	93	42	.	.	PUNCT
chd-120	94	1	cases	case	NOUN
chd-120	94	2	of	of	ADP
chd-120	94	3	carcinoma	carcinoma	NOUN
chd-120	94	4	in	in	ADP
chd-120	94	5	prostatectomy	prostatectomy	SCONJ
chd-120	94	6	specimen	speciman	NOUN
chd-120	94	7	tend	tend	VERB
chd-120	94	8	to	to	PART
chd-120	94	9	be	be	AUX
chd-120	94	10	an	an	DET
chd-120	94	11	incidental	incidental	ADJ
chd-120	94	12	finding	finding	NOUN
chd-120	94	13	,	,	PUNCT
chd-120	94	14	as	as	SCONJ
chd-120	94	15	most	most	ADJ
chd-120	94	16	prostatectomies	prostatectomy	NOUN
chd-120	94	17	are	be	AUX
chd-120	94	18	done	do	VERB
chd-120	94	19	on	on	ADP
chd-120	94	20	the	the	DET
chd-120	94	21	grounds	ground	NOUN
chd-120	94	22	of	of	ADP
chd-120	94	23	an	an	DET
chd-120	94	24	impression	impression	NOUN
chd-120	94	25	of	of	ADP
chd-120	94	26	benign	benign	ADJ
chd-120	94	27	prostate	prostate	NOUN
chd-120	94	28	disease	disease	NOUN
chd-120	94	29	.	.	PUNCT
chd-120	95	1	this	this	DET
chd-120	95	2	observation	observation	NOUN
chd-120	95	3	draws	draw	VERB
chd-120	95	4	attention	attention	NOUN
chd-120	95	5	to	to	ADP
chd-120	95	6	the	the	DET
chd-120	95	7	need	need	NOUN
chd-120	95	8	for	for	ADP
chd-120	95	9	thorough	thorough	ADJ
chd-120	95	10	histological	histological	ADJ
chd-120	95	11	examination	examination	NOUN
chd-120	95	12	of	of	ADP
chd-120	95	13	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	PUNCT
chd-120	95	14	e7	e7	PROPN
chd-120	95	15	cancer	cancer	NOUN
chd-120	95	16	health	health	NOUN
chd-120	95	17	disparities	disparity	NOUN
chd-120	95	18	research	research	VERB
chd-120	95	19	prostatectomy	prostatectomy	ADP
chd-120	95	20	specimens	specimen	NOUN
chd-120	95	21	considering	consider	VERB
chd-120	95	22	the	the	DET
chd-120	95	23	possibility	possibility	NOUN
chd-120	95	24	of	of	ADP
chd-120	95	25	finding	find	VERB
chd-120	95	26	a	a	DET
chd-120	95	27	focus	focus	NOUN
chd-120	95	28	of	of	ADP
chd-120	95	29	cancer	cancer	NOUN
chd-120	95	30	.	.	PUNCT
chd-120	96	1	an	an	DET
chd-120	96	2	important	important	ADJ
chd-120	96	3	highlight	highlight	NOUN
chd-120	96	4	of	of	ADP
chd-120	96	5	the	the	DET
chd-120	96	6	present	present	ADJ
chd-120	96	7	study	study	NOUN
chd-120	96	8	is	be	AUX
chd-120	96	9	the	the	DET
chd-120	96	10	fact	fact	NOUN
chd-120	96	11	that	that	SCONJ
chd-120	96	12	majority	majority	NOUN
chd-120	96	13	of	of	ADP
chd-120	96	14	the	the	DET
chd-120	96	15	prostate	prostate	NOUN
chd-120	96	16	cancer	cancer	NOUN
chd-120	96	17	were	be	AUX
chd-120	96	18	adenocarcinoma	adenocarcinoma	ADJ
chd-120	96	19	(	(	PUNCT
chd-120	96	20	97.8	97.8	NUM
chd-120	96	21	%	%	NOUN
chd-120	96	22	)	)	PUNCT
chd-120	96	23	.	.	PUNCT
chd-120	97	1	this	this	PRON
chd-120	97	2	is	be	AUX
chd-120	97	3	similar	similar	ADJ
chd-120	97	4	to	to	ADP
chd-120	97	5	the	the	DET
chd-120	97	6	observation	observation	NOUN
chd-120	97	7	of	of	ADP
chd-120	97	8	authors	author	NOUN
chd-120	97	9	of	of	ADP
chd-120	97	10	similar	similar	ADJ
chd-120	97	11	studies	study	NOUN
chd-120	97	12	both	both	CCONJ
chd-120	97	13	locally	locally	ADV
chd-120	97	14	and	and	CCONJ
chd-120	97	15	around	around	ADP
chd-120	97	16	the	the	DET
chd-120	97	17	world	world	NOUN
chd-120	97	18	(	(	PUNCT
chd-120	97	19	haas	haas	PROPN
chd-120	97	20	et	et	PROPN
chd-120	97	21	al	al	PROPN
chd-120	97	22	.	.	PROPN
chd-120	97	23	,	,	PUNCT
chd-120	97	24	2008	2008	NUM
chd-120	97	25	,	,	PUNCT
chd-120	97	26	oluwole	oluwole	NOUN
chd-120	97	27	et	et	PROPN
chd-120	97	28	al	al	PROPN
chd-120	97	29	.	.	PROPN
chd-120	97	30	,	,	PUNCT
chd-120	97	31	2015	2015	NUM
chd-120	97	32	,	,	PUNCT
chd-120	97	33	obiorah	obiorah	NOUN
chd-120	97	34	et	et	PROPN
chd-120	97	35	al	al	PROPN
chd-120	97	36	.	.	PROPN
chd-120	97	37	,	,	PUNCT
chd-120	97	38	2011	2011	NUM
chd-120	97	39	,	,	PUNCT
chd-120	97	40	odedina	odedina	NOUN
chd-120	97	41	et	et	PROPN
chd-120	97	42	al	al	PROPN
chd-120	97	43	.	.	PROPN
chd-120	97	44	,	,	PUNCT
chd-120	97	45	gueye	gueye	PROPN
chd-120	97	46	et	et	PROPN
chd-120	97	47	al	al	PROPN
chd-120	97	48	2003	2003	NUM
chd-120	97	49	,	,	PUNCT
chd-120	97	50	elen	elen	PROPN
chd-120	97	51	et	et	PROPN
chd-120	97	52	al	al	PROPN
chd-120	97	53	.	.	PROPN
chd-120	97	54	,	,	PUNCT
chd-120	97	55	1991	1991	NUM
chd-120	97	56	and	and	CCONJ
chd-120	97	57	anunobi	anunobi	NOUN
chd-120	97	58	et	et	PROPN
chd-120	97	59	al	al	PROPN
chd-120	97	60	.	.	PROPN
chd-120	97	61	,	,	PUNCT
chd-120	97	62	2011	2011	NUM
chd-120	97	63	)	)	PUNCT
chd-120	97	64	.	.	PUNCT
chd-120	98	1	our	our	PRON
chd-120	98	2	study	study	NOUN
chd-120	98	3	shows	show	VERB
chd-120	98	4	that	that	SCONJ
chd-120	98	5	grade	grade	NOUN
chd-120	98	6	5	5	NUM
chd-120	98	7	prostate	prostate	NOUN
chd-120	98	8	cancer	cancer	NOUN
chd-120	98	9	is	be	AUX
chd-120	98	10	the	the	DET
chd-120	98	11	most	most	ADV
chd-120	98	12	commonly	commonly	ADV
chd-120	98	13	diagnosed	diagnose	VERB
chd-120	98	14	at	at	ADP
chd-120	98	15	our	our	PRON
chd-120	98	16	centre	centre	NOUN
chd-120	98	17	(	(	PUNCT
chd-120	98	18	37.5	37.5	NUM
chd-120	98	19	%	%	NOUN
chd-120	98	20	)	)	PUNCT
chd-120	98	21	.	.	PUNCT
chd-120	99	1	this	this	PRON
chd-120	99	2	is	be	AUX
chd-120	99	3	followed	follow	VERB
chd-120	99	4	by	by	ADP
chd-120	99	5	grade	grade	NOUN
chd-120	99	6	3	3	NUM
chd-120	99	7	disease	disease	NOUN
chd-120	99	8	,	,	PUNCT
chd-120	99	9	seen	see	VERB
chd-120	99	10	in	in	ADP
chd-120	99	11	10.2	10.2	NUM
chd-120	99	12	%	%	NOUN
chd-120	99	13	of	of	ADP
chd-120	99	14	cases	case	NOUN
chd-120	99	15	.	.	PUNCT
chd-120	100	1	this	this	PRON
chd-120	100	2	is	be	AUX
chd-120	100	3	in	in	ADP
chd-120	100	4	contrast	contrast	NOUN
chd-120	100	5	to	to	ADP
chd-120	100	6	the	the	DET
chd-120	100	7	finding	finding	NOUN
chd-120	100	8	in	in	ADP
chd-120	100	9	ibadan	ibadan	PROPN
chd-120	100	10	,	,	PUNCT
chd-120	100	11	nigeria	nigeria	PROPN
chd-120	100	12	where	where	SCONJ
chd-120	100	13	it	it	PRON
chd-120	100	14	was	be	AUX
chd-120	100	15	observed	observe	VERB
chd-120	100	16	that	that	SCONJ
chd-120	100	17	the	the	DET
chd-120	100	18	commonest	commonest	NOUN
chd-120	100	19	gleason	gleason	PROPN
chd-120	100	20	grade	grade	NOUN
chd-120	100	21	was	be	AUX
chd-120	100	22	3	3	NUM
chd-120	100	23	(	(	PUNCT
chd-120	100	24	okolo	okolo	PROPN
chd-120	100	25	et	et	PROPN
chd-120	100	26	al	al	PROPN
chd-120	100	27	.	.	PROPN
chd-120	100	28	,	,	PUNCT
chd-120	100	29	2008	2008	NUM
chd-120	100	30	)	)	PUNCT
chd-120	100	31	.	.	PUNCT
chd-120	101	1	on	on	ADP
chd-120	101	2	the	the	DET
chd-120	101	3	other	other	ADJ
chd-120	101	4	hand	hand	NOUN
chd-120	101	5	,	,	PUNCT
chd-120	101	6	the	the	DET
chd-120	101	7	study	study	NOUN
chd-120	101	8	in	in	ADP
chd-120	101	9	port	port	NOUN
chd-120	101	10	harcourt	harcourt	PROPN
chd-120	101	11	,	,	PUNCT
chd-120	101	12	south	south	PROPN
chd-120	101	13	-	-	PUNCT
chd-120	101	14	south	south	NOUN
chd-120	101	15	nigeria	nigeria	PROPN
chd-120	101	16	,	,	PUNCT
chd-120	101	17	(	(	PUNCT
chd-120	101	18	obiorah	obiorah	NOUN
chd-120	101	19	et	et	PROPN
chd-120	101	20	al	al	PROPN
chd-120	101	21	.	.	PROPN
chd-120	101	22	,	,	PUNCT
chd-120	101	23	2011	2011	NUM
chd-120	101	24	)	)	PUNCT
chd-120	101	25	shows	show	VERB
chd-120	101	26	that	that	SCONJ
chd-120	101	27	the	the	DET
chd-120	101	28	majority	majority	NOUN
chd-120	101	29	of	of	ADP
chd-120	101	30	the	the	DET
chd-120	101	31	cases	case	NOUN
chd-120	101	32	in	in	ADP
chd-120	101	33	that	that	DET
chd-120	101	34	series	series	NOUN
chd-120	101	35	were	be	AUX
chd-120	101	36	of	of	ADP
chd-120	101	37	gleason	gleason	PROPN
chd-120	101	38	score	score	NOUN
chd-120	101	39	of	of	ADP
chd-120	101	40	8	8	NUM
chd-120	101	41	(	(	PUNCT
chd-120	101	42	grade	grade	NOUN
chd-120	101	43	4	4	NUM
chd-120	101	44	)	)	PUNCT
chd-120	101	45	which	which	PRON
chd-120	101	46	is	be	AUX
chd-120	101	47	similar	similar	ADJ
chd-120	101	48	to	to	ADP
chd-120	101	49	findings	finding	NOUN
chd-120	101	50	in	in	ADP
chd-120	101	51	zaria	zaria	PROPN
chd-120	101	52	(	(	PUNCT
chd-120	101	53	oluwole	oluwole	NOUN
chd-120	101	54	et	et	PROPN
chd-120	101	55	al	al	PROPN
chd-120	101	56	.	.	PROPN
chd-120	101	57	,	,	PUNCT
chd-120	101	58	2015	2015	NUM
chd-120	101	59	)	)	PUNCT
chd-120	101	60	and	and	CCONJ
chd-120	101	61	another	another	DET
chd-120	101	62	study	study	NOUN
chd-120	101	63	in	in	ADP
chd-120	101	64	lagos	lagos	PROPN
chd-120	101	65	(	(	PUNCT
chd-120	101	66	anunobi	anunobi	NOUN
chd-120	101	67	et	et	PROPN
chd-120	101	68	al	al	PROPN
chd-120	101	69	.	.	PROPN
chd-120	101	70	,	,	PUNCT
chd-120	101	71	2011	2011	NUM
chd-120	101	72	)	)	PUNCT
chd-120	101	73	.	.	PUNCT
chd-120	102	1	however	however	ADV
chd-120	102	2	,	,	PUNCT
chd-120	102	3	a	a	DET
chd-120	102	4	study	study	NOUN
chd-120	102	5	in	in	ADP
chd-120	102	6	the	the	DET
chd-120	102	7	united	united	PROPN
chd-120	102	8	states	states	PROPN
chd-120	102	9	shows	show	VERB
chd-120	102	10	that	that	SCONJ
chd-120	102	11	the	the	DET
chd-120	102	12	commonest	commonest	NOUN
chd-120	102	13	gleason	gleason	PROPN
chd-120	102	14	grade	grade	NOUN
chd-120	102	15	is	be	AUX
chd-120	102	16	3	3	NUM
chd-120	102	17	with	with	ADP
chd-120	102	18	an	an	DET
chd-120	102	19	overall	overall	ADJ
chd-120	102	20	decline	decline	NOUN
chd-120	102	21	in	in	ADP
chd-120	102	22	scores	score	NOUN
chd-120	102	23	from	from	ADP
chd-120	102	24	8	8	NUM
chd-120	102	25	-	-	SYM
chd-120	102	26	10	10	NUM
chd-120	102	27	to	to	ADP
chd-120	102	28	less	less	ADJ
chd-120	102	29	than	than	ADP
chd-120	102	30	6	6	NUM
chd-120	102	31	in	in	ADP
chd-120	102	32	recent	recent	ADJ
chd-120	102	33	years	year	NOUN
chd-120	102	34	(	(	PUNCT
chd-120	102	35	gueye	gueye	NOUN
chd-120	102	36	et	et	PROPN
chd-120	102	37	al	al	PROPN
chd-120	102	38	.	.	PROPN
chd-120	102	39	,	,	PUNCT
chd-120	102	40	2003	2003	NUM
chd-120	102	41	)	)	PUNCT
chd-120	102	42	.	.	PUNCT
chd-120	103	1	a	a	DET
chd-120	103	2	plausible	plausible	ADJ
chd-120	103	3	explanation	explanation	NOUN
chd-120	103	4	for	for	ADP
chd-120	103	5	the	the	DET
chd-120	103	6	higher	high	ADJ
chd-120	103	7	proportion	proportion	NOUN
chd-120	103	8	of	of	ADP
chd-120	103	9	high	high	ADJ
chd-120	103	10	grade	grade	NOUN
chd-120	103	11	cancers	cancer	NOUN
chd-120	103	12	diagnosed	diagnose	VERB
chd-120	103	13	at	at	ADP
chd-120	103	14	our	our	PRON
chd-120	103	15	centre	centre	NOUN
chd-120	103	16	is	be	AUX
chd-120	103	17	that	that	SCONJ
chd-120	103	18	most	most	ADJ
chd-120	103	19	of	of	ADP
chd-120	103	20	the	the	DET
chd-120	103	21	patients	patient	NOUN
chd-120	103	22	present	present	VERB
chd-120	103	23	late	late	ADV
chd-120	103	24	to	to	ADP
chd-120	103	25	the	the	DET
chd-120	103	26	hospital	hospital	NOUN
chd-120	103	27	and	and	CCONJ
chd-120	103	28	already	already	ADV
chd-120	103	29	have	have	VERB
chd-120	103	30	advanced	advanced	ADJ
chd-120	103	31	disease	disease	NOUN
chd-120	103	32	at	at	ADP
chd-120	103	33	diagnosis	diagnosis	NOUN
chd-120	103	34	.	.	PUNCT
chd-120	104	1	the	the	DET
chd-120	104	2	decline	decline	NOUN
chd-120	104	3	noted	note	VERB
chd-120	104	4	in	in	ADP
chd-120	104	5	the	the	DET
chd-120	104	6	us	us	PROPN
chd-120	104	7	study	study	NOUN
chd-120	104	8	is	be	AUX
chd-120	104	9	as	as	ADP
chd-120	104	10	a	a	DET
chd-120	104	11	result	result	NOUN
chd-120	104	12	of	of	ADP
chd-120	104	13	improved	improve	VERB
chd-120	104	14	early	early	ADJ
chd-120	104	15	detection	detection	NOUN
chd-120	104	16	and	and	CCONJ
chd-120	104	17	diagnosis	diagnosis	NOUN
chd-120	104	18	of	of	ADP
chd-120	104	19	prostate	prostate	NOUN
chd-120	104	20	cancer	cancer	NOUN
chd-120	104	21	in	in	ADP
chd-120	104	22	that	that	DET
chd-120	104	23	country	country	NOUN
chd-120	104	24	(	(	PUNCT
chd-120	104	25	harget	harget	VERB
chd-120	104	26	et	et	NOUN
chd-120	104	27	al	al	PROPN
chd-120	104	28	.	.	PROPN
chd-120	104	29	,	,	PUNCT
chd-120	104	30	2016	2016	NUM
chd-120	104	31	)	)	PUNCT
chd-120	104	32	.	.	PUNCT
chd-120	105	1	grade	grade	NOUN
chd-120	105	2	1	1	NUM
chd-120	105	3	tumour	tumour	NOUN
chd-120	105	4	was	be	AUX
chd-120	105	5	most	most	ADV
chd-120	105	6	commonly	commonly	ADV
chd-120	105	7	observed	observe	VERB
chd-120	105	8	in	in	ADP
chd-120	105	9	the	the	DET
chd-120	105	10	50	50	NUM
chd-120	105	11	-	-	SYM
chd-120	105	12	60	60	NUM
chd-120	105	13	years	year	NOUN
chd-120	105	14	age	age	NOUN
chd-120	105	15	group	group	NOUN
chd-120	105	16	(	(	PUNCT
chd-120	105	17	11	11	NUM
chd-120	105	18	,	,	PUNCT
chd-120	105	19	28.2	28.2	NUM
chd-120	105	20	%	%	NOUN
chd-120	105	21	)	)	PUNCT
chd-120	105	22	.	.	PUNCT
chd-120	106	1	conversely	conversely	ADV
chd-120	106	2	,	,	PUNCT
chd-120	106	3	high	high	ADJ
chd-120	106	4	grade	grade	NOUN
chd-120	106	5	tumour	tumour	NOUN
chd-120	106	6	(	(	PUNCT
chd-120	106	7	grade	grade	NOUN
chd-120	106	8	5	5	NUM
chd-120	106	9	)	)	PUNCT
chd-120	106	10	was	be	AUX
chd-120	106	11	most	most	ADV
chd-120	106	12	frequently	frequently	ADV
chd-120	106	13	seen	see	VERB
chd-120	106	14	in	in	ADP
chd-120	106	15	the	the	DET
chd-120	106	16	71	71	NUM
chd-120	106	17	-	-	SYM
chd-120	106	18	80	80	NUM
chd-120	106	19	years	year	NOUN
chd-120	106	20	group	group	NOUN
chd-120	106	21	.	.	PUNCT
chd-120	107	1	it	it	PRON
chd-120	107	2	is	be	AUX
chd-120	107	3	pertinent	pertinent	ADJ
chd-120	107	4	to	to	PART
chd-120	107	5	note	note	VERB
chd-120	107	6	that	that	SCONJ
chd-120	107	7	grade	grade	NOUN
chd-120	107	8	is	be	AUX
chd-120	107	9	not	not	PART
chd-120	107	10	statistically	statistically	ADV
chd-120	107	11	dependent	dependent	ADJ
chd-120	107	12	on	on	ADP
chd-120	107	13	age	age	NOUN
chd-120	107	14	at	at	ADP
chd-120	107	15	diagnosis	diagnosis	NOUN
chd-120	107	16	(	(	PUNCT
chd-120	107	17	p>0.05	p>0.05	NOUN
chd-120	107	18	)	)	PUNCT
chd-120	107	19	.	.	PUNCT
chd-120	108	1	our	our	PRON
chd-120	108	2	study	study	NOUN
chd-120	108	3	shows	show	VERB
chd-120	108	4	that	that	SCONJ
chd-120	108	5	the	the	DET
chd-120	108	6	most	most	ADV
chd-120	108	7	frequent	frequent	ADJ
chd-120	108	8	number	number	NOUN
chd-120	108	9	of	of	ADP
chd-120	108	10	prostate	prostate	NOUN
chd-120	108	11	biopsy	biopsy	NOUN
chd-120	108	12	cores	core	NOUN
chd-120	108	13	sent	send	VERB
chd-120	108	14	to	to	ADP
chd-120	108	15	our	our	PRON
chd-120	108	16	laboratory	laboratory	NOUN
chd-120	108	17	is	be	AUX
chd-120	108	18	10	10	NUM
chd-120	108	19	(	(	PUNCT
chd-120	108	20	11.2	11.2	NUM
chd-120	108	21	%	%	NOUN
chd-120	108	22	)	)	PUNCT
chd-120	108	23	,	,	PUNCT
chd-120	108	24	with	with	ADP
chd-120	108	25	some	some	DET
chd-120	108	26	surgeons	surgeon	NOUN
chd-120	108	27	rarely	rarely	ADV
chd-120	108	28	sending	send	VERB
chd-120	108	29	as	as	ADV
chd-120	108	30	few	few	ADJ
chd-120	108	31	as	as	ADP
chd-120	108	32	2	2	NUM
chd-120	108	33	cores	core	NOUN
chd-120	108	34	and	and	CCONJ
chd-120	108	35	as	as	ADV
chd-120	108	36	many	many	ADJ
chd-120	108	37	as	as	ADP
chd-120	108	38	32	32	NUM
chd-120	108	39	.	.	PUNCT
chd-120	109	1	or	or	CCONJ
chd-120	109	2	observation	observation	NOUN
chd-120	109	3	is	be	AUX
chd-120	109	4	consistent	consistent	ADJ
chd-120	109	5	with	with	ADP
chd-120	109	6	the	the	DET
chd-120	109	7	finding	finding	NOUN
chd-120	109	8	in	in	ADP
chd-120	109	9	an	an	DET
chd-120	109	10	asian	asian	ADJ
chd-120	109	11	study	study	NOUN
chd-120	109	12	which	which	PRON
chd-120	109	13	revealed	reveal	VERB
chd-120	109	14	that	that	SCONJ
chd-120	109	15	6	6	NUM
chd-120	109	16	to	to	PART
chd-120	109	17	12	12	NUM
chd-120	109	18	cores	core	NOUN
chd-120	109	19	of	of	ADP
chd-120	109	20	prostate	prostate	NOUN
chd-120	109	21	biopsy	biopsy	NOUN
chd-120	109	22	provide	provide	VERB
chd-120	109	23	similar	similar	ADJ
chd-120	109	24	efficacy	efficacy	NOUN
chd-120	109	25	as	as	ADP
chd-120	109	26	more	more	ADJ
chd-120	109	27	biopsy	biopsy	NOUN
chd-120	109	28	cores	core	NOUN
chd-120	109	29	(	(	PUNCT
chd-120	109	30	tanaka	tanaka	PROPN
chd-120	109	31	et	et	PROPN
chd-120	109	32	al	al	PROPN
chd-120	109	33	.	.	PROPN
chd-120	109	34	,	,	PUNCT
chd-120	109	35	2015	2015	NUM
chd-120	109	36	)	)	PUNCT
chd-120	109	37	.	.	PUNCT
chd-120	110	1	these	these	DET
chd-120	110	2	authors	author	NOUN
chd-120	110	3	also	also	ADV
chd-120	110	4	opined	opine	VERB
chd-120	110	5	that	that	SCONJ
chd-120	110	6	the	the	DET
chd-120	110	7	number	number	NOUN
chd-120	110	8	of	of	ADP
chd-120	110	9	cores	core	NOUN
chd-120	110	10	to	to	PART
chd-120	110	11	be	be	AUX
chd-120	110	12	taken	take	VERB
chd-120	110	13	should	should	AUX
chd-120	110	14	be	be	AUX
chd-120	110	15	determined	determine	VERB
chd-120	110	16	by	by	ADP
chd-120	110	17	the	the	DET
chd-120	110	18	prostate	prostate	NOUN
chd-120	110	19	volume	volume	NOUN
chd-120	110	20	.	.	PUNCT
chd-120	111	1	they	they	PRON
chd-120	111	2	further	far	ADV
chd-120	111	3	suggested	suggest	VERB
chd-120	111	4	that	that	SCONJ
chd-120	111	5	increasing	increase	VERB
chd-120	111	6	the	the	DET
chd-120	111	7	number	number	NOUN
chd-120	111	8	of	of	ADP
chd-120	111	9	cores	core	NOUN
chd-120	111	10	increases	increase	VERB
chd-120	111	11	the	the	DET
chd-120	111	12	rate	rate	NOUN
chd-120	111	13	of	of	ADP
chd-120	111	14	cancer	cancer	NOUN
chd-120	111	15	detection	detection	NOUN
chd-120	111	16	;	;	PUNCT
chd-120	111	17	however	however	ADV
chd-120	111	18	,	,	PUNCT
chd-120	111	19	the	the	DET
chd-120	111	20	optimal	optimal	ADJ
chd-120	111	21	number	number	NOUN
chd-120	111	22	of	of	ADP
chd-120	111	23	prostate	prostate	NOUN
chd-120	111	24	cores	core	NOUN
chd-120	111	25	to	to	PART
chd-120	111	26	obtain	obtain	VERB
chd-120	111	27	is	be	AUX
chd-120	111	28	still	still	ADV
chd-120	111	29	an	an	DET
chd-120	111	30	open	open	ADJ
chd-120	111	31	question	question	NOUN
chd-120	111	32	.	.	PUNCT
chd-120	112	1	conclusion	conclusion	NOUN
chd-120	112	2	this	this	DET
chd-120	112	3	study	study	NOUN
chd-120	112	4	shows	show	VERB
chd-120	112	5	that	that	SCONJ
chd-120	112	6	most	most	ADJ
chd-120	112	7	of	of	ADP
chd-120	112	8	the	the	DET
chd-120	112	9	prostate	prostate	NOUN
chd-120	112	10	cancer	cancer	NOUN
chd-120	112	11	diagnoses	diagnosis	NOUN
chd-120	112	12	made	make	VERB
chd-120	112	13	in	in	ADP
chd-120	112	14	the	the	DET
chd-120	112	15	mayo	mayo	NOUN
chd-120	112	16	height	height	NOUN
chd-120	112	17	laboratory	laboratory	NOUN
chd-120	112	18	,	,	PUNCT
chd-120	112	19	lagos	lagos	NOUN
chd-120	112	20	state	state	NOUN
chd-120	112	21	university	university	PROPN
chd-120	112	22	teaching	teaching	NOUN
chd-120	112	23	hospital	hospital	NOUN
chd-120	112	24	were	be	AUX
chd-120	112	25	on	on	ADP
chd-120	112	26	trucut	trucut	ADJ
chd-120	112	27	biopsy	biopsy	NOUN
chd-120	112	28	specimen	speciman	NOUN
chd-120	112	29	.	.	PUNCT
chd-120	113	1	prostate	prostate	NOUN
chd-120	113	2	cancer	cancer	NOUN
chd-120	113	3	is	be	AUX
chd-120	113	4	more	more	ADV
chd-120	113	5	commonly	commonly	ADV
chd-120	113	6	seen	see	VERB
chd-120	113	7	in	in	ADP
chd-120	113	8	men	man	NOUN
chd-120	113	9	in	in	ADP
chd-120	113	10	the	the	DET
chd-120	113	11	7th	7th	ADJ
chd-120	113	12	decade	decade	NOUN
chd-120	113	13	of	of	ADP
chd-120	113	14	life	life	NOUN
chd-120	113	15	(	(	PUNCT
chd-120	113	16	61	61	NUM
chd-120	113	17	-	-	SYM
chd-120	113	18	70	70	NUM
chd-120	113	19	years	year	NOUN
chd-120	113	20	)	)	PUNCT
chd-120	113	21	with	with	ADP
chd-120	113	22	a	a	DET
chd-120	113	23	median	median	ADJ
chd-120	113	24	age	age	NOUN
chd-120	113	25	of	of	ADP
chd-120	113	26	70	70	NUM
chd-120	113	27	years	year	NOUN
chd-120	113	28	.	.	PUNCT
chd-120	114	1	majority	majority	NOUN
chd-120	114	2	of	of	ADP
chd-120	114	3	these	these	DET
chd-120	114	4	patients	patient	NOUN
chd-120	114	5	already	already	ADV
chd-120	114	6	have	have	VERB
chd-120	114	7	high	high	ADJ
chd-120	114	8	grade	grade	NOUN
chd-120	114	9	adenocarcinoma	adenocarcinoma	NOUN
chd-120	114	10	at	at	ADP
chd-120	114	11	diagnosis	diagnosis	NOUN
chd-120	114	12	.	.	PUNCT
chd-120	115	1	this	this	DET
chd-120	115	2	observation	observation	NOUN
chd-120	115	3	calls	call	VERB
chd-120	115	4	for	for	ADP
chd-120	115	5	the	the	DET
chd-120	115	6	need	need	NOUN
chd-120	115	7	for	for	ADP
chd-120	115	8	early	early	ADJ
chd-120	115	9	detection	detection	NOUN
chd-120	115	10	so	so	SCONJ
chd-120	115	11	as	as	SCONJ
chd-120	115	12	to	to	PART
chd-120	115	13	reduce	reduce	VERB
chd-120	115	14	mortality	mortality	NOUN
chd-120	115	15	from	from	ADP
chd-120	115	16	the	the	DET
chd-120	115	17	disease	disease	NOUN
chd-120	115	18	.	.	PUNCT
chd-120	116	1	public	public	ADJ
chd-120	116	2	awareness	awareness	NOUN
chd-120	116	3	on	on	ADP
chd-120	116	4	prostate	prostate	NOUN
chd-120	116	5	cancer	cancer	NOUN
chd-120	116	6	will	will	AUX
chd-120	116	7	enable	enable	VERB
chd-120	116	8	men	man	NOUN
chd-120	116	9	to	to	PART
chd-120	116	10	recognize	recognize	VERB
chd-120	116	11	early	early	ADJ
chd-120	116	12	symptoms	symptom	NOUN
chd-120	116	13	and	and	CCONJ
chd-120	116	14	seek	seek	VERB
chd-120	116	15	medical	medical	ADJ
chd-120	116	16	help	help	NOUN
chd-120	116	17	before	before	SCONJ
chd-120	116	18	the	the	DET
chd-120	116	19	disease	disease	NOUN
chd-120	116	20	advances	advance	VERB
chd-120	116	21	.	.	PUNCT
chd-120	117	1	the	the	DET
chd-120	117	2	need	need	NOUN
chd-120	117	3	for	for	ADP
chd-120	117	4	routine	routine	ADJ
chd-120	117	5	screening	screening	NOUN
chd-120	117	6	for	for	ADP
chd-120	117	7	early	early	ADJ
chd-120	117	8	detection	detection	NOUN
chd-120	117	9	is	be	AUX
chd-120	117	10	also	also	ADV
chd-120	117	11	very	very	ADV
chd-120	117	12	crucial	crucial	ADJ
chd-120	117	13	.	.	PUNCT
chd-120	118	1	this	this	DET
chd-120	118	2	study	study	NOUN
chd-120	118	3	also	also	ADV
chd-120	118	4	shows	show	VERB
chd-120	118	5	that	that	SCONJ
chd-120	118	6	surgeons	surgeon	NOUN
chd-120	118	7	frequently	frequently	ADV
chd-120	118	8	sent	send	VERB
chd-120	118	9	between	between	ADP
chd-120	118	10	6	6	NUM
chd-120	118	11	to	to	PART
chd-120	118	12	10	10	NUM
chd-120	118	13	prostate	prostate	NOUN
chd-120	118	14	biopsy	biopsy	NOUN
chd-120	118	15	cores	core	NOUN
chd-120	118	16	to	to	ADP
chd-120	118	17	our	our	PRON
chd-120	118	18	centre	centre	NOUN
chd-120	118	19	.	.	PUNCT
chd-120	119	1	this	this	DET
chd-120	119	2	number	number	NOUN
chd-120	119	3	is	be	AUX
chd-120	119	4	shown	show	VERB
chd-120	119	5	to	to	PART
chd-120	119	6	be	be	AUX
chd-120	119	7	adequate	adequate	ADJ
chd-120	119	8	for	for	ADP
chd-120	119	9	diagnosis	diagnosis	NOUN
chd-120	119	10	.	.	PUNCT
chd-120	120	1	the	the	DET
chd-120	120	2	observation	observation	NOUN
chd-120	120	3	that	that	SCONJ
chd-120	120	4	carcinoma	carcinoma	NOUN
chd-120	120	5	was	be	AUX
chd-120	120	6	diagnosed	diagnose	VERB
chd-120	120	7	in	in	ADP
chd-120	120	8	some	some	DET
chd-120	120	9	prostatectomy	prostatectomy	ADP
chd-120	120	10	specimen	speciman	NOUN
chd-120	120	11	which	which	PRON
chd-120	120	12	were	be	AUX
chd-120	120	13	believed	believe	VERB
chd-120	120	14	to	to	PART
chd-120	120	15	be	be	AUX
chd-120	120	16	benign	benign	ADJ
chd-120	120	17	,	,	PUNCT
chd-120	120	18	draws	draw	VERB
chd-120	120	19	attention	attention	NOUN
chd-120	120	20	to	to	ADP
chd-120	120	21	the	the	DET
chd-120	120	22	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	NUM
chd-120	120	23	e8	e8	PROPN
chd-120	120	24	cancer	cancer	NOUN
chd-120	120	25	health	health	NOUN
chd-120	120	26	disparities	disparity	NOUN
chd-120	120	27	research	research	NOUN
chd-120	120	28	need	need	VERB
chd-120	120	29	for	for	SCONJ
chd-120	120	30	pathologists	pathologist	NOUN
chd-120	120	31	to	to	PART
chd-120	120	32	thoroughly	thoroughly	ADV
chd-120	120	33	examine	examine	VERB
chd-120	120	34	prostatectomy	prostatectomy	ADP
chd-120	120	35	tissues	tissue	NOUN
chd-120	120	36	as	as	SCONJ
chd-120	120	37	foci	focus	NOUN
chd-120	120	38	of	of	ADP
chd-120	120	39	cancer	cancer	NOUN
chd-120	120	40	may	may	AUX
chd-120	120	41	present	present	VERB
chd-120	120	42	.	.	PUNCT
chd-120	121	1	acknowledgements	acknowledgement	NOUN
chd-120	121	2	the	the	DET
chd-120	121	3	authors	author	NOUN
chd-120	121	4	want	want	VERB
chd-120	121	5	to	to	PART
chd-120	121	6	acknowledge	acknowledge	VERB
chd-120	121	7	the	the	DET
chd-120	121	8	assistance	assistance	NOUN
chd-120	121	9	rendered	render	VERB
chd-120	121	10	by	by	ADP
chd-120	121	11	the	the	DET
chd-120	121	12	management	management	NOUN
chd-120	121	13	of	of	ADP
chd-120	121	14	mayo	mayo	NOUN
chd-120	121	15	heights	height	NOUN
chd-120	121	16	laboratory	laboratory	NOUN
chd-120	121	17	in	in	ADP
chd-120	121	18	extracting	extract	VERB
chd-120	121	19	relevant	relevant	ADJ
chd-120	121	20	data	datum	NOUN
chd-120	121	21	from	from	ADP
chd-120	121	22	the	the	DET
chd-120	121	23	laboratory	laboratory	NOUN
chd-120	121	24	information	information	NOUN
chd-120	121	25	system	system	NOUN
chd-120	121	26	.	.	PUNCT
chd-120	122	1	conflict	conflict	NOUN
chd-120	122	2	of	of	ADP
chd-120	122	3	interest	interest	NOUN
chd-120	122	4	the	the	DET
chd-120	122	5	authors	author	NOUN
chd-120	122	6	confirm	confirm	VERB
chd-120	122	7	that	that	SCONJ
chd-120	122	8	there	there	PRON
chd-120	122	9	is	be	VERB
chd-120	122	10	no	no	DET
chd-120	122	11	conflict	conflict	NOUN
chd-120	122	12	of	of	ADP
chd-120	122	13	interest	interest	NOUN
chd-120	122	14	and	and	CCONJ
chd-120	122	15	no	no	DET
chd-120	122	16	funding	funding	NOUN
chd-120	122	17	was	be	AUX
chd-120	122	18	received	receive	VERB
chd-120	122	19	for	for	ADP
chd-120	122	20	this	this	DET
chd-120	122	21	work	work	NOUN
chd-120	122	22	.	.	PUNCT
chd-120	123	1	authors	author	NOUN
chd-120	123	2	’	'	PUNCT
chd-120	123	3	contributions	contribution	NOUN
chd-120	123	4	emiogun	emiogun	VERB
chd-120	123	5	ef	ef	PROPN
chd-120	123	6	,	,	PUNCT
chd-120	123	7	was	be	AUX
chd-120	123	8	responsible	responsible	ADJ
chd-120	123	9	for	for	ADP
chd-120	123	10	study	study	NOUN
chd-120	123	11	conceptualization	conceptualization	NOUN
chd-120	123	12	,	,	PUNCT
chd-120	123	13	design	design	NOUN
chd-120	123	14	and	and	CCONJ
chd-120	123	15	literature	literature	NOUN
chd-120	123	16	search	search	NOUN
chd-120	123	17	.	.	PUNCT
chd-120	124	1	williams	williams	PROPN
chd-120	124	2	oo	oo	PROPN
chd-120	124	3	,	,	PUNCT
chd-120	124	4	performed	perform	VERB
chd-120	124	5	literature	literature	NOUN
chd-120	124	6	search	search	NOUN
chd-120	124	7	and	and	CCONJ
chd-120	124	8	data	datum	NOUN
chd-120	124	9	collation	collation	NOUN
chd-120	124	10	.	.	PUNCT
chd-120	125	1	obafunwa	obafunwa	PROPN
chd-120	125	2	jo	jo	PROPN
chd-120	125	3	was	be	AUX
chd-120	125	4	involved	involve	VERB
chd-120	125	5	in	in	ADP
chd-120	125	6	study	study	NOUN
chd-120	125	7	conceptualization	conceptualization	NOUN
chd-120	125	8	,	,	PUNCT
chd-120	125	9	data	datum	NOUN
chd-120	125	10	analysis	analysis	NOUN
chd-120	125	11	and	and	CCONJ
chd-120	125	12	editing	editing	NOUN
chd-120	125	13	of	of	ADP
chd-120	125	14	final	final	ADJ
chd-120	125	15	draft	draft	NOUN
chd-120	125	16	.	.	PUNCT
chd-120	126	1	references	reference	NOUN
chd-120	126	2	anunobi	anunobi	PROPN
chd-120	126	3	cc	cc	PROPN
chd-120	126	4	,	,	PUNCT
chd-120	126	5	akinde	akinde	VERB
chd-120	126	6	or	or	CCONJ
chd-120	126	7	,	,	PUNCT
chd-120	126	8	elesha	elesha	PROPN
chd-120	126	9	so	so	ADV
chd-120	126	10	,	,	PUNCT
chd-120	126	11	daramola	daramola	PROPN
chd-120	126	12	ao	ao	PROPN
chd-120	126	13	,	,	PUNCT
chd-120	126	14	tijani	tijani	PROPN
chd-120	126	15	kh	kh	PROPN
chd-120	126	16	,	,	PUNCT
chd-120	126	17	ojewola	ojewola	PROPN
chd-120	126	18	rw	rw	NOUN
chd-120	126	19	.	.	PUNCT
chd-120	127	1	(	(	PUNCT
chd-120	127	2	2011	2011	NUM
chd-120	127	3	)	)	PUNCT
chd-120	127	4	.	.	PUNCT
chd-120	128	1	prostate	prostate	NOUN
chd-120	128	2	diseases	disease	NOUN
chd-120	128	3	in	in	ADP
chd-120	128	4	lagos	lago	NOUN
chd-120	128	5	,	,	PUNCT
chd-120	128	6	nigeria	nigeria	PROPN
chd-120	128	7	:	:	PUNCT
chd-120	128	8	a	a	DET
chd-120	128	9	histologic	histologic	ADJ
chd-120	128	10	study	study	NOUN
chd-120	128	11	with	with	ADP
chd-120	128	12	tpsa	tpsa	NOUN
chd-120	128	13	correlation	correlation	NOUN
chd-120	128	14	.	.	PUNCT
chd-120	129	1	niger	niger	NOUN
chd-120	129	2	postgrad	postgrad	NOUN
chd-120	129	3	med	med	PROPN
chd-120	129	4	j	j	PROPN
chd-120	129	5	18	18	NUM
chd-120	129	6	,	,	PUNCT
chd-120	129	7	98	98	NUM
chd-120	129	8	-	-	SYM
chd-120	129	9	104	104	NUM
chd-120	129	10	.	.	PUNCT
chd-120	130	1	amin	amin	PROPN
chd-120	130	2	mb	mb	PROPN
chd-120	130	3	,	,	PUNCT
chd-120	130	4	boccon	boccon	NOUN
chd-120	130	5	-	-	PUNCT
chd-120	130	6	gibod	gibod	NOUN
chd-120	130	7	l	l	NOUN
chd-120	130	8	,	,	PUNCT
chd-120	130	9	egevad	egevad	NOUN
chd-120	130	10	l	l	PROPN
chd-120	130	11	,	,	PUNCT
chd-120	130	12	epstein	epstein	PROPN
chd-120	130	13	ji	ji	PROPN
chd-120	130	14	,	,	PUNCT
chd-120	130	15	humphrey	humphrey	PROPN
chd-120	130	16	pa	pa	PROPN
chd-120	130	17	,	,	PUNCT
chd-120	130	18	mikuz	mikuz	PROPN
chd-120	130	19	g	g	PROPN
chd-120	130	20	,	,	PUNCT
chd-120	130	21	newling	newle	VERB
chd-120	130	22	d	d	PROPN
chd-120	130	23	,	,	PUNCT
chd-120	130	24	nilsson	nilsson	PROPN
chd-120	130	25	s	s	PROPN
chd-120	130	26	,	,	PUNCT
chd-120	130	27	sakr	sakr	PROPN
chd-120	130	28	w	w	PROPN
chd-120	130	29	,	,	PUNCT
chd-120	130	30	srigley	srigley	PROPN
chd-120	130	31	jr	jr	PROPN
chd-120	130	32	,	,	PUNCT
chd-120	130	33	wheeler	wheeler	NOUN
chd-120	130	34	tm	tm	PROPN
chd-120	130	35	,	,	PUNCT
chd-120	130	36	montirono	montirono	PROPN
chd-120	130	37	r.	r.	PROPN
chd-120	130	38	(	(	PUNCT
chd-120	130	39	2005	2005	NUM
chd-120	130	40	)	)	PUNCT
chd-120	130	41	.	.	PUNCT
chd-120	131	1	prognostic	prognostic	ADJ
chd-120	131	2	and	and	CCONJ
chd-120	131	3	predictive	predictive	ADJ
chd-120	131	4	factors	factor	NOUN
chd-120	131	5	and	and	CCONJ
chd-120	131	6	reporting	reporting	NOUN
chd-120	131	7	of	of	ADP
chd-120	131	8	prostate	prostate	NOUN
chd-120	131	9	carcinoma	carcinoma	NOUN
chd-120	131	10	in	in	ADP
chd-120	131	11	prostate	prostate	NOUN
chd-120	131	12	needle	needle	NOUN
chd-120	131	13	biopsy	biopsy	NOUN
chd-120	131	14	specimens	specimens	PROPN
chd-120	131	15	.	.	PUNCT
chd-120	132	1	scand	scand	PROPN
chd-120	132	2	j	j	PROPN
chd-120	132	3	urol	urol	PROPN
chd-120	132	4	nephrol	nephrol	PROPN
chd-120	132	5	suppl	suppl	PROPN
chd-120	132	6	216	216	NUM
chd-120	132	7	,	,	PUNCT
chd-120	132	8	20–33	20–33	PROPN
chd-120	132	9	babb	babb	NOUN
chd-120	132	10	c	c	PROPN
chd-120	132	11	,	,	PUNCT
chd-120	132	12	urban	urban	PROPN
chd-120	132	13	m	m	PROPN
chd-120	132	14	,	,	PUNCT
chd-120	132	15	kielkowski	kielkowski	ADJ
chd-120	132	16	d	d	PROPN
chd-120	132	17	,	,	PUNCT
chd-120	132	18	kellett	kellett	PROPN
chd-120	132	19	p.	p.	PROPN
chd-120	132	20	prostate	prostate	NOUN
chd-120	132	21	cancer	cancer	NOUN
chd-120	132	22	in	in	ADP
chd-120	132	23	south	south	PROPN
chd-120	132	24	africa	africa	PROPN
chd-120	132	25	:	:	PUNCT
chd-120	132	26	pathology	pathology	PROPN
chd-120	132	27	based	base	VERB
chd-120	132	28	national	national	PROPN
chd-120	132	29	cancer	cancer	PROPN
chd-120	132	30	registry	registry	PROPN
chd-120	132	31	data	datum	NOUN
chd-120	132	32	(	(	PUNCT
chd-120	132	33	1986–2006	1986–2006	NUM
chd-120	132	34	)	)	PUNCT
chd-120	132	35	and	and	CCONJ
chd-120	132	36	mortality	mortality	NOUN
chd-120	132	37	rates	rate	NOUN
chd-120	132	38	(	(	PUNCT
chd-120	132	39	1997–2009	1997–2009	NUM
chd-120	132	40	)	)	PUNCT
chd-120	132	41	.	.	PUNCT
chd-120	133	1	prostate	prostate	NOUN
chd-120	133	2	cancer	cancer	NOUN
chd-120	133	3	.	.	PUNCT
chd-120	134	1	2014	2014	NUM
chd-120	134	2	419801	419801	NUM
chd-120	134	3	.	.	PUNCT
chd-120	135	1	http://doi.org/10.1155/2014/419801	http://doi.org/10.1155/2014/419801	PROPN
chd-120	135	2	.	.	PUNCT
chd-120	135	3	baade	baade	PROPN
chd-120	135	4	pd	pd	PROPN
chd-120	135	5	,	,	PUNCT
chd-120	135	6	youlden	youlden	PROPN
chd-120	135	7	dr	dr	PROPN
chd-120	135	8	,	,	PUNCT
chd-120	135	9	krnjacki	krnjacki	PROPN
chd-120	135	10	lj	lj	PROPN
chd-120	135	11	.	.	PUNCT
chd-120	135	12	(	(	PUNCT
chd-120	135	13	2009	2009	NUM
chd-120	135	14	)	)	PUNCT
chd-120	135	15	.	.	PUNCT
chd-120	136	1	international	international	ADJ
chd-120	136	2	epidemiology	epidemiology	NOUN
chd-120	136	3	of	of	ADP
chd-120	136	4	prostate	prostate	NOUN
chd-120	136	5	cancer	cancer	NOUN
chd-120	136	6	:	:	PUNCT
chd-120	136	7	geographical	geographical	ADJ
chd-120	136	8	distribution	distribution	NOUN
chd-120	136	9	and	and	CCONJ
chd-120	136	10	secular	secular	ADJ
chd-120	136	11	trends	trend	NOUN
chd-120	136	12	.	.	PUNCT
chd-120	137	1	mol	mol	ADP
chd-120	137	2	nutr	nutr	NOUN
chd-120	137	3	food	food	NOUN
chd-120	137	4	res	re	NOUN
chd-120	137	5	53	53	NUM
chd-120	137	6	,	,	PUNCT
chd-120	137	7	171–84	171–84	NOUN
chd-120	137	8	.	.	PUNCT
chd-120	138	1	baade	baade	PROPN
chd-120	138	2	pd	pd	PROPN
chd-120	138	3	,	,	PUNCT
chd-120	138	4	youlden	youlden	PROPN
chd-120	138	5	dr	dr	PROPN
chd-120	138	6	,	,	PUNCT
chd-120	138	7	cramb	cramb	PROPN
chd-120	138	8	sm	sm	PROPN
chd-120	138	9	,	,	PUNCT
chd-120	138	10	dunn	dunn	PROPN
chd-120	138	11	j	j	PROPN
chd-120	138	12	,	,	PUNCT
chd-120	138	13	gardiner	gardiner	PROPN
chd-120	138	14	ra	ra	PROPN
chd-120	138	15	.	.	PROPN
chd-120	139	1	(	(	PUNCT
chd-120	139	2	2013	2013	NUM
chd-120	139	3	)	)	PUNCT
chd-120	139	4	.	.	PUNCT
chd-120	140	1	epidemiology	epidemiology	NOUN
chd-120	140	2	of	of	ADP
chd-120	140	3	prostate	prostate	NOUN
chd-120	140	4	cancer	cancer	NOUN
chd-120	140	5	in	in	ADP
chd-120	140	6	the	the	DET
chd-120	140	7	asiapacific	asiapacific	ADJ
chd-120	140	8	region	region	NOUN
chd-120	140	9	.	.	PUNCT
chd-120	141	1	prostate	prostate	NOUN
chd-120	141	2	int	int	PROPN
chd-120	141	3	.	.	PUNCT
chd-120	142	1	1	1	NUM
chd-120	142	2	,	,	PUNCT
chd-120	142	3	47	47	NUM
chd-120	142	4	-	-	SYM
chd-120	142	5	58	58	NUM
chd-120	142	6	.	.	PUNCT
chd-120	143	1	bah	bah	VERB
chd-120	144	1	e	e	NOUN
chd-120	144	2	,	,	PUNCT
chd-120	144	3	parkin	parkin	ADJ
chd-120	144	4	dm	dm	PROPN
chd-120	144	5	,	,	PUNCT
chd-120	144	6	hall	hall	PROPN
chd-120	144	7	aj	aj	PROPN
chd-120	144	8	,	,	PUNCT
chd-120	144	9	jack	jack	PROPN
chd-120	144	10	ad	ad	NOUN
chd-120	144	11	,	,	PUNCT
chd-120	144	12	whittle	whittle	VERB
chd-120	144	13	h.	h.	PROPN
chd-120	144	14	cancer	cancer	NOUN
chd-120	144	15	in	in	ADP
chd-120	144	16	the	the	DET
chd-120	144	17	gambia	gambia	NOUN
chd-120	144	18	:	:	PUNCT
chd-120	144	19	1988–97	1988–97	X
chd-120	144	20	.	.	PUNCT
chd-120	145	1	(	(	PUNCT
chd-120	145	2	2001).br	2001).br	NUM
chd-120	145	3	j	j	NOUN
chd-120	145	4	cancer	cancer	NOUN
chd-120	145	5	84	84	NUM
chd-120	145	6	,	,	PUNCT
chd-120	145	7	1207–1214	1207–1214	NUM
chd-120	145	8	.	.	PUNCT
chd-120	146	1	elen	elen	PROPN
chd-120	146	2	b	b	PROPN
chd-120	146	3	,	,	PUNCT
chd-120	146	4	patil	patil	PROPN
chd-120	146	5	ps	ps	PROPN
chd-120	146	6	.	.	PUNCT
chd-120	146	7	(	(	PUNCT
chd-120	146	8	1991)pattern	1991)pattern	NUM
chd-120	146	9	of	of	ADP
chd-120	146	10	urological	urological	ADJ
chd-120	146	11	malignancy	malignancy	NOUN
chd-120	146	12	in	in	ADP
chd-120	146	13	zambia	zambia	PROPN
chd-120	146	14	:	:	PUNCT
chd-120	146	15	a	a	DET
chd-120	146	16	hospital	hospital	NOUN
chd-120	146	17	-	-	PUNCT
chd-120	146	18	based	base	VERB
chd-120	146	19	histopathological	histopathological	ADJ
chd-120	146	20	study	study	NOUN
chd-120	146	21	.	.	PUNCT
chd-120	147	1	br	br	PROPN
chd-120	148	1	j	j	PROPN
chd-120	148	2	urol	urol	PROPN
chd-120	148	3	67	67	NUM
chd-120	148	4	,	,	PUNCT
chd-120	148	5	37	37	NUM
chd-120	148	6	-	-	SYM
chd-120	148	7	39	39	NUM
chd-120	148	8	.	.	PUNCT
chd-120	149	1	ferlay	ferlay	PROPN
chd-120	149	2	j	j	PROPN
chd-120	149	3	,	,	PUNCT
chd-120	149	4	soerjomataram	soerjomataram	PROPN
chd-120	149	5	i	i	PROPN
chd-120	149	6	,	,	PUNCT
chd-120	149	7	dikshit	dikshit	PROPN
chd-120	149	8	r	r	PROPN
chd-120	149	9	,	,	PUNCT
chd-120	149	10	eser	eser	NOUN
chd-120	149	11	s	s	PROPN
chd-120	149	12	,	,	PUNCT
chd-120	149	13	mathers	mathers	PROPN
chd-120	149	14	c	c	PROPN
chd-120	149	15	,	,	PUNCT
chd-120	149	16	rebelo	rebelo	NOUN
chd-120	149	17	m	m	PRON
chd-120	149	18	,	,	PUNCT
chd-120	149	19	parkin	parkin	ADJ
chd-120	149	20	dm	dm	PROPN
chd-120	149	21	,	,	PUNCT
chd-120	149	22	forman	forman	NOUN
chd-120	149	23	d	d	PROPN
chd-120	149	24	,	,	PUNCT
chd-120	149	25	bray	bray	PROPN
chd-120	149	26	f.	f.	PROPN
chd-120	149	27	(	(	PUNCT
chd-120	149	28	2015	2015	NUM
chd-120	149	29	)	)	PUNCT
chd-120	149	30	.	.	PUNCT
chd-120	150	1	cancer	cancer	NOUN
chd-120	150	2	incidence	incidence	NOUN
chd-120	150	3	and	and	CCONJ
chd-120	150	4	mortality	mortality	NOUN
chd-120	150	5	worldwide	worldwide	ADV
chd-120	150	6	:	:	PUNCT
chd-120	150	7	sources	source	NOUN
chd-120	150	8	,	,	PUNCT
chd-120	150	9	methods	method	NOUN
chd-120	150	10	and	and	CCONJ
chd-120	150	11	major	major	ADJ
chd-120	150	12	patterns	pattern	NOUN
chd-120	150	13	in	in	ADP
chd-120	150	14	globocan	globocan	PROPN
chd-120	150	15	2012	2012	NUM
chd-120	150	16	.	.	PUNCT
chd-120	151	1	int	int	NOUN
chd-120	151	2	j	j	PROPN
chd-120	151	3	cancer	cancer	NOUN
chd-120	151	4	136	136	NUM
chd-120	151	5	,	,	PUNCT
chd-120	151	6	359–86	359–86	NUM
chd-120	151	7	.	.	PUNCT
chd-120	152	1	gleason	gleason	PROPN
chd-120	152	2	df	df	PROPN
chd-120	152	3	(	(	PUNCT
chd-120	152	4	1966	1966	NUM
chd-120	152	5	)	)	PUNCT
chd-120	152	6	.	.	PUNCT
chd-120	153	1	classification	classification	NOUN
chd-120	153	2	of	of	ADP
chd-120	153	3	prostatic	prostatic	ADJ
chd-120	153	4	carcinomas	carcinoma	NOUN
chd-120	153	5	.	.	PUNCT
chd-120	154	1	cancer	cancer	NOUN
chd-120	154	2	chemother	chemother	PROPN
chd-120	154	3	rep	rep	PROPN
chd-120	154	4	.	.	PROPN
chd-120	154	5	50	50	NUM
chd-120	154	6	,	,	PUNCT
chd-120	154	7	125	125	NUM
chd-120	154	8	-	-	SYM
chd-120	154	9	128	128	NUM
chd-120	154	10	.	.	PUNCT
chd-120	155	1	gueye	gueye	PROPN
chd-120	155	2	sm	sm	PROPN
chd-120	155	3	,	,	PUNCT
chd-120	155	4	zeigler	zeigler	PROPN
chd-120	155	5	-	-	PUNCT
chd-120	155	6	johnson	johnson	PROPN
chd-120	155	7	cm	cm	PROPN
chd-120	155	8	,	,	PUNCT
chd-120	155	9	friebel	friebel	PROPN
chd-120	155	10	t	t	PROPN
chd-120	155	11	,	,	PUNCT
chd-120	155	12	spangler	spangler	NOUN
chd-120	155	13	e	e	PROPN
chd-120	155	14	,	,	PUNCT
chd-120	155	15	jalloh	jalloh	PROPN
chd-120	155	16	m	m	PROPN
chd-120	155	17	,	,	PUNCT
chd-120	155	18	macbride	macbride	PROPN
chd-120	155	19	s	s	PROPN
chd-120	155	20	,	,	PUNCT
chd-120	155	21	malkowicz	malkowicz	PROPN
chd-120	155	22	sb	sb	PROPN
chd-120	155	23	,	,	PUNCT
chd-120	155	24	rebbeck	rebbeck	PROPN
chd-120	155	25	tr	tr	VERB
chd-120	155	26	.	.	PUNCT
chd-120	155	27	(	(	PUNCT
chd-120	155	28	2003	2003	NUM
chd-120	155	29	)	)	PUNCT
chd-120	155	30	clinical	clinical	ADJ
chd-120	155	31	characteristics	characteristic	NOUN
chd-120	155	32	of	of	ADP
chd-120	155	33	prostate	prostate	NOUN
chd-120	155	34	cancer	cancer	NOUN
chd-120	155	35	in	in	ADP
chd-120	155	36	african	african	ADJ
chd-120	155	37	americans	americans	PROPN
chd-120	155	38	,	,	PUNCT
chd-120	155	39	american	american	ADJ
chd-120	155	40	whites	white	NOUN
chd-120	155	41	,	,	PUNCT
chd-120	155	42	and	and	CCONJ
chd-120	155	43	senegalese	senegalese	ADJ
chd-120	155	44	men	man	NOUN
chd-120	155	45	.	.	PUNCT
chd-120	156	1	urology	urology	NOUN
chd-120	156	2	61	61	NUM
chd-120	156	3	,	,	PUNCT
chd-120	156	4	987992	987992	NUM
chd-120	156	5	.	.	PUNCT
chd-120	157	1	haas	haas	PROPN
chd-120	157	2	gp	gp	PROPN
chd-120	157	3	,	,	PUNCT
chd-120	157	4	delongchamps	delongchamp	NOUN
chd-120	157	5	n	n	CCONJ
chd-120	157	6	,	,	PUNCT
chd-120	157	7	brawley	brawley	PROPN
chd-120	157	8	ow	ow	PROPN
chd-120	157	9	,	,	PUNCT
chd-120	157	10	wang	wang	PROPN
chd-120	157	11	cy	cy	PROPN
chd-120	157	12	,	,	PUNCT
chd-120	157	13	de	de	PROPN
chd-120	157	14	la	la	PROPN
chd-120	157	15	roza	roza	PROPN
chd-120	157	16	g.	g.	PROPN
chd-120	157	17	(	(	PUNCT
chd-120	157	18	2008	2008	NUM
chd-120	157	19	)	)	PUNCT
chd-120	157	20	.	.	PUNCT
chd-120	158	1	the	the	DET
chd-120	158	2	worldwide	worldwide	ADJ
chd-120	158	3	epidemiology	epidemiology	NOUN
chd-120	158	4	of	of	ADP
chd-120	158	5	prostate	prostate	NOUN
chd-120	158	6	cancer	cancer	NOUN
chd-120	158	7	:	:	PUNCT
chd-120	158	8	perspectives	perspective	NOUN
chd-120	158	9	from	from	ADP
chd-120	158	10	autopsy	autopsy	ADJ
chd-120	158	11	studies	study	NOUN
chd-120	158	12	.	.	PUNCT
chd-120	159	1	can	can	AUX
chd-120	159	2	j	j	PROPN
chd-120	159	3	urol	urol	PROPN
chd-120	159	4	.	.	PROPN
chd-120	160	1	15	15	NUM
chd-120	160	2	,	,	PUNCT
chd-120	160	3	3866–3871	3866–3871	NUM
chd-120	160	4	.	.	PUNCT
chd-120	161	1	herget	herget	PROPN
chd-120	161	2	ka	ka	PROPN
chd-120	161	3	,	,	PUNCT
chd-120	161	4	patel	patel	PROPN
chd-120	161	5	dp	dp	PROPN
chd-120	161	6	,	,	PUNCT
chd-120	161	7	hanson	hanson	PROPN
chd-120	161	8	ha	ha	PROPN
chd-120	161	9	,	,	PUNCT
chd-120	161	10	sweeney	sweeney	PROPN
chd-120	161	11	c	c	PROPN
chd-120	161	12	,	,	PUNCT
chd-120	161	13	lowrance	lowrance	PROPN
chd-120	161	14	wt	wt	PROPN
chd-120	161	15	.	.	PUNCT
chd-120	161	16	(	(	PUNCT
chd-120	161	17	2016	2016	NUM
chd-120	161	18	)	)	PUNCT
chd-120	161	19	.	.	PUNCT
chd-120	162	1	recent	recent	ADJ
chd-120	162	2	decline	decline	NOUN
chd-120	162	3	in	in	ADP
chd-120	162	4	prostate	prostate	NOUN
chd-120	162	5	cancer	cancer	NOUN
chd-120	162	6	incidence	incidence	NOUN
chd-120	162	7	in	in	ADP
chd-120	162	8	the	the	DET
chd-120	162	9	united	united	PROPN
chd-120	162	10	states	states	PROPN
chd-120	162	11	,	,	PUNCT
chd-120	162	12	by	by	ADP
chd-120	162	13	age	age	NOUN
chd-120	162	14	,	,	PUNCT
chd-120	162	15	stage	stage	NOUN
chd-120	162	16	,	,	PUNCT
chd-120	162	17	and	and	CCONJ
chd-120	162	18	gleason	gleason	PROPN
chd-120	162	19	score	score	PROPN
chd-120	162	20	.	.	PUNCT
chd-120	163	1	cancer	cancer	NOUN
chd-120	163	2	med	me	VERB
chd-120	163	3	5	5	NUM
chd-120	163	4	,	,	PUNCT
chd-120	163	5	136	136	NUM
chd-120	163	6	-	-	SYM
chd-120	163	7	141	141	NUM
chd-120	163	8	.	.	PUNCT
chd-120	164	1	magoha	magoha	PROPN
chd-120	164	2	ga	ga	PROPN
chd-120	164	3	.	.	PROPN
chd-120	164	4	(	(	PUNCT
chd-120	164	5	2007	2007	NUM
chd-120	164	6	)	)	PUNCT
chd-120	164	7	.	.	PUNCT
chd-120	165	1	overview	overview	NOUN
chd-120	165	2	of	of	ADP
chd-120	165	3	prostate	prostate	NOUN
chd-120	165	4	cancer	cancer	NOUN
chd-120	165	5	in	in	ADP
chd-120	165	6	indigenous	indigenous	ADJ
chd-120	165	7	black	black	ADJ
chd-120	165	8	africans	africans	PROPN
chd-120	165	9	and	and	CCONJ
chd-120	165	10	blacks	black	NOUN
chd-120	165	11	of	of	ADP
chd-120	165	12	african	african	ADJ
chd-120	165	13	ancestry	ancestry	NOUN
chd-120	165	14	in	in	ADP
chd-120	165	15	diaspora	diaspora	PROPN
chd-120	165	16	1935	1935	NUM
chd-120	165	17	-	-	SYM
chd-120	165	18	2007	2007	NUM
chd-120	165	19	.	.	PUNCT
chd-120	166	1	east	east	PROPN
chd-120	166	2	afr	afr	PROPN
chd-120	166	3	med	med	PROPN
chd-120	166	4	j	j	PROPN
chd-120	166	5	8	8	NUM
chd-120	166	6	,	,	PUNCT
chd-120	166	7	3	3	NUM
chd-120	166	8	-	-	SYM
chd-120	166	9	11	11	NUM
chd-120	166	10	.	.	PUNCT
chd-120	167	1	mohammed	mohammed	PROPN
chd-120	167	2	az	az	PROPN
chd-120	167	3	,	,	PUNCT
chd-120	167	4	alhassan	alhassan	PROPN
chd-120	167	5	su	su	PROPN
chd-120	167	6	,	,	PUNCT
chd-120	167	7	edino	edino	PROPN
chd-120	167	8	st	st	PROPN
chd-120	167	9	,	,	PUNCT
chd-120	167	10	chicha	chicha	ADJ
chd-120	167	11	o.	o.	NOUN
chd-120	167	12	(	(	PUNCT
chd-120	167	13	2003	2003	NUM
chd-120	167	14	)	)	PUNCT
chd-120	167	15	histopathological	histopathological	ADJ
chd-120	167	16	review	review	NOUN
chd-120	167	17	of	of	ADP
chd-120	167	18	prostatic	prostatic	ADJ
chd-120	167	19	diseases	disease	NOUN
chd-120	167	20	in	in	ADP
chd-120	167	21	kano	kano	PROPN
chd-120	167	22	,	,	PUNCT
chd-120	167	23	nigeria	nigeria	PROPN
chd-120	167	24	.	.	PUNCT
chd-120	168	1	niger	niger	PROPN
chd-120	168	2	post	post	PROPN
chd-120	168	3	grad	grad	PROPN
chd-120	168	4	med	med	PROPN
chd-120	168	5	j	j	PROPN
chd-120	168	6	10	10	NUM
chd-120	168	7	,	,	PUNCT
chd-120	168	8	1	1	NUM
chd-120	168	9	-	-	SYM
chd-120	168	10	5	5	NUM
chd-120	168	11	.	.	PUNCT
chd-120	168	12	murphy	murphy	PROPN
chd-120	168	13	gp	gp	PROPN
chd-120	168	14	,	,	PUNCT
chd-120	168	15	busch	busch	PROPN
chd-120	168	16	c	c	PROPN
chd-120	168	17	,	,	PUNCT
chd-120	168	18	abrahamsson	abrahamsson	PROPN
chd-120	168	19	pa	pa	PROPN
chd-120	168	20	,	,	PUNCT
chd-120	168	21	epstein	epstein	PROPN
chd-120	168	22	ji	ji	PROPN
chd-120	168	23	,	,	PUNCT
chd-120	168	24	mcneal	mcneal	PROPN
chd-120	168	25	je	je	PROPN
chd-120	168	26	,	,	PUNCT
chd-120	168	27	miller	miller	PROPN
chd-120	168	28	gj	gj	PROPN
chd-120	168	29	.	.	PUNCT
chd-120	168	30	(	(	PUNCT
chd-120	168	31	1994	1994	NUM
chd-120	168	32	)	)	PUNCT
chd-120	168	33	.	.	PUNCT
chd-120	169	1	histopathology	histopathology	NOUN
chd-120	169	2	of	of	ADP
chd-120	169	3	localized	localized	ADJ
chd-120	169	4	prostate	prostate	NOUN
chd-120	169	5	cancer	cancer	NOUN
chd-120	169	6	.	.	PUNCT
chd-120	170	1	consensus	consensus	NOUN
chd-120	170	2	conference	conference	NOUN
chd-120	170	3	on	on	ADP
chd-120	170	4	diagnosis	diagnosis	NOUN
chd-120	170	5	and	and	CCONJ
chd-120	170	6	prognostic	prognostic	ADJ
chd-120	170	7	parameters	parameter	NOUN
chd-120	170	8	in	in	ADP
chd-120	170	9	localized	localized	ADJ
chd-120	170	10	prostate	prostate	NOUN
chd-120	170	11	cancer	cancer	NOUN
chd-120	170	12	.	.	PUNCT
chd-120	171	1	stockholm	stockholm	PROPN
chd-120	171	2	,	,	PUNCT
chd-120	171	3	sweden	sweden	PROPN
chd-120	171	4	,	,	PUNCT
chd-120	171	5	may	may	AUX
chd-120	171	6	12	12	NUM
chd-120	171	7	-	-	SYM
chd-120	171	8	13	13	NUM
chd-120	171	9	,	,	PUNCT
chd-120	171	10	1993	1993	NUM
chd-120	171	11	.	.	PUNCT
chd-120	172	1	scand	scand	PROPN
chd-120	172	2	j	j	PROPN
chd-120	172	3	urol	urol	PROPN
chd-120	172	4	nephrol	nephrol	PROPN
chd-120	172	5	suppl	suppl	PROPN
chd-120	172	6	162	162	NUM
chd-120	172	7	,	,	PUNCT
chd-120	172	8	7	7	NUM
chd-120	172	9	-	-	SYM
chd-120	172	10	42	42	NUM
chd-120	172	11	.	.	PUNCT
chd-120	173	1	odedina	odedina	PROPN
chd-120	173	2	ft	ft	PROPN
chd-120	173	3	,	,	PUNCT
chd-120	173	4	akinremi	akinremi	ADV
chd-120	173	5	to	to	ADP
chd-120	173	6	,	,	PUNCT
chd-120	173	7	chinegwundoh	chinegwundoh	PROPN
chd-120	173	8	f	f	PROPN
chd-120	173	9	,	,	PUNCT
chd-120	173	10	roberts	roberts	PROPN
chd-120	173	11	r	r	PROPN
chd-120	173	12	,	,	PUNCT
chd-120	173	13	yu	yu	PROPN
chd-120	173	14	d	d	PROPN
chd-120	173	15	,	,	PUNCT
chd-120	173	16	reams	ream	VERB
chd-120	173	17	r	r	NOUN
chd-120	173	18	,	,	PUNCT
chd-120	173	19	freedman	freedman	PROPN
chd-120	173	20	ml	ml	NOUN
chd-120	173	21	,	,	PUNCT
chd-120	173	22	rivers	river	NOUN
chd-120	173	23	b	b	PROPN
chd-120	173	24	,	,	PUNCT
chd-120	173	25	green	green	PROPN
chd-120	173	26	bl	bl	PROPN
chd-120	173	27	,	,	PUNCT
chd-120	173	28	kumar	kumar	PROPN
chd-120	173	29	n.	n.	PROPN
chd-120	173	30	(	(	PUNCT
chd-120	173	31	2009	2009	NUM
chd-120	173	32	)	)	PUNCT
chd-120	173	33	.	.	PUNCT
chd-120	174	1	prostate	prostate	NOUN
chd-120	174	2	cancer	cancer	NOUN
chd-120	174	3	disparities	disparity	NOUN
chd-120	174	4	in	in	ADP
chd-120	174	5	black	black	ADJ
chd-120	174	6	men	man	NOUN
chd-120	174	7	of	of	ADP
chd-120	174	8	african	african	ADJ
chd-120	174	9	descent	descent	NOUN
chd-120	174	10	:	:	PUNCT
chd-120	174	11	a	a	DET
chd-120	174	12	comparative	comparative	ADJ
chd-120	174	13	literature	literature	NOUN
chd-120	174	14	review	review	NOUN
chd-120	174	15	of	of	ADP
chd-120	174	16	prostate	prostate	NOUN
chd-120	174	17	cancer	cancer	NOUN
chd-120	174	18	burden	burden	NOUN
chd-120	174	19	among	among	ADP
chd-120	174	20	black	black	ADJ
chd-120	174	21	men	man	NOUN
chd-120	174	22	in	in	ADP
chd-120	174	23	the	the	DET
chd-120	174	24	united	united	PROPN
chd-120	174	25	states	states	PROPN
chd-120	174	26	,	,	PUNCT
chd-120	174	27	carribean	carribean	PROPN
chd-120	174	28	,	,	PUNCT
chd-120	174	29	united	united	ADJ
chd-120	174	30	kingdom	kingdom	PROPN
chd-120	174	31	,	,	PUNCT
chd-120	174	32	and	and	CCONJ
chd-120	174	33	west	west	PROPN
chd-120	174	34	africa	africa	PROPN
chd-120	174	35	.	.	PUNCT
chd-120	175	1	infect	infect	VERB
chd-120	175	2	agent	agent	NOUN
chd-120	175	3	cancer	cancer	NOUN
chd-120	175	4	4	4	NUM
chd-120	175	5	(	(	PUNCT
chd-120	175	6	suppl	suppl	PROPN
chd-120	175	7	.	.	PROPN
chd-120	175	8	):	):	PUNCT
chd-120	175	9	s2	s2	PROPN
chd-120	175	10	.	.	PROPN
chd-120	175	11	ogunbiyi	ogunbiyi	PROPN
chd-120	175	12	jo	jo	PROPN
chd-120	175	13	,	,	PUNCT
chd-120	175	14	shittu	shittu	VERB
chd-120	175	15	ob	ob	NOUN
chd-120	175	16	.	.	PUNCT
chd-120	175	17	(	(	PUNCT
chd-120	175	18	1999	1999	NUM
chd-120	175	19	)	)	PUNCT
chd-120	175	20	.	.	PUNCT
chd-120	176	1	increased	increase	VERB
chd-120	176	2	incidence	incidence	NOUN
chd-120	176	3	of	of	ADP
chd-120	176	4	prostate	prostate	NOUN
chd-120	176	5	cancer	cancer	NOUN
chd-120	176	6	in	in	ADP
chd-120	176	7	nigerians	nigerians	PROPN
chd-120	176	8	.	.	PUNCT
chd-120	177	1	j	j	PROPN
chd-120	177	2	natl	natl	PROPN
chd-120	177	3	med	med	PROPN
chd-120	177	4	assoc	assoc	PROPN
chd-120	177	5	91	91	NUM
chd-120	177	6	,	,	PUNCT
chd-120	177	7	159164	159164	NUM
chd-120	177	8	.	.	PUNCT
chd-120	178	1	okolo	okolo	PROPN
chd-120	178	2	ca	can	AUX
chd-120	178	3	,	,	PUNCT
chd-120	178	4	akinosun	akinosun	NOUN
chd-120	178	5	om	om	PROPN
chd-120	178	6	,	,	PUNCT
chd-120	178	7	shittu	shittu	ADJ
chd-120	178	8	ob	ob	ADJ
chd-120	178	9	,	,	PUNCT
chd-120	178	10	olapade	olapade	NOUN
chd-120	178	11	-	-	PUNCT
chd-120	178	12	olaopa	olaopa	ADV
chd-120	178	13	eo	eo	NOUN
chd-120	178	14	,	,	PUNCT
chd-120	178	15	okeke	okeke	ADJ
chd-120	178	16	li	li	PROPN
chd-120	178	17	,	,	PUNCT
chd-120	178	18	akang	akang	PROPN
chd-120	178	19	ee	ee	PROPN
chd-120	178	20	,	,	PUNCT
chd-120	178	21	ogunbiyi	ogunbiyi	PROPN
chd-120	178	22	jo	jo	PROPN
chd-120	178	23	.	.	PUNCT
chd-120	179	1	(	(	PUNCT
chd-120	179	2	2008	2008	NUM
chd-120	179	3	)	)	PUNCT
chd-120	179	4	.	.	PUNCT
chd-120	180	1	correlation	correlation	NOUN
chd-120	180	2	of	of	ADP
chd-120	180	3	serum	serum	NOUN
chd-120	180	4	psa	psa	NOUN
chd-120	180	5	and	and	CCONJ
chd-120	180	6	gleason	gleason	PROPN
chd-120	180	7	score	score	NOUN
chd-120	180	8	in	in	ADP
chd-120	180	9	nigerian	nigerian	ADJ
chd-120	180	10	men	man	NOUN
chd-120	180	11	with	with	ADP
chd-120	180	12	prostate	prostate	NOUN
chd-120	180	13	cancer	cancer	NOUN
chd-120	180	14	afr	afr	PROPN
chd-120	180	15	j	j	PROPN
chd-120	180	16	urol	urol	PROPN
chd-120	180	17	14	14	NUM
chd-120	180	18	,	,	PUNCT
chd-120	180	19	15	15	NUM
chd-120	180	20	-	-	SYM
chd-120	180	21	22	22	NUM
chd-120	180	22	.	.	PUNCT
chd-120	181	1	oluwole	oluwole	NOUN
chd-120	181	2	op	op	NOUN
chd-120	181	3	,	,	PUNCT
chd-120	181	4	rafindadi	rafindadi	PROPN
chd-120	181	5	ah	ah	INTJ
chd-120	181	6	,	,	PUNCT
chd-120	181	7	shehu	shehu	PROPN
chd-120	181	8	ms	ms	PROPN
chd-120	181	9	,	,	PUNCT
chd-120	181	10	samaila	samaila	PROPN
chd-120	181	11	moa	moa	PROPN
chd-120	181	12	.	.	PUNCT
chd-120	182	1	(	(	PUNCT
chd-120	182	2	2015	2015	NUM
chd-120	182	3	)	)	PUNCT
chd-120	182	4	.	.	PUNCT
chd-120	183	1	a	a	DET
chd-120	183	2	ten	ten	NUM
chd-120	183	3	-	-	PUNCT
chd-120	183	4	year	year	NOUN
chd-120	183	5	study	study	NOUN
chd-120	183	6	of	of	ADP
chd-120	183	7	prostate	prostate	NOUN
chd-120	183	8	cancer	cancer	NOUN
chd-120	183	9	specimens	specimen	NOUN
chd-120	183	10	at	at	ADP
chd-120	183	11	ahmadu	ahmadu	NOUN
chd-120	183	12	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	NUM
chd-120	183	13	e9	e9	PROPN
chd-120	183	14	cancer	cancer	NOUN
chd-120	183	15	health	health	NOUN
chd-120	183	16	disparities	disparity	NOUN
chd-120	183	17	research	research	NOUN
chd-120	183	18	bello	bello	PROPN
chd-120	183	19	university	university	PROPN
chd-120	183	20	teaching	teaching	NOUN
chd-120	183	21	hospital	hospital	NOUN
chd-120	183	22	(	(	PUNCT
chd-120	183	23	a.b.u.t.h	a.b.u.t.h	NOUN
chd-120	183	24	)	)	PUNCT
chd-120	183	25	,	,	PUNCT
chd-120	183	26	zaria	zaria	PROPN
chd-120	183	27	,	,	PUNCT
chd-120	183	28	nigeria	nigeria	PROPN
chd-120	183	29	.	.	PUNCT
chd-120	184	1	afr	afr	PROPN
chd-120	184	2	j	j	PROPN
chd-120	184	3	urol	urol	PROPN
chd-120	184	4	21	21	NUM
chd-120	184	5	,	,	PUNCT
chd-120	184	6	5	5	NUM
chd-120	184	7	-	-	SYM
chd-120	184	8	18	18	NUM
chd-120	184	9	.	.	PUNCT
chd-120	185	1	seyed	seyed	PROPN
chd-120	185	2	mk	mk	PROPN
chd-120	185	3	,	,	PUNCT
chd-120	185	4	shahrokh	shahrokh	VERB
chd-120	185	5	fs	fs	PROPN
chd-120	185	6	,	,	PUNCT
chd-120	185	7	yair	yair	PROPN
chd-120	185	8	l	l	PROPN
chd-120	185	9	,	,	PUNCT
chd-120	185	10	hossein	hossein	PROPN
chd-120	185	11	s	s	PROPN
chd-120	185	12	,	,	PUNCT
chd-120	185	13	john	john	PROPN
chd-120	185	14	dm	dm	PROPN
chd-120	185	15	,	,	PUNCT
chd-120	185	16	arthur	arthur	PROPN
chd-120	185	17	is	be	AUX
chd-120	185	18	,	,	PUNCT
chd-120	185	19	claus	claus	PROPN
chd-120	185	20	gr	gr	PROPN
chd-120	185	21	,	,	PUNCT
chd-120	185	22	kenneth	kenneth	PROPN
chd-120	185	23	sk	sk	PROPN
chd-120	185	24	.	.	PUNCT
chd-120	186	1	(	(	PUNCT
chd-120	186	2	2004	2004	NUM
chd-120	186	3	)	)	PUNCT
chd-120	186	4	.	.	PUNCT
chd-120	187	1	predictive	predictive	ADJ
chd-120	187	2	value	value	NOUN
chd-120	187	3	of	of	ADP
chd-120	187	4	primary	primary	ADJ
chd-120	187	5	gleason	gleason	PROPN
chd-120	187	6	pattern	pattern	NOUN
chd-120	187	7	4	4	NUM
chd-120	187	8	in	in	ADP
chd-120	187	9	patients	patient	NOUN
chd-120	187	10	with	with	ADP
chd-120	187	11	gleason	gleason	PROPN
chd-120	187	12	score	score	NOUN
chd-120	187	13	7	7	NUM
chd-120	187	14	tumours	tumour	NOUN
chd-120	187	15	treated	treat	VERB
chd-120	187	16	with	with	ADP
chd-120	187	17	radical	radical	ADJ
chd-120	187	18	prostatectomy	prostatectomy	NOUN
chd-120	187	19	.	.	PUNCT
chd-120	188	1	bju	bju	NOUN
chd-120	188	2	94	94	NUM
chd-120	188	3	,	,	PUNCT
chd-120	188	4	426	426	NUM
chd-120	188	5	.	.	PUNCT
chd-120	189	1	tanaka	tanaka	PROPN
chd-120	189	2	n	n	PROPN
chd-120	189	3	,	,	PUNCT
chd-120	189	4	shimada	shimada	PROPN
chd-120	189	5	k	k	PROPN
chd-120	189	6	,	,	PUNCT
chd-120	189	7	fujimoto	fujimoto	PROPN
chd-120	189	8	k.	k.	PROPN
chd-120	189	9	(	(	PUNCT
chd-120	189	10	2015	2015	NUM
chd-120	189	11	)	)	PUNCT
chd-120	189	12	.	.	PUNCT
chd-120	190	1	the	the	DET
chd-120	190	2	optimal	optimal	ADJ
chd-120	190	3	number	number	NOUN
chd-120	190	4	of	of	ADP
chd-120	190	5	initial	initial	ADJ
chd-120	190	6	prostate	prostate	NOUN
chd-120	190	7	biopsy	biopsy	NOUN
chd-120	190	8	cores	core	NOUN
chd-120	190	9	in	in	ADP
chd-120	190	10	daily	daily	ADJ
chd-120	190	11	practice	practice	NOUN
chd-120	190	12	:	:	PUNCT
chd-120	190	13	a	a	DET
chd-120	190	14	prospective	prospective	ADJ
chd-120	190	15	study	study	NOUN
chd-120	190	16	using	use	VERB
chd-120	190	17	the	the	DET
chd-120	190	18	nara	nara	PROPN
chd-120	190	19	urological	urological	PROPN
chd-120	190	20	research	research	PROPN
chd-120	190	21	and	and	CCONJ
chd-120	190	22	treatment	treatment	NOUN
chd-120	190	23	group	group	NOUN
chd-120	190	24	normogram	normogram	PROPN
chd-120	190	25	.	.	PUNCT
chd-120	191	1	bmc	bmc	PROPN
chd-120	191	2	res	re	NOUN
chd-120	191	3	notes	note	NOUN
chd-120	191	4	8	8	NUM
chd-120	191	5	,	,	PUNCT
chd-120	191	6	689	689	NUM
chd-120	191	7	.	.	PUNCT
chd-120	192	1	tumours	tumour	NOUN
chd-120	192	2	of	of	ADP
chd-120	192	3	the	the	DET
chd-120	192	4	prostate	prostate	NOUN
chd-120	192	5	.	.	PUNCT
chd-120	193	1	in	in	ADP
chd-120	193	2	:	:	PUNCT
chd-120	193	3	eble	eble	ADJ
chd-120	193	4	j.n	j.n	PROPN
chd-120	193	5	.	.	PROPN
chd-120	193	6	,	,	PUNCT
chd-120	193	7	sauter	sauter	PROPN
chd-120	193	8	g.	g.	PROPN
chd-120	193	9	,	,	PUNCT
chd-120	193	10	epstein	epstein	PROPN
chd-120	193	11	j.i	j.i	PROPN
chd-120	193	12	.	.	PROPN
chd-120	193	13	,	,	PUNCT
chd-120	193	14	sesterhenn	sesterhenn	PROPN
chd-120	193	15	i.a	i.a	PROPN
chd-120	193	16	.	.	PROPN
chd-120	193	17	(	(	PUNCT
chd-120	193	18	eds	ed	NOUN
chd-120	193	19	.	.	PUNCT
chd-120	193	20	)	)	PUNCT
chd-120	193	21	(	(	PUNCT
chd-120	193	22	2004	2004	NUM
chd-120	193	23	):	):	PUNCT
chd-120	193	24	world	world	NOUN
chd-120	193	25	health	health	NOUN
chd-120	193	26	organization	organization	NOUN
chd-120	193	27	classification	classification	NOUN
chd-120	193	28	of	of	ADP
chd-120	193	29	tumours	tumours	PROPN
chd-120	193	30	.	.	PUNCT
chd-120	194	1	pathology	pathology	NOUN
chd-120	194	2	and	and	CCONJ
chd-120	194	3	genetics	genetic	NOUN
chd-120	194	4	of	of	ADP
chd-120	194	5	tumours	tumour	NOUN
chd-120	194	6	of	of	ADP
chd-120	194	7	the	the	DET
chd-120	194	8	urinary	urinary	ADJ
chd-120	194	9	system	system	NOUN
chd-120	194	10	and	and	CCONJ
chd-120	194	11	male	male	ADJ
chd-120	194	12	genital	genital	ADJ
chd-120	194	13	organs	organ	NOUN
chd-120	194	14	.	.	PUNCT
chd-120	195	1	iarc	iarc	PROPN
chd-120	195	2	press	press	PROPN
chd-120	195	3	:	:	PUNCT
chd-120	195	4	lyon	lyon	PROPN
chd-120	195	5	.	.	PUNCT
chd-120	196	1	p.	p.	NOUN
chd-120	196	2	158	158	NUM
chd-120	197	1	-	-	SYM
chd-120	197	2	214	214	NUM
chd-120	197	3	.	.	PUNCT